data_2m0v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HB2' HD23 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.604 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 167' ' ' ASN . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.672 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.765 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.451 ' HB2' HG11 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.548 ' HB2' HD13 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 ' HE3' ' A' ' 207' ' ' MET . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.609 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 2.9 t-20 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.643 ' SD ' HG11 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.643 HG11 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.439 ' HA3' ' ND2' ' A' ' 203' ' ' ASN . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.609 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.52 ' HB3' HD13 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.528 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.58 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.517 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.421 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo . . . . . 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.42 0.629 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.436 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.5 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.52 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.768 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.805 0.114 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.411 ' HG2' HG22 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.768 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.432 ' HB2' HG13 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.527 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.679 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 247' ' ' SER . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 207' ' ' MET . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.473 HG11 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.563 HG21 HD11 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.436 HG22 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.489 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.663 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.587 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.663 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.546 ' HB2' HG21 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.679 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.511 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.412 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.149 0.5 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.513 ' HG2' HD23 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 159' ' ' LYS . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.875 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.522 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.415 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.74 ' HG3' HG13 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.487 HG13 HD12 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.875 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.487 HD12 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.611 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.611 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.412 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.517 HG12 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 202' ' ' VAL . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.505 ' O ' HG23 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.74 HG13 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG1' HG12 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.412 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.48 ' CD ' ' HZ1' ' A' ' 240' ' ' LYS . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.669 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.48 ' HZ1' ' CD ' ' A' ' 237' ' ' GLU . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.513 HD23 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 244' ' ' VAL . 73.7 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 121.284 0.564 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.531 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.586 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.586 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.839 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.789 0.105 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.731 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.548 HD11 HD12 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.839 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.554 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.548 HD12 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.674 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.514 HG21 HD12 ' B' ' 5' ' ' LEU . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.669 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.531 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.42 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.68 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.622 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 244' ' ' VAL . 73.1 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.454 ' HB3' HG21 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.78 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.508 ' HG2' HG21 ' A' ' 215' ' ' VAL . 1.4 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.419 HD13 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.78 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.695 ' SD ' HG11 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.642 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.642 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.695 HG11 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.624 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.406 ' CB ' HG22 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.806 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.806 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.531 HG12 ' CG ' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.546 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.531 ' CG ' HG12 ' A' ' 244' ' ' VAL . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.409 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HB3' HG11 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.871 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.58 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.661 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.793 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.793 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.478 ' HB2' HG13 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.474 ' OG ' ' HE2' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.537 ' HB2' HD13 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.493 HG13 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 201' ' ' GLU . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 207' ' ' MET . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.473 ' O ' HG21 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.46 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.562 HG22 HD11 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.871 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.703 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.498 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.703 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.634 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo . . . . . 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.58 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.285 0.565 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.698 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' HG13 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.787 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.922 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.738 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.627 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.922 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.541 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.514 HD11 HD12 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.554 HG23 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.457 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.522 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.457 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.753 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.753 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.458 ' HB2' HG13 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.516 ' HG2' HG12 ' A' ' 244' ' ' VAL . 24.5 Cg_exo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.738 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.502 0.667 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.549 HD22 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.451 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.947 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.947 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.557 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.436 ' OG ' ' HE2' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.533 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.756 ' HB ' ' HE2' ' A' ' 207' ' ' MET . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.638 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.756 ' HE2' ' HB ' ' A' ' 202' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.665 HG11 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 HG12 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.611 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.451 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HE3' HD22 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.465 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.564 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.517 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.532 ' HB2' HG11 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.59 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 256' ' ' PRO . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 244' ' ' VAL . 58.3 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.428 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 2.2 m-20 . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.412 HD11 HG22 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.406 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.27 0.081 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.544 ' HG2' HD22 ' A' ' 255' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.486 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.498 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.498 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 44.3 t-80 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 112.764 -0.135 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.649 HE21 ' N ' ' A' ' 177' ' ' GLN . 0.0 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.707 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.419 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 15.4 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.885 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.45 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.885 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.51 ' CG1' HG13 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.43 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 240' ' ' LYS . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 237' ' ' GLU . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.431 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.544 HD22 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.25 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.642 ' HG ' HG22 ' A' ' 235' ' ' THR . 13.9 tp . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.403 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.73 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.54 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.522 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.731 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 167' ' ' ASN . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.517 ' HB3' ' CE1' ' A' ' 178' ' ' PHE . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.56 ' HG2' HG22 ' A' ' 215' ' ' VAL . 2.2 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.508 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.53 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.731 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.452 ' HA ' ' HE1' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 21.8 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.4 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.728 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.659 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.659 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.455 ' O ' HG23 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.407 HG21 HG22 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.73 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.407 HG22 HG21 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.538 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.538 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.642 HG22 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.643 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.475 ' HB2' HG23 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.557 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.442 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.594 ' HG2' HD22 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.442 ' HG ' ' C ' ' A' ' 192' ' ' GLY . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.849 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.948 ' HG3' HG13 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.681 HD12 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.49 HG22 ' HB1' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.849 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.441 ' HA ' ' HE3' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.442 ' C ' ' HG ' ' A' ' 155' ' ' CYS . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.56 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.561 ' HB2' HD11 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.687 ' HB ' ' HE1' ' A' ' 207' ' ' MET . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.559 ' ND2' HG11 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.687 ' HE1' ' HB ' ' A' ' 202' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG21 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.948 HG13 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.447 ' HA ' HD11 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.668 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.594 HD22 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.503 ' HG3' HG13 ' A' ' 244' ' ' VAL . 37.6 Cg_endo . . . . . 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.573 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.656 0.265 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.664 ' HD2' HD22 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.822 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD21 ' A' ' 167' ' ' ASN . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.604 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.409 ' OG ' ' HE1' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.836 ' HA2' HE22 ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.571 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.604 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.453 ' CG1' HG12 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.467 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.481 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.529 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.529 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.642 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.836 HE22 ' HA2' ' A' ' 204' ' ' GLY . 63.6 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.664 HD22 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.818 ' HG3' HD23 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.525 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.515 ' HA ' HD22 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.681 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.725 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.459 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 177' ' ' GLN . 0.0 OUTLIER -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.725 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.451 ' OG ' ' HE1' ' A' ' 157' ' ' MET . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.535 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 196' ' ' GLN . 20.1 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.535 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.744 ' HG2' HD13 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.459 HG22 ' HE2' ' A' ' 207' ' ' MET . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.404 ' HG ' ' CD ' ' A' ' 208' ' ' GLU . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.684 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 206' ' ' CYS . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.446 HG23 HD12 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.681 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.539 HG22 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HB3' HD23 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.744 HD13 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.519 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.598 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.611 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.534 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.818 HD23 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 168' ' ' LEU . 22.7 m-20 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG13 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.918 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG3' HG23 ' A' ' 215' ' ' VAL . 13.7 mm100 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.581 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.73 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.918 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.73 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.476 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.45 HG13 HG12 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.745 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.432 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.423 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.402 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.402 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.404 ' HB2' HG13 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HG2' HG12 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.432 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.326 0.108 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.484 ' HG ' ' HA ' ' A' ' 193' ' ' LEU . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.835 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.586 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.855 ' HG3' HG22 ' A' ' 215' ' ' VAL . 31.6 mm-40 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.473 HG23 ' CD1' ' A' ' 193' ' ' LEU . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HG ' ' A' ' 155' ' ' CYS . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.484 ' HA ' ' HG ' ' A' ' 155' ' ' CYS . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.484 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.436 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.47 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.47 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.726 ' SD ' HG13 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.451 ' O ' HG11 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.855 HG22 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.561 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.835 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.528 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.475 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.484 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.623 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.407 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.67 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.152 0.501 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.565 HG23 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 68.5 mt . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.612 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.431 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.877 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.67 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.484 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.484 ' N ' HD21 ' A' ' 167' ' ' ASN . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.47 ' HD2' ' OD1' ' B' ' 2' ' ' ASP . 11.1 t-160 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.777 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.454 ' NE2' HG23 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.562 HD11 HD12 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.67 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.594 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.407 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.56 ' HB2' HD13 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.522 HG13 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.517 ' HE2' ' HA ' ' A' ' 207' ' ' MET . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.454 HG23 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.522 ' CG1' HG13 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.877 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.431 HG22 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.407 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.628 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.47 ' HB3' HG13 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.41 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG13 ' A' ' 231' ' ' VAL . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.4 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.519 HD21 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.43 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.573 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.949 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.466 ' HG2' HG12 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.46 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.525 HD12 HD13 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.949 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD13 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.525 HD13 HD12 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.612 ' HB ' ' HE3' ' A' ' 207' ' ' MET . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.728 ' SD ' HG13 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.728 HG13 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.45 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.625 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.662 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.606 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.662 ' HZ3' ' HA ' ' A' ' 237' ' ' GLU . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.419 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.418 ' HB3' HD22 ' A' ' 167' ' ' ASN . 2.9 m-20 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.64 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.443 ' HE3' ' HA ' ' A' ' 188' ' ' ALA . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.493 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.706 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.673 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.514 ' HG3' HG13 ' A' ' 215' ' ' VAL . 15.6 mm100 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.673 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.544 HD12 HD12 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.491 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.706 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HE3' ' A' ' 157' ' ' MET . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.491 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HD12 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 3.3 t-20 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.68 ' SD ' HG11 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.68 HG11 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.458 HG21 HD11 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.451 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.693 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.776 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.552 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.515 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 254' ' ' PRO . 36.8 m80 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 250' ' ' HIS . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.439 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo . . . . . 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.107 0.479 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.493 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.624 ' HG2' HD22 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.628 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.53 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.501 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . . . . . . 0 N--CA 1.441 -0.976 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.574 ' HG3' HG12 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.636 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.453 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.487 HG13 ' HE2' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.647 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.501 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.724 HG13 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.545 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.496 ' HA ' HD11 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . 0.416 ' HB2' HG13 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.481 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 8.7 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.439 ' N ' HD11 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.624 HD22 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG13 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.553 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.555 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.555 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.544 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.409 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.719 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.554 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.544 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.552 ' HB2' HD13 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.489 HG13 ' HE2' ' A' ' 207' ' ' MET . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.515 ' HG ' ' CD ' ' A' ' 208' ' ' GLU . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' HG ' ' A' ' 206' ' ' CYS . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.549 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.556 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.504 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.457 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.457 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.1 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.656 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.02 131.02 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.874 0.369 . . . . 0.0 110.055 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 45.7 m-20 -103.69 119.09 55.77 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.211 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -26.07 77.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.223 2.615 . . . . 0.0 113.637 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.4 34.7 4.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.378 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 7.3 t -78.01 -25.52 48.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.639 . . . . 0.0 109.478 176.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.6 mtt -88.49 76.47 8.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.32 80.74 9.1 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HB2' HD23 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.604 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 167' ' ' ASN . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.672 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -137.11 163.68 30.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -95.79 47.49 1.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 23.0 t -162.84 -48.43 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.415 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -100.24 97.59 6.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.43 166.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 173' ' ' SER . 5.3 Cg_exo -79.05 -16.79 12.3 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.111 2.541 . . . . 0.0 112.708 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.76 166.53 34.23 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.765 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.451 ' HB2' HG11 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.548 ' HB2' HD13 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.482 HG12 ' HE3' ' A' ' 207' ' ' MET . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.609 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 2.9 t-20 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.643 ' SD ' HG11 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.643 HG11 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.439 ' HA3' ' ND2' ' A' ' 203' ' ' ASN . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.609 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.52 ' HB3' HD13 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.528 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.58 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.517 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.421 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo -72.49 174.16 12.07 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.13 152.47 67.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.348 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.97 170.51 15.47 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.485 2.124 . . . . 0.0 111.408 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.436 ' C ' ' H ' ' A' ' 261' ' ' ASN . 86.0 m-85 55.78 49.01 17.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -71.24 39.51 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.311 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 259' ' ' PHE . 21.0 m120 -92.44 -20.64 20.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -75.14 -36.99 44.07 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.495 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.58 114.38 17.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.81 88.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.919 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.594 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 6.4 tp-100 -66.8 132.64 48.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.473 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -85.32 66.65 9.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.489 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.594 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 50.6 mt-10 -102.43 119.94 39.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.761 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.95 151.45 45.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.9 t 70.87 169.45 0.32 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.838 0.711 . . . . 0.0 109.925 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.542 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER 61.8 -173.72 0.14 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 171.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.5 mt -91.49 77.37 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.34 113.33 64.73 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.713 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.07 -26.75 50.25 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.767 2.311 . . . . 0.0 112.264 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -88.14 45.0 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.313 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.23 -25.9 12.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.464 ' HG3' HD21 ' A' ' 150' ' ' LEU . 26.2 ptt? -92.57 -178.34 4.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.559 -174.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 149' ' ' MET . 4.6 mm? 59.73 51.11 6.45 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.72 0.637 . . . . 0.0 111.032 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.436 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.5 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.52 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.768 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 8.0 t70 -139.62 160.72 39.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 172' ' ' LYS . 28.2 mtmt -88.05 -16.41 33.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.03 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.5 t -107.39 -5.4 17.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.4 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 30.6 mmtp -114.02 138.75 22.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.655 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 2.2 Cg_endo -81.14 106.55 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.065 2.51 . . . . 0.0 113.481 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.19 49.48 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.096 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.411 ' HG2' HG22 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.768 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.432 ' HB2' HG13 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.527 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.679 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 247' ' ' SER . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 207' ' ' MET . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.473 HG11 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.563 HG21 HD11 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.436 HG22 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.489 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.663 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.587 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.663 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.546 ' HB2' HG21 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.679 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.511 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.0 144.33 18.73 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.13 130.37 92.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.26 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.442 ' HB3' ' HE1' ' A' ' 238' ' ' PHE . 67.7 Cg_endo -74.34 172.41 16.13 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.737 2.291 . . . . 0.0 113.072 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 61.36 35.91 17.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.592 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.26 63.97 0.82 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.564 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -76.67 -31.57 57.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 66.79 -90.11 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.827 172.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.75 135.4 54.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.188 0.518 . . . . 0.0 112.035 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 264' ' ' ILE . 4.1 mp -84.21 84.95 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -94.18 151.93 19.1 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.17 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 60.96 90.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.122 0.889 . . . . 0.0 111.582 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 70.06 96.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.014 0.911 . . . . 0.0 112.06 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -109.39 -14.66 14.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.572 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 20.5 m -136.37 156.06 49.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.747 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.168 176.082 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.239 0.542 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.412 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 -129.92 169.11 15.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 -176.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mt -84.39 74.74 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -95.12 103.74 12.89 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.183 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.23 -22.45 19.0 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.084 1.856 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.1 30.62 6.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -89.26 -8.47 53.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.734 0.778 . . . . 0.0 108.951 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 20.9 ptm -92.82 70.53 4.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.716 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp -81.68 81.9 7.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.513 ' HG2' HD23 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 159' ' ' LYS . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.875 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.522 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.415 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 -155.99 170.36 22.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -112.37 -6.44 14.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.614 0.245 . . . . 0.0 110.519 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.6 p -84.75 -54.4 4.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.02 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 91.5 mttt -81.01 134.65 52.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.095 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 11.0 Cg_endo -86.79 100.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.12 2.547 . . . . 0.0 112.234 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.81 176.07 14.47 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.693 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.74 ' HG3' HG13 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.487 HG13 HD12 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.875 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.487 HD12 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.611 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.611 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.412 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.517 HG12 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 202' ' ' VAL . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.505 ' O ' HG23 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.74 HG13 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG1' HG12 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.412 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.48 ' CD ' ' HZ1' ' A' ' 240' ' ' LYS . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.669 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.48 ' HZ1' ' CD ' ' A' ' 237' ' ' GLU . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.728 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.447 HD23 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.513 HD23 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 244' ' ' VAL . 73.7 Cg_endo -76.77 124.56 7.58 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 256' ' ' PRO . 1.1 m 63.67 134.47 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 125.053 1.341 . . . . 0.0 112.015 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.95 116.09 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.343 2.028 . . . . 0.0 112.913 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -101.46 18.69 19.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.822 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 262' ' ' GLY . 6.1 m -65.81 136.66 56.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.861 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 76.13 -21.4 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.727 0.642 . . . . 0.0 110.594 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -97.03 23.86 33.86 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 172.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -70.55 160.04 33.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 264' ' ' ILE . 3.5 mp -71.42 111.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.389 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.84 156.1 28.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.236 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -113.68 133.93 55.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.312 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.75 126.51 16.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.372 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 63.73 91.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.834 0.826 . . . . 0.0 111.147 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 55.1 m -138.81 91.53 2.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.316 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.517 -0.754 . . . . 0.0 109.523 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.563 0.697 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.79 166.57 21.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.082 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 mt 59.15 52.48 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.959 0.885 . . . . 0.0 109.003 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -97.34 124.13 50.16 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.469 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.47 -11.79 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.5 2.134 . . . . 0.0 112.093 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -98.95 18.06 18.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.122 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -81.07 -13.26 58.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.719 0.771 . . . . 0.0 109.183 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 149' ' ' MET . 21.9 ptt? -129.02 94.6 3.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.869 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.83 -68.61 0.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.56 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.531 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.586 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.586 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.839 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.419 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 18.6 t70 -148.36 158.86 44.36 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -90.47 -11.53 40.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.214 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.2 p -127.82 18.85 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.493 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.419 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 48.5 mmtm -108.54 134.91 20.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.06 97.62 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 113.095 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.51 177.96 34.06 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.199 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.731 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.548 HD11 HD12 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.839 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.554 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.548 HD12 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.674 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.514 HG21 HD12 ' B' ' 5' ' ' LEU . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.669 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.531 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.42 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.68 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.622 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 244' ' ' VAL . 73.1 Cg_endo -78.63 151.28 25.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.96 144.7 28.27 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.948 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.32 107.31 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.835 2.356 . . . . 0.0 112.297 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -108.34 77.41 1.1 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.884 0.85 . . . . 0.0 109.069 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -77.48 74.83 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.733 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.77 -33.87 60.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 84.95 -50.22 4.36 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.596 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.42 6.05 7.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.381 0.61 . . . . 0.0 112.317 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.6 mt -91.69 91.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.105 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -111.23 168.74 9.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.7 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -149.78 100.08 2.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.63 176.77 7.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.37 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.0 m120 55.66 44.18 26.89 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 110.325 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.9 p -116.52 170.32 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.985 -178.082 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 70.46 -179.67 0.23 Allowed 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 124.199 0.937 . . . . 0.0 111.569 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.6 153.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.727 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -110.58 103.95 55.12 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.524 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.28 -20.17 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.788 2.325 . . . . 0.0 111.32 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -80.62 19.28 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.26 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -78.82 -17.06 56.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.636 0.731 . . . . 0.0 109.47 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 62.2 mtm -85.88 56.39 3.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.857 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.37 86.58 6.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.454 ' HB3' HG21 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.78 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -113.62 152.46 30.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.22 -11.91 59.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.3 m -96.62 -5.38 39.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.445 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.54 144.58 29.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.53 104.85 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.807 2.338 . . . . 0.0 112.756 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 -161.75 20.66 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.847 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.508 ' HG2' HG21 ' A' ' 215' ' ' VAL . 1.4 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.419 HD13 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.78 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.695 ' SD ' HG11 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.642 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.642 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.695 HG11 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.624 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.406 ' CB ' HG22 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.806 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.806 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.531 HG12 ' CG ' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.546 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.531 ' CG ' HG12 ' A' ' 244' ' ' VAL . 31.2 Cg_exo -60.44 156.31 42.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 25.0 t 62.42 82.75 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.193 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.71 137.2 53.03 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.295 2.663 . . . . 0.0 113.159 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -119.22 6.41 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.608 0.718 . . . . 0.0 109.343 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 38.1 p -99.2 107.9 20.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.301 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.11 -36.99 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -84.69 78.48 2.0 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.226 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.56 142.96 42.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 111.216 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.2 mp -76.14 87.4 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.542 0.687 . . . . 0.0 110.152 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -76.19 158.66 31.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.52 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -73.1 84.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.091 0.472 . . . . 0.0 109.824 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.84 104.89 0.49 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.865 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -91.49 145.42 24.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.7 p -120.91 112.72 19.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.083 0.468 . . . . 0.0 111.141 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 177.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.516 0.198 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 -62.88 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.409 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.62 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 58.8 mt -87.37 111.77 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -86.53 107.07 12.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.146 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 0.9 OUTLIER -85.23 -44.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.908 2.405 . . . . 0.0 111.757 175.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -86.71 24.11 1.53 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.425 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.3 t -83.34 -19.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.423 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 72.5 mtm 41.56 69.25 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.588 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt -76.16 86.72 3.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 149' ' ' MET . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HB3' HG11 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.871 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.58 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.661 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.793 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' A' ' 174' ' ' LYS . 50.1 m-20 -109.62 165.17 11.88 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -72.14 -7.56 49.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.622 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.8 p -121.91 16.99 10.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.553 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 171' ' ' ASP . 32.2 mmtp -128.78 100.96 20.75 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.43 -33.48 6.89 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.595 2.197 . . . . 0.0 112.417 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.04 149.96 41.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.136 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.793 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.478 ' HB2' HG13 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.474 ' OG ' ' HE2' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.537 ' HB2' HD13 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.493 HG13 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 201' ' ' GLU . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 207' ' ' MET . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.473 ' O ' HG21 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.46 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.562 HG22 HD11 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.871 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.703 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.498 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.703 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.634 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.53 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo -53.02 156.44 9.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 2.4 p -120.9 137.94 27.13 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.224 -171.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 14.2 Cg_exo -70.37 178.79 4.58 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.025 2.483 . . . . 0.0 112.561 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 58.94 28.19 17.26 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.061 0.545 . . . . 0.0 111.986 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.4 p -106.36 45.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.359 0.599 . . . . 0.0 111.702 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -91.33 -9.54 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.694 0.759 . . . . 0.0 109.377 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -117.82 116.66 3.52 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.812 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -81.95 137.72 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 51.0 mm -63.13 124.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.152 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.43 91.73 5.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.52 125.26 25.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.097 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.09 107.56 14.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.476 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.72 108.56 19.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.0 p -92.98 154.21 18.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.232 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.446 -179.01 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.23 -179.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.639 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.58 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.3 pt -79.74 136.49 23.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.908 0.385 . . . . 0.0 110.536 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 148' ' ' THR . 24.3 t70 -150.04 128.36 5.93 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.874 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.44 -13.12 32.66 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.437 2.091 . . . . 0.0 113.53 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.83 13.96 24.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 145' ' ' ASP . 9.6 t -108.25 -2.52 19.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.808 0.813 . . . . 0.0 108.983 168.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.434 ' C ' ' H ' ' A' ' 151' ' ' ARG . 75.1 mtp -78.2 83.37 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.418 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt 65.4 2.49 1.98 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.5 0.72 . . . . 0.0 111.661 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.698 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB3' HG13 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.787 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.922 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.738 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.627 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.617 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -126.64 161.4 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.8 -2.49 26.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.389 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -124.21 11.88 8.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.579 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.42 107.7 19.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -81.69 -11.03 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.348 2.699 . . . . 0.0 111.759 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -111.04 146.88 17.72 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.87 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.922 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.541 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.514 HD11 HD12 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.554 HG23 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.457 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.522 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.457 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.753 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.753 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.458 ' HB2' HG13 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.516 ' HG2' HG12 ' A' ' 244' ' ' VAL . 24.5 Cg_exo -63.4 86.64 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 95.1 t -139.95 95.03 8.73 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.98 121.54 9.65 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.676 2.25 . . . . 0.0 112.812 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -100.15 -2.07 35.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.555 0.693 . . . . 0.0 109.869 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.79 HG22 ' HB2' ' A' ' 265' ' ' GLN . 2.3 m -106.34 78.63 1.3 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.323 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.6 -23.58 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.099 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.22 -51.36 13.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.703 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.87 145.02 30.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 21.6 mt -81.69 66.86 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.759 0.79 . . . . 0.0 110.385 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.79 ' HB2' HG22 ' A' ' 260' ' ' THR . 73.1 mm-40 -105.08 83.04 1.93 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.943 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 267' ' ' GLU . 96.4 mttt -123.94 70.24 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.648 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 266' ' ' LYS . 35.9 tt0 71.51 133.15 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.919 0.762 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 54.8 t30 69.59 -68.67 0.19 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.256 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.9 m 53.02 79.89 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.987 0.804 . . . . 0.0 111.406 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.523 -178.055 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . 0.617 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 8.4 tp-100 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.857 0.361 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -93.34 170.16 9.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.305 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.738 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.8 mt -110.15 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.651 0.262 . . . . 0.0 110.489 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.85 108.07 39.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.33 -13.05 23.09 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.569 2.179 . . . . 0.0 111.303 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -93.47 15.96 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.619 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -72.67 -22.36 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.139 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -86.43 60.68 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.823 0.82 . . . . 0.0 110.392 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp -80.48 88.58 5.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.662 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.549 HD22 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.451 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.613 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.63 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.51 173.77 11.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -72.83 -11.24 60.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.56 -166.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.0 t -136.08 28.75 3.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.109 0.481 . . . . 0.0 110.426 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -121.19 97.42 47.7 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.71 -16.28 18.78 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.039 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -105.56 146.01 16.01 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.947 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.947 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.557 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.436 ' OG ' ' HE2' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.533 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.756 ' HB ' ' HE2' ' A' ' 207' ' ' MET . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.638 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.756 ' HE2' ' HB ' ' A' ' 202' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.665 HG11 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.43 HG13 HG12 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.611 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.451 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HE3' HD22 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.465 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.564 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.517 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.532 ' HB2' HG11 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.59 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.529 ' HB2' ' HZ ' ' A' ' 259' ' ' PHE . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.628 ' O ' HG22 ' A' ' 257' ' ' VAL . 58.3 Cg_endo -72.38 152.93 55.6 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 256' ' ' PRO . 1.8 m 61.13 158.76 0.11 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.87 1.268 . . . . 0.0 112.56 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.43 143.28 17.13 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.756 2.304 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.529 ' HZ ' ' HB2' ' A' ' 255' ' ' LEU . 61.8 m-85 -83.03 68.91 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.412 0.625 . . . . 0.0 110.293 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.8 t -90.05 32.04 0.94 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.762 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.64 -12.11 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -87.43 41.5 3.09 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.15 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.84 -157.49 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 53.5 mt -68.54 96.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.38 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -83.76 70.26 10.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.534 0.683 . . . . 0.0 109.469 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -114.48 83.04 1.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.859 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -85.92 114.53 22.9 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -88.58 -0.9 57.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.431 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.6 p -122.05 63.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.408 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . 0.63 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 3.6 pt20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.988 0.423 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.428 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 2.2 m-20 -136.01 168.36 19.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.412 HD11 HG22 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.6 pt -124.7 106.56 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.287 0.565 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.6 112.43 65.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.235 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.22 -15.86 22.62 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.511 2.141 . . . . 0.0 112.283 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.71 38.09 0.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.072 0.463 . . . . 0.0 111.087 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.4 t -78.9 -27.39 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt 43.68 94.7 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.406 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt -67.65 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.95 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.544 ' HG2' HD22 ' A' ' 255' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.486 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.498 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.498 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 44.3 t-80 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.966 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . 20.1 m-20 -133.84 155.96 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -80.96 12.71 3.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.939 0.876 . . . . 0.0 109.955 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.6 m -127.26 12.63 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.555 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.966 ' HG2' ' HB2' ' A' ' 171' ' ' ASP . 34.0 mmtp -115.01 140.68 25.88 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.143 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.83 -20.6 19.65 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.793 2.328 . . . . 0.0 113.404 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -162.55 -169.05 25.38 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.764 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.649 HE21 ' N ' ' A' ' 177' ' ' GLN . 0.0 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.707 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.419 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 15.4 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.885 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.45 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.885 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.51 ' CG1' HG13 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.43 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 240' ' ' LYS . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.475 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 237' ' ' GLU . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.431 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.544 HD22 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo -77.61 -155.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.32 152.38 96.54 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.58 -163.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.398 2.732 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.473 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.2 p90 -100.51 4.4 43.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.525 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 29.3 m -66.89 146.37 54.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 260' ' ' THR . 12.4 m120 79.83 -3.74 1.99 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.062 0.851 . . . . 0.0 110.456 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.73 -0.27 75.67 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -68.6 137.25 54.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.9 mt -75.73 94.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.69 135.48 49.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.459 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.95 17.21 24.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.485 0.659 . . . . 0.0 109.533 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.17 138.62 31.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.273 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -143.72 85.05 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.714 0.768 . . . . 0.0 110.874 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.2 t -156.28 118.19 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.617 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.85 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 64.42 -176.39 0.17 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.523 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.937 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 144' ' ' ILE . 0.2 OUTLIER -83.95 151.48 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -111.64 93.93 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.427 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.02 -22.05 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.244 1.963 . . . . 0.0 112.051 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -88.22 -1.17 57.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.709 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.2 t -70.62 -18.76 62.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mtp -81.02 72.89 8.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.642 ' HG ' HG22 ' A' ' 235' ' ' THR . 13.9 tp -74.77 80.75 2.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 -172.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.403 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.73 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.54 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.522 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.731 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 167' ' ' ASN . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.62 ' HD2' ' HB3' ' B' ' 1' ' ' GLN . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -101.06 152.97 19.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -94.15 15.76 16.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.819 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.8 m -119.41 -62.67 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 132.76 28.27 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.83 135.79 6.87 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.507 2.138 . . . . 0.0 112.394 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 133.03 168.13 11.87 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.854 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.56 ' HG2' HG22 ' A' ' 215' ' ' VAL . 2.2 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.508 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.53 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.731 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.452 ' HA ' ' HE1' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.403 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 21.8 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.4 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.728 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.659 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.659 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.455 ' O ' HG23 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.407 HG21 HG22 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.73 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.407 HG22 HG21 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.538 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.538 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.642 HG22 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.643 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.475 ' HB2' HG23 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.557 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo -62.03 170.02 6.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.82 98.86 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.115 0.566 . . . . 0.0 110.89 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.79 167.46 21.21 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.733 2.289 . . . . 0.0 112.453 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -115.98 29.61 7.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 261' ' ' ASN . 0.5 OUTLIER 72.79 173.77 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.921 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.439 ' N ' HG22 ' A' ' 260' ' ' THR . 67.1 t30 77.95 -11.98 1.13 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.725 0.81 . . . . 0.0 110.357 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -170.97 77.93 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.679 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.56 110.74 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.424 0.631 . . . . 0.0 109.961 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.02 120.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.741 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -74.81 121.04 21.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.384 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -79.24 135.68 36.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.973 0.415 . . . . 0.0 111.106 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.37 150.41 22.63 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -87.83 17.17 5.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.027 0.441 . . . . 0.0 111.318 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -92.23 120.34 32.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.434 -177.047 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 169' ' ' HIS . 10.7 mt-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.752 0.311 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.442 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 57.97 -103.15 0.17 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.873 0.869 . . . . 0.0 112.843 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -87.57 118.45 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.821 0.343 . . . . 0.0 110.227 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -87.82 117.3 68.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.109 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.5 -7.67 15.89 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.587 2.192 . . . . 0.0 111.877 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -89.11 17.81 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.484 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -83.65 -16.09 46.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.546 0.689 . . . . 0.0 109.401 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.5 mtt -103.9 76.3 1.36 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.583 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt -81.67 -83.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.594 ' HG2' HD22 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.442 ' HG ' ' C ' ' A' ' 192' ' ' GLY . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.849 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.42 152.34 19.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -95.09 59.28 2.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.824 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.4 p -169.55 -65.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.174 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -83.39 146.84 51.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.01 0.433 . . . . 0.0 111.582 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -88.48 120.74 1.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.172 2.581 . . . . 0.0 112.427 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.86 127.03 1.13 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.607 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.948 ' HG3' HG13 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.681 HD12 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.49 HG22 ' HB1' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.849 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.441 ' HA ' ' HE3' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.442 ' C ' ' HG ' ' A' ' 155' ' ' CYS . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.56 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.561 ' HB2' HD11 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.687 ' HB ' ' HE1' ' A' ' 207' ' ' MET . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.559 ' ND2' HG11 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.687 ' HE1' ' HB ' ' A' ' 202' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG21 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.948 HG13 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.447 ' HA ' HD11 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.668 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.594 HD22 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.503 ' HG3' HG13 ' A' ' 244' ' ' VAL . 37.6 Cg_endo -72.2 108.32 2.46 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 256' ' ' PRO . 4.7 m -149.01 129.45 6.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.076 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 31.4 Cg_exo -61.35 109.66 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.972 2.448 . . . . 0.0 112.635 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -107.29 104.57 14.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.265 0.555 . . . . 0.0 110.792 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 262' ' ' GLY . 27.2 m 72.5 -74.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.126 175.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' THR . 6.1 m-20 69.14 -21.79 0.15 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.278 0.631 . . . . 0.0 112.2 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -80.97 58.05 4.82 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.561 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -117.59 113.98 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 110.019 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.84 75.01 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.69 0.757 . . . . 0.0 110.812 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -130.62 32.02 4.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.987 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -63.15 128.91 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.009 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -55.52 110.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.655 0.597 . . . . 0.0 111.905 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -117.61 73.99 0.91 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.906 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.4 t -84.13 62.35 7.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.297 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.083 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.008 0.432 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.573 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 -119.72 -171.48 2.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.975 -172.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.791 -0.523 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.97 80.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' CB ' ' HB ' ' A' ' 148' ' ' THR . 20.4 m-20 -66.45 118.6 55.23 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.177 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.33 -19.8 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.761 2.307 . . . . 0.0 110.839 170.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -108.78 35.66 3.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.505 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.462 ' HB ' ' CB ' ' A' ' 145' ' ' ASP . 11.3 t -96.88 -8.11 31.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.348 0.594 . . . . 0.0 109.823 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.9 mtt -79.12 131.93 36.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt -77.84 87.98 4.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.664 ' HD2' HD22 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.822 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD21 ' A' ' 167' ' ' ASN . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 38.3 t70 -128.15 168.48 15.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -78.66 -37.56 41.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.869 0.366 . . . . 0.0 110.34 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 m -84.65 -16.0 43.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.194 0.521 . . . . 0.0 110.23 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 69.2 mmtt -120.76 80.41 32.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.111 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.66 -33.05 22.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.84 2.36 . . . . 0.0 111.912 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.47 132.5 18.34 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.604 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.409 ' OG ' ' HE1' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.836 ' HA2' HE22 ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.571 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.771 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.604 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.453 ' CG1' HG12 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.467 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.481 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.529 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.529 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.642 ' HB2' ' HZ2' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.479 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.836 HE22 ' HA2' ' A' ' 204' ' ' GLY . 63.6 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.664 HD22 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo -94.31 -169.31 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.85 122.44 25.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 120.814 0.34 . . . . 0.0 110.296 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.52 152.3 82.23 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.74 2.293 . . . . 0.0 111.708 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -85.87 9.72 15.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 110.948 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 80.4 m -154.57 114.2 3.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.685 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.89 -16.75 26.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.541 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 86.7 -63.09 4.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.73 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.22 152.97 23.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.73 125.86 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 265' ' ' GLN . 5.0 pm0 -58.8 118.23 5.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.374 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -100.7 114.24 27.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.345 0.593 . . . . 0.0 111.108 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 270' ' ' ARG . 78.2 tt0 -109.78 127.96 54.99 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.53 -31.38 72.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.89 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.2 p -123.49 65.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 267' ' ' GLU . 15.5 tpp180 . . . . . 0 C--O 1.243 0.762 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.882 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.528 0.204 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.57 -77.25 0.08 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.491 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.987 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.9 mt -88.05 84.93 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -56.9 118.44 23.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.271 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.04 -23.22 73.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.797 2.331 . . . . 0.0 111.874 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.36 19.66 6.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -75.23 -10.8 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.666 0.746 . . . . 0.0 109.228 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 76.5 mtp -101.68 98.39 8.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.779 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? -92.51 87.31 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.818 ' HG3' HD23 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG13 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.525 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.515 ' HA ' HD22 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.681 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.725 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.459 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -117.29 156.33 27.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -103.76 -20.49 13.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.6 m -96.63 -40.99 8.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -109.18 139.74 21.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.0 -11.92 7.38 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.916 2.41 . . . . 0.0 113.172 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.52 135.75 27.35 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.014 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 177' ' ' GLN . 0.0 OUTLIER -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.725 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.509 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.451 ' OG ' ' HE1' ' A' ' 157' ' ' MET . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.535 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 196' ' ' GLN . 20.1 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.535 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.744 ' HG2' HD13 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.459 HG22 ' HE2' ' A' ' 207' ' ' MET . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.404 ' HG ' ' CD ' ' A' ' 208' ' ' GLU . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.684 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 206' ' ' CYS . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.446 HG23 HD12 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.681 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.539 HG22 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HB3' HD23 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.744 HD13 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.519 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.598 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.611 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 258' ' ' PRO . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.534 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.818 HD23 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -82.19 176.56 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.34 101.01 44.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.69 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.534 ' HG3' ' CE1' ' A' ' 238' ' ' PHE . 62.6 Cg_endo -73.01 133.86 20.48 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.352 2.035 . . . . 0.0 112.518 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -95.44 2.87 54.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.728 0.775 . . . . 0.0 109.423 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.534 HG22 HG13 ' A' ' 264' ' ' ILE . 5.6 m -105.09 77.87 1.35 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -61.79 -33.98 75.07 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.441 ' O ' HG21 ' A' ' 260' ' ' THR . . . -129.56 -113.28 1.63 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -129.41 143.26 50.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.069 0.462 . . . . 0.0 110.492 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.563 HG23 ' HG2' ' A' ' 266' ' ' LYS . 49.4 mt -101.41 128.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -79.72 88.84 5.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.851 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.563 ' HG2' HG23 ' A' ' 264' ' ' ILE . 34.7 mmtp -123.63 117.51 25.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.48 61.25 3.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.966 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.03 45.37 21.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.541 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.5 p -69.16 118.06 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.527 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.708 -178.5 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . 0.725 ' HG3' ' H ' ' B' ' 2' ' ' ASP . 19.2 pt20 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.725 ' H ' ' HG3' ' B' ' 1' ' ' GLN . 22.7 m-20 55.15 -163.94 0.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 174.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.1 mt -88.12 89.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 148' ' ' THR . 13.6 m-20 -114.42 75.92 3.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.953 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 -22.41 14.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.14 1.893 . . . . 0.0 111.956 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -112.66 35.01 4.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.663 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 145' ' ' ASP . 14.5 t -78.03 -21.78 50.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.777 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -79.78 89.54 5.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.25 -78.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.437 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG13 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.918 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 -138.69 166.06 25.34 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.9 -11.83 12.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 p -100.5 -23.1 14.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 110.803 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -100.11 136.26 20.16 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.45 102.16 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.359 2.706 . . . . 0.0 112.179 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 128.77 -172.77 19.44 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.486 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG3' HG23 ' A' ' 215' ' ' VAL . 13.7 mm100 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.581 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.73 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.918 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.73 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.476 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.45 HG13 HG12 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.745 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.432 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.423 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.402 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.402 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.404 ' HB2' HG13 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HG2' HG12 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.98 142.92 42.13 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 11.7 m -60.79 122.17 66.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.117 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 16.5 Cg_exo -67.13 145.53 73.38 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.91 2.406 . . . . 0.0 111.428 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -140.4 11.55 2.33 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.513 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.1 m 63.85 86.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.425 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -68.87 -33.37 73.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.867 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.24 -139.88 3.01 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.735 -1.221 . . . . 0.0 113.638 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -93.01 153.25 18.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.133 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 48.2 mm -86.21 84.23 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.48 157.49 28.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.369 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -105.02 24.76 11.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -89.64 123.51 33.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.024 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -105.84 90.73 3.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 43.1 m -129.98 43.7 3.08 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.399 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.704 -178.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -126.67 -175.88 3.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.432 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.946 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 21.4 mt 52.35 54.03 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -75.45 110.74 11.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.472 -171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.59 -23.91 14.27 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.799 2.333 . . . . 0.0 112.307 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.69 29.79 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.153 0.502 . . . . 0.0 111.237 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.744 HG23 ' HG3' ' A' ' 149' ' ' MET . 9.0 t -85.63 -20.49 29.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.744 ' HG3' HG23 ' A' ' 148' ' ' THR . 56.5 mtt -123.22 84.69 2.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.309 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.9 -79.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.03 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.484 ' HG ' ' HA ' ' A' ' 193' ' ' LEU . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.835 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.586 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.74 174.25 11.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.19 38.97 0.88 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -150.65 -33.59 0.16 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.607 0.242 . . . . 0.0 111.003 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.87 117.53 53.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.13 0.491 . . . . 0.0 111.154 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.03 -29.95 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.143 2.562 . . . . 0.0 111.748 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.93 141.82 38.73 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.855 ' HG3' HG22 ' A' ' 215' ' ' VAL . 31.6 mm-40 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.473 HG23 ' CD1' ' A' ' 193' ' ' LEU . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HG ' ' A' ' 155' ' ' CYS . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.484 ' HA ' ' HG ' ' A' ' 155' ' ' CYS . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.484 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.436 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.47 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.47 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.726 ' SD ' HG13 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.451 ' O ' HG11 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.855 HG22 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.561 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.835 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.528 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.475 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.484 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.623 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.407 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.67 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.37 177.86 1.9 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.69 147.98 94.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.203 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.36 151.0 85.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.834 2.356 . . . . 0.0 111.69 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -87.45 10.89 16.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.857 -176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 88.6 m -64.66 132.48 49.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 260' ' ' THR . 5.9 m120 76.63 -9.01 1.57 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.448 0.699 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.06 55.02 3.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.83 141.87 46.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.985 0.421 . . . . 0.0 110.718 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.5 124.23 39.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.382 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -69.73 133.6 47.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.358 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -97.45 138.43 34.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.495 ' HG3' HD21 ' A' ' 268' ' ' ASN . 9.0 tp10 67.75 143.8 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.722 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.495 HD21 ' HG3' ' A' ' 267' ' ' GLU . 32.3 m-80 61.72 40.81 12.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.412 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.7 m -80.85 58.38 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.652 . . . . 0.0 109.419 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.993 -174.419 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 -127.25 176.86 7.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.094 -174.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.565 HG23 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.33 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' O ' HG21 ' A' ' 148' ' ' THR . 10.9 m-20 -117.08 152.89 49.42 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -171.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.25 -14.56 9.43 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.75 2.3 . . . . 0.0 113.216 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.13 33.6 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.361 0.601 . . . . 0.0 111.425 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 151' ' ' ARG . 10.2 t -137.89 39.38 2.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.727 1.251 . . . . 0.0 109.375 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.607 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 24.7 ptp -60.15 -33.64 72.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.926 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.607 ' HG ' ' HG3' ' A' ' 149' ' ' MET . 68.5 mt -113.59 26.63 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.612 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.431 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.877 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.67 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.484 HD21 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.484 ' N ' HD21 ' A' ' 167' ' ' ASN . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.47 ' HD2' ' OD1' ' B' ' 2' ' ' ASP . 11.1 t-160 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -142.65 160.37 40.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -89.8 -17.19 28.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.609 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -100.98 -23.14 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.043 0.449 . . . . 0.0 110.149 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.04 122.23 56.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.01 142.48 12.4 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.796 2.331 . . . . 0.0 112.144 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.78 -160.17 32.33 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.892 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.454 ' NE2' HG23 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.562 HD11 HD12 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.67 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.594 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.407 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.56 ' HB2' HD13 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.522 HG13 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.517 ' HE2' ' HA ' ' A' ' 207' ' ' MET . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.454 HG23 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.522 ' CG1' HG13 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.877 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.431 HG22 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.407 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.628 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.47 ' HB3' HG13 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.41 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.77 166.14 7.09 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.11 117.0 50.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.059 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 163.72 35.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.774 2.316 . . . . 0.0 112.129 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -86.18 35.35 0.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.434 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.7 m 57.52 53.9 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.525 0.678 . . . . 0.0 111.447 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -99.41 -28.44 13.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.675 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 71.48 -90.21 0.45 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.271 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -110.69 -179.74 3.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.784 0.434 . . . . 0.0 110.124 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 38.5 mt -114.99 63.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 27.1 tp60 -84.08 112.74 20.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.887 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -85.17 88.32 7.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 41.9 mt-10 -82.3 141.07 33.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.989 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 t30 63.28 99.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.927 0.767 . . . . 0.0 110.881 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -140.89 93.91 2.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.639 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.492 -179.885 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -81.73 -83.2 0.12 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.114 -0.394 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.4 mt -77.34 94.46 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -57.03 113.23 5.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.643 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.7 -14.88 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.04 2.493 . . . . 0.0 110.978 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.8 14.18 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.981 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.1 t -81.79 -2.37 50.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 110.057 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -67.04 107.33 2.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.708 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt -96.33 -95.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.541 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG13 ' A' ' 231' ' ' VAL . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.4 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.519 HD21 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.43 ' SD ' HG22 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.573 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.949 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.32 152.47 40.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -86.69 71.39 10.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.612 0.72 . . . . 0.0 109.216 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.2 m -151.47 -39.29 0.12 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.982 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -158.83 156.82 27.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.97 159.19 11.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.2 2.6 . . . . 0.0 111.352 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.85 90.94 1.67 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.098 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.466 ' HG2' HG12 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.46 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.525 HD12 HD13 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.949 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD13 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.525 HD13 HD12 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.612 ' HB ' ' HE3' ' A' ' 207' ' ' MET . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.728 ' SD ' HG13 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.728 HG13 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.45 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.625 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.662 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.606 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.662 ' HZ3' ' HA ' ' A' ' 237' ' ' GLU . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.419 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.42 150.29 57.86 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.1 t 56.84 86.7 0.16 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.2 119.13 6.08 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.748 2.298 . . . . 0.0 111.524 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -84.01 3.09 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.111 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 262' ' ' GLY . 2.9 m 67.95 166.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.452 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 77.42 -23.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.587 0.755 . . . . 0.0 111.348 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -76.92 61.23 3.38 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.463 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.11 149.71 26.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.88 129.35 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.91 136.83 39.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -103.54 65.51 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.39 151.85 19.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.15 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -161.19 96.73 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.749 0.785 . . . . 0.0 110.726 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.7 p -63.97 -28.42 69.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.864 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.552 175.29 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.418 ' HB3' HD22 ' A' ' 167' ' ' ASN . 2.9 m-20 -137.61 178.47 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.3 mt 68.29 99.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.48 0.657 . . . . 0.0 111.767 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -115.98 96.12 46.19 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.47 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.83 -51.95 0.44 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.028 2.485 . . . . 0.0 113.615 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.05 31.78 0.96 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -88.15 -24.58 23.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.804 0.811 . . . . 0.0 108.906 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 93.9 mmm -97.44 66.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt -78.11 -84.91 0.07 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.64 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.443 ' HE3' ' HA ' ' A' ' 188' ' ' ALA . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.493 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.706 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.673 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.68 174.12 6.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -50.86 -52.93 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.724 0.64 . . . . 0.0 110.483 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 t -143.33 72.29 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.404 0.621 . . . . 0.0 109.802 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -63.23 145.82 96.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.745 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.08 -15.5 18.41 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.202 2.601 . . . . 0.0 111.899 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -177.72 171.97 44.61 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.514 ' HG3' HG13 ' A' ' 215' ' ' VAL . 15.6 mm100 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.673 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.544 HD12 HD12 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.491 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.706 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HE3' ' A' ' 157' ' ' MET . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.491 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.544 HD12 HD12 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 3.3 t-20 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.68 ' SD ' HG11 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.68 HG11 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.458 HG21 HD11 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.451 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.693 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.776 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.552 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.515 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 254' ' ' PRO . 36.8 m80 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 250' ' ' HIS . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.439 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo -70.48 122.13 8.63 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 18.9 m -54.37 144.07 43.45 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.533 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 6.0 Cg_exo -79.43 106.13 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.964 2.443 . . . . 0.0 111.651 173.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -98.31 23.58 8.22 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.397 0.618 . . . . 0.0 110.226 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.9 m -86.33 72.52 10.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.712 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -75.53 -30.51 59.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.418 0.628 . . . . 0.0 110.304 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -100.29 66.95 0.54 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.481 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.71 137.92 53.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.3 mt -87.48 87.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.122 0.486 . . . . 0.0 109.843 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -95.44 151.5 19.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.128 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -107.09 98.73 8.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.101 0.477 . . . . 0.0 110.086 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 129.45 38.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.824 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 62.61 54.55 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.647 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 63.2 m -150.26 110.11 4.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.127 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.205 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 62.11 -168.3 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.493 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.0 146.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -112.75 98.81 46.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.754 0.312 . . . . 0.0 110.396 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.49 -15.15 37.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.377 2.051 . . . . 0.0 112.015 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.13 20.32 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.526 HG23 ' HG3' ' A' ' 149' ' ' MET . 14.8 t -79.25 -18.38 52.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.452 0.644 . . . . 0.0 109.485 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.526 ' HG3' HG23 ' A' ' 148' ' ' THR . 51.8 mtt -116.56 119.12 34.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.351 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? -83.85 69.78 10.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.624 ' HG2' HD22 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.628 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.53 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.502 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 12.9 t70 -140.98 165.61 27.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -51.74 -56.87 11.25 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.606 0.566 . . . . 0.0 111.536 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -101.09 34.02 2.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.463 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 70.3 mmtt -112.86 100.0 49.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.655 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.36 -0.87 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.415 . . . . 0.0 111.869 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.501 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . -123.81 143.46 14.93 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.691 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.574 ' HG3' HG12 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.636 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.453 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.843 ' HB ' HD11 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.487 HG13 ' HE2' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.647 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.724 ' SD ' HG13 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.501 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.724 HG13 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.545 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.628 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.843 HD11 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.496 ' HA ' HD11 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . 0.416 ' HB2' HG13 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.481 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 8.7 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.439 ' N ' HD11 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.624 HD22 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo -54.46 123.5 13.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.37 131.06 33.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.294 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.81 106.93 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.599 2.199 . . . . 0.0 111.747 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.28 41.17 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.7 m -116.89 62.85 0.72 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.648 0.737 . . . . 0.0 109.51 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.45 -16.22 17.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.218 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.52 74.04 0.92 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.683 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.08 144.45 55.25 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.742 0.417 . . . . 0.0 110.938 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.9 mt -85.21 67.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.692 0.758 . . . . 0.0 109.956 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -118.65 111.15 18.17 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.33 126.45 29.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.698 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.71 159.13 42.85 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 268' ' ' ASN . 0.1 OUTLIER -140.02 170.25 16.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.618 0.247 . . . . 0.0 111.034 -175.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.5 t 63.32 79.86 0.25 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.071 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.249 176.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -111.0 -176.49 2.97 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.488 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 39.9 pt -116.25 172.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.271 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 1.6 m-20 -100.97 99.78 11.33 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.727 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 18.0 Cg_exo -65.46 -22.55 59.02 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.425 2.084 . . . . 0.0 110.614 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -110.69 35.13 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.596 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 11.9 t -69.74 -27.27 64.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 110.055 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 56.8 mtm -103.18 92.49 4.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? -75.0 79.39 2.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG13 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.553 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.555 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.555 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 167' ' ' ASN . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -111.44 167.56 10.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 172' ' ' LYS . 9.1 mmpt? -66.65 -29.29 69.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.193 0.521 . . . . 0.0 110.035 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.9 m -91.1 -8.19 49.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.215 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -122.32 87.05 48.26 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.942 -176.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -22.01 10.53 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.187 2.591 . . . . 0.0 112.163 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.544 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . -76.55 117.1 4.86 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.61 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.409 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.719 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.554 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.544 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.552 ' HB2' HD13 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.489 HG13 ' HE2' ' A' ' 207' ' ' MET . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.515 ' HG ' ' CD ' ' A' ' 208' ' ' GLU . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' HG ' ' A' ' 206' ' ' CYS . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.549 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.556 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.504 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.457 ' CD1' ' HG1' ' A' ' 226' ' ' THR . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.457 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.1 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.22 158.48 39.59 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.17 121.11 61.4 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.17 128.28 17.29 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.803 2.335 . . . . 0.0 111.579 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -92.12 50.67 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.208 0.528 . . . . 0.0 109.962 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 262' ' ' GLY . 10.7 m 57.42 -96.03 0.06 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.348 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 260' ' ' THR . 5.7 t-20 70.04 -43.49 0.54 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.063 0.545 . . . . 0.0 110.86 -174.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 260' ' ' THR . . . 157.17 -154.07 25.22 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.57 173.04 12.75 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.61 97.48 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.24 111.53 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.95 0.781 . . . . 0.0 111.039 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -121.61 50.11 1.45 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.92 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.51 80.28 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.699 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -103.2 21.69 15.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 48.2 t -91.27 108.82 20.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.298 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.958 176.575 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . 0.421 ' CD ' ' H1 ' ' B' ' 1' ' ' GLN . 22.9 mp0 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.46 164.02 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.656 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.545 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.678 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 219' ' ' ILE . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 0.1 OUTLIER 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.456 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.445 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.587 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.689 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo . . . . . 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.42 0.629 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.46 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.515 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.805 0.114 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.541 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.688 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.691 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 219' ' ' ILE . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 210' ' ' LYS . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.482 HG12 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.586 HG21 HD13 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 220' ' ' ARG . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.681 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.601 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 244' ' ' VAL . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.681 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.688 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.66 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.425 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.149 0.5 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.577 HG22 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.692 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' B' ' 5' ' ' LEU . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.76 ' HG3' HG11 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.504 HG13 HD11 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.9 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.501 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.504 HD11 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.431 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.635 ' HG2' HD12 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.563 HG11 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 207' ' ' MET . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.501 ' O ' HG22 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.563 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.692 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.577 ' HG2' HG22 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.635 HD12 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 233' ' ' ARG . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.431 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.78 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.518 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.669 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.7 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 121.284 0.564 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.625 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.789 0.105 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.865 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.597 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.576 HG11 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.682 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 215' ' ' VAL . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.734 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.576 ' CG1' HG11 ' A' ' 202' ' ' VAL . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.578 ' HB3' HD11 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.686 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.628 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.522 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.1 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.63 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD23 HD13 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.534 ' HG2' HG21 ' A' ' 215' ' ' VAL . 13.9 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.814 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.706 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.64 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.413 ' O ' HG22 ' A' ' 215' ' ' VAL . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.64 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.706 HG12 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.498 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.42 ' CB ' HG23 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.818 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 151' ' ' ARG . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.553 ' HG2' HG11 ' A' ' 244' ' ' VAL . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 4' ' ' ARG . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.694 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.902 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.587 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.694 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.818 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.456 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 179' ' ' ILE . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG11 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.471 ' HA ' ' CG ' ' A' ' 210' ' ' LYS . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.59 HG21 HD13 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.527 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.902 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 234' ' ' GLU . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.635 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo . . . . . 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 219' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.285 0.565 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.722 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.531 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.739 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.953 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.533 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 187' ' ' PRO . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.505 HG11 ' CG1' ' A' ' 219' ' ' ILE . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.548 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.4 ' O ' HG22 ' A' ' 215' ' ' VAL . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.548 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.505 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.531 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.816 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.466 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.766 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.547 ' HG2' HG11 ' A' ' 244' ' ' VAL . 24.5 Cg_exo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.739 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.502 0.667 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.641 HD21 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.466 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.636 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.633 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 13.2 t-20 -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.586 ' HG3' HG11 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.934 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.934 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.56 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.438 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.545 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.728 HG21 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 219' ' ' ILE . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.65 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.657 ' SD ' HG12 ' A' ' 215' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.657 HG12 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.633 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.636 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.466 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.641 ' HE3' HD21 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.423 ' HD2' HG13 ' A' ' 244' ' ' VAL . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.527 ' HB2' HG12 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.527 HG12 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.728 ' HG2' HG21 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 256' ' ' PRO . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.435 ' HG3' HG11 ' A' ' 244' ' ' VAL . 58.3 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 2.2 m-20 . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.417 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.27 0.081 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.519 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.506 ' ND2' ' HG2' ' B' ' 4' ' ' ARG . 28.1 t-20 -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 12.6 t60 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 112.764 -0.135 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' A' ' 212' ' ' HIS . 0.1 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.762 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.773 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.762 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 87.2 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.45 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.893 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.606 ' HA ' ' NE2' ' A' ' 177' ' ' GLN . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.893 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.45 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 236' ' ' ASP . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.535 HD21 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.25 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.494 ' HG1' ' HE2' ' A' ' 212' ' ' HIS . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.506 ' HG2' ' ND2' ' A' ' 167' ' ' ASN . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 235' ' ' THR . 13.9 tp . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.42 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.762 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.548 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.573 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.6 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.762 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.423 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 96.0 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.421 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.733 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.733 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.685 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.421 HG23 HH11 ' A' ' 198' ' ' ARG . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.551 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.468 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.551 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.664 HG23 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.494 ' HB2' HG22 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.562 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.629 ' HG2' HD21 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG12 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.878 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' B' ' 4' ' ' ARG . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.588 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.951 ' HG3' HG11 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.878 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.405 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 203' ' ' ASN . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.686 ' SD ' HG12 ' A' ' 215' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.508 ' O ' HG22 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.55 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.951 HG11 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 212' ' ' HIS . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.566 ' HB3' HD11 ' A' ' 154' ' ' LEU . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.435 ' HA ' HD13 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.405 ' HB3' HG12 ' A' ' 244' ' ' VAL . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.687 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.548 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.629 HD21 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.531 ' HG3' HG11 ' A' ' 244' ' ' VAL . 37.6 Cg_endo . . . . . 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.656 0.265 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.669 ' HD2' HD21 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.852 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.597 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.42 HG13 HD11 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 180' ' ' ARG . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 189' ' ' GLU . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 179' ' ' ILE . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.442 ' HA2' ' OE1' ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 214' ' ' ASP . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.775 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.529 ' CG1' HG11 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.472 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.53 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.586 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 22.8 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.669 HD21 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.824 ' HG3' HD21 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HB3' HG12 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.54 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.712 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.719 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.54 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.769 ' HG2' HD12 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.588 HG12 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.445 HG21 HD13 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.712 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.55 HG23 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.54 ' HB3' HD21 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.769 HD12 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.6 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.634 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.54 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.824 HD21 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 94.4 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 168' ' ' LEU . 22.7 m-20 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.795 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HB3' HG12 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.539 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.942 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.489 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.605 ' HG3' HG21 ' A' ' 215' ' ' VAL . 24.6 mm-40 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.797 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.942 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 219' ' ' ILE . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.491 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.491 HG13 HG11 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.572 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.435 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.521 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.56 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB2' HG12 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 200' ' ' VAL . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.487 ' HG2' HG11 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.55 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.795 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.448 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.326 0.108 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.643 ' HG2' HD21 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.52 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.854 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.608 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.862 ' HG3' HG21 ' A' ' 215' ' ' VAL . 15.9 mm100 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 179' ' ' ILE . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.454 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 219' ' ' ILE . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.751 ' SD ' HG12 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.862 HG21 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.854 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.559 ' HB3' HD21 ' A' ' 154' ' ' LEU . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 248' ' ' GLN . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.636 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.152 0.501 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.569 HG22 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.724 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 68.5 mt . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.912 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 14.6 t60 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.777 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 198' ' ' ARG . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.551 ' HA ' ' HB1' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.605 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.584 ' HB2' HD12 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.513 ' HE3' ' HB ' ' A' ' 202' ' ' VAL . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' B' ' 2' ' ' ASP . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.559 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.912 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.516 ' HB3' HD21 ' A' ' 154' ' ' LEU . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.408 ' HD1' HG13 ' A' ' 244' ' ' VAL . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.421 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD3' ' CE2' ' A' ' 239' ' ' PHE . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.98 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.481 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.98 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 189' ' ' GLU . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 ' CG1' ' A' ' 219' ' ' ILE . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.735 ' SD ' HG12 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.735 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.511 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 234' ' ' GLU . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 233' ' ' ARG . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.538 ' HA ' HD13 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.638 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.508 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.418 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 255' ' ' LEU . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.476 ' HB3' HD21 ' A' ' 167' ' ' ASN . 2.9 m-20 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.591 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 164' ' ' TYR . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.483 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.513 ' HG3' HG11 ' A' ' 215' ' ' VAL . 30.8 mm-40 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.68 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.519 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.733 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.519 HG12 ' CE ' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 215' ' ' VAL . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 225' ' ' GLU . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.57 ' HA ' HD13 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.802 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.671 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.468 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo . . . . . 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.107 0.479 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.483 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.632 ' HG2' HD21 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB2' HD21 ' A' ' 229' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.686 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' B' ' 5' ' ' LEU . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.54 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . . . . . . 0 N--CA 1.441 -0.976 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG3' HG11 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.665 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.859 ' HB ' HD12 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.531 HG12 ' HE3' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.656 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.734 ' SD ' HG12 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.54 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 214' ' ' ASP . 74.2 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 216' ' ' VAL . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 211' ' ' GLN . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.734 HG12 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.561 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.686 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.859 HD12 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.51 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.442 ' HB2' HG12 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 53.8 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.568 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.562 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.557 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.562 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 22.2 t-20 -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.449 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 189' ' ' GLU . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 183' ' ' ASP . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.573 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.564 ' HB2' HD12 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 219' ' ' ILE . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 219' ' ' ILE . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.683 ' SD ' HG12 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.683 HG12 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.571 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.557 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.516 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB3' HD11 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.427 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 27.6 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.663 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.02 131.02 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.874 0.369 . . . . 0.0 110.055 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.603 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 45.7 m-20 -103.69 119.09 55.77 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.211 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -26.07 77.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.223 2.615 . . . . 0.0 113.637 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.4 34.7 4.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.378 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 7.3 t -78.01 -25.52 48.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.639 . . . . 0.0 109.478 176.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.6 mtt -88.49 76.47 8.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.32 80.74 9.1 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.545 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.678 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -137.11 163.68 30.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -95.79 47.49 1.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 23.0 t -162.84 -48.43 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.415 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -100.24 97.59 6.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.43 166.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 173' ' ' SER . 5.3 Cg_exo -79.05 -16.79 12.3 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.111 2.541 . . . . 0.0 112.708 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.76 166.53 34.23 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 219' ' ' ILE . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 0.1 OUTLIER 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.456 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.445 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.587 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.689 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo -72.49 174.16 12.07 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.13 152.47 67.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.348 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.97 170.51 15.47 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.485 2.124 . . . . 0.0 111.408 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 55.78 49.01 17.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -71.24 39.51 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.311 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -92.44 -20.64 20.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -75.14 -36.99 44.07 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.495 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.58 114.38 17.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.81 88.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.919 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.625 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 6.4 tp-100 -66.8 132.64 48.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.473 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -85.32 66.65 9.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.489 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.625 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 50.6 mt-10 -102.43 119.94 39.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.761 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.95 151.45 45.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.9 t 70.87 169.45 0.32 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.838 0.711 . . . . 0.0 109.925 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.542 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER 61.8 -173.72 0.14 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 171.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.5 mt -91.49 77.37 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.34 113.33 64.73 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.713 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.07 -26.75 50.25 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.767 2.311 . . . . 0.0 112.264 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -88.14 45.0 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.313 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.23 -25.9 12.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.48 ' HG3' HD23 ' A' ' 150' ' ' LEU . 26.2 ptt? -92.57 -178.34 4.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.559 -174.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 149' ' ' MET . 4.6 mm? 59.73 51.11 6.45 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.72 0.637 . . . . 0.0 111.032 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.46 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.515 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 8.0 t70 -139.62 160.72 39.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 172' ' ' LYS . 28.2 mtmt -88.05 -16.41 33.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.03 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.5 t -107.39 -5.4 17.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.4 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 30.6 mmtp -114.02 138.75 22.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.655 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 2.2 Cg_endo -81.14 106.55 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.065 2.51 . . . . 0.0 113.481 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.19 49.48 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.096 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.541 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.688 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.691 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 219' ' ' ILE . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 210' ' ' LYS . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.482 HG12 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.586 HG21 HD13 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 220' ' ' ARG . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.681 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.601 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 244' ' ' VAL . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.681 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 261' ' ' ASN . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.688 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.66 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.0 144.33 18.73 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.13 130.37 92.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.26 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.47 ' HB3' ' HE1' ' A' ' 238' ' ' PHE . 67.7 Cg_endo -74.34 172.41 16.13 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.737 2.291 . . . . 0.0 113.072 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 61.36 35.91 17.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.592 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.26 63.97 0.82 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.564 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 243' ' ' ARG . 51.5 m-80 -76.67 -31.57 57.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 66.79 -90.11 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.827 172.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.75 135.4 54.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.188 0.518 . . . . 0.0 112.035 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 264' ' ' ILE . 4.1 mp -84.21 84.95 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -94.18 151.93 19.1 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.17 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 60.96 90.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.122 0.889 . . . . 0.0 111.582 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 70.06 96.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.014 0.911 . . . . 0.0 112.06 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -109.39 -14.66 14.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.572 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 20.5 m -136.37 156.06 49.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.747 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.168 176.082 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.239 0.542 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.425 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 -129.92 169.11 15.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 -176.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mt -84.39 74.74 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -95.12 103.74 12.89 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.183 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.23 -22.45 19.0 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.084 1.856 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.1 30.62 6.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -89.26 -8.47 53.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.734 0.778 . . . . 0.0 108.951 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 20.9 ptm -92.82 70.53 4.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.716 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp -81.68 81.9 7.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.577 HG22 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.692 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' B' ' 5' ' ' LEU . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 -155.99 170.36 22.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -112.37 -6.44 14.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.614 0.245 . . . . 0.0 110.519 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.6 p -84.75 -54.4 4.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.02 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 91.5 mttt -81.01 134.65 52.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.095 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 11.0 Cg_endo -86.79 100.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.12 2.547 . . . . 0.0 112.234 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.81 176.07 14.47 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.693 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.76 ' HG3' HG11 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.504 HG13 HD11 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.9 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.501 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.504 HD11 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.431 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.635 ' HG2' HD12 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.563 HG11 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 207' ' ' MET . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.501 ' O ' HG22 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.563 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.692 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.577 ' HG2' HG22 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.635 HD12 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 233' ' ' ARG . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.431 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.78 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.518 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.669 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.7 Cg_endo -76.77 124.56 7.58 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 256' ' ' PRO . 1.1 m 63.67 134.47 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 125.053 1.341 . . . . 0.0 112.015 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.95 116.09 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.343 2.028 . . . . 0.0 112.913 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -101.46 18.69 19.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.822 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 262' ' ' GLY . 6.1 m -65.81 136.66 56.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.861 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 260' ' ' THR . 26.9 t-20 76.13 -21.4 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.727 0.642 . . . . 0.0 110.594 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -97.03 23.86 33.86 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 172.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -70.55 160.04 33.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 264' ' ' ILE . 3.5 mp -71.42 111.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.389 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.84 156.1 28.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.236 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -113.68 133.93 55.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.312 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.75 126.51 16.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.372 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 63.73 91.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.834 0.826 . . . . 0.0 111.147 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 55.1 m -138.81 91.53 2.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.316 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.517 -0.754 . . . . 0.0 109.523 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.563 0.697 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.79 166.57 21.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.082 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 mt 59.15 52.48 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.959 0.885 . . . . 0.0 109.003 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -97.34 124.13 50.16 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.469 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.47 -11.79 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.5 2.134 . . . . 0.0 112.093 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -98.95 18.06 18.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.122 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -81.07 -13.26 58.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.719 0.771 . . . . 0.0 109.183 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.403 ' O ' ' HG3' ' A' ' 149' ' ' MET . 21.9 ptt? -129.02 94.6 3.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.869 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.83 -68.61 0.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.56 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.625 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 18.6 t70 -148.36 158.86 44.36 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -90.47 -11.53 40.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.214 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.2 p -127.82 18.85 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.493 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 48.5 mmtm -108.54 134.91 20.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.06 97.62 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 113.095 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.51 177.96 34.06 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.199 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.865 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.597 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.576 HG11 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.682 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 215' ' ' VAL . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.734 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.576 ' CG1' HG11 ' A' ' 202' ' ' VAL . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.578 ' HB3' HD11 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.686 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.628 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.522 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.1 Cg_endo -78.63 151.28 25.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.96 144.7 28.27 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.948 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.32 107.31 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.835 2.356 . . . . 0.0 112.297 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -108.34 77.41 1.1 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.884 0.85 . . . . 0.0 109.069 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -77.48 74.83 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.733 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.77 -33.87 60.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 84.95 -50.22 4.36 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.596 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.42 6.05 7.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.381 0.61 . . . . 0.0 112.317 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.6 mt -91.69 91.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.105 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -111.23 168.74 9.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.7 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -149.78 100.08 2.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.63 176.77 7.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.37 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.0 m120 55.66 44.18 26.89 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 110.325 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.9 p -116.52 170.32 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 270' ' ' ARG . 60.4 mtt-85 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.985 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 70.46 -179.67 0.23 Allowed 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 124.199 0.937 . . . . 0.0 111.569 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.6 153.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.727 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -110.58 103.95 55.12 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.524 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.28 -20.17 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.788 2.325 . . . . 0.0 111.32 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -80.62 19.28 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.26 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -78.82 -17.06 56.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.636 0.731 . . . . 0.0 109.47 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 62.2 mtm -85.88 56.39 3.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.857 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.37 86.58 6.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.63 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD23 HD13 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -113.62 152.46 30.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.22 -11.91 59.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.3 m -96.62 -5.38 39.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.445 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.54 144.58 29.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.53 104.85 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.807 2.338 . . . . 0.0 112.756 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 -161.75 20.66 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.847 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.534 ' HG2' HG21 ' A' ' 215' ' ' VAL . 13.9 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.814 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.706 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.64 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.413 ' O ' HG22 ' A' ' 215' ' ' VAL . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.64 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.706 HG12 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.498 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.42 ' CB ' HG23 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.818 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 151' ' ' ARG . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.553 ' HG2' HG11 ' A' ' 244' ' ' VAL . 31.2 Cg_exo -60.44 156.31 42.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 25.0 t 62.42 82.75 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.193 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.71 137.2 53.03 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.295 2.663 . . . . 0.0 113.159 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -119.22 6.41 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.608 0.718 . . . . 0.0 109.343 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 38.1 p -99.2 107.9 20.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.301 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -68.11 -36.99 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -84.69 78.48 2.0 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.226 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.56 142.96 42.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 111.216 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 264' ' ' ILE . 4.2 mp -76.14 87.4 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.542 0.687 . . . . 0.0 110.152 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -76.19 158.66 31.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.52 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -73.1 84.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.091 0.472 . . . . 0.0 109.824 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.84 104.89 0.49 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.865 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -91.49 145.42 24.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.7 p -120.91 112.72 19.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.083 0.468 . . . . 0.0 111.141 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 177.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.516 0.198 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 -62.88 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 4' ' ' ARG . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.606 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 58.8 mt -87.37 111.77 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -86.53 107.07 12.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.146 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 0.9 OUTLIER -85.23 -44.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.908 2.405 . . . . 0.0 111.757 175.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -86.71 24.11 1.53 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.425 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.3 t -83.34 -19.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.462 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 72.5 mtm 41.56 69.25 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.588 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt -76.16 86.72 3.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.462 ' HE ' ' HB3' ' A' ' 149' ' ' MET . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.694 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.902 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.587 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.694 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.586 ' H ' ' HB2' ' A' ' 174' ' ' LYS . 50.1 m-20 -109.62 165.17 11.88 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -72.14 -7.56 49.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.622 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.8 p -121.91 16.99 10.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.553 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.586 ' HB2' ' H ' ' A' ' 171' ' ' ASP . 32.2 mmtp -128.78 100.96 20.75 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.43 -33.48 6.89 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.595 2.197 . . . . 0.0 112.417 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.04 149.96 41.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.136 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.818 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.456 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 179' ' ' ILE . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG11 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.471 ' HA ' ' CG ' ' A' ' 210' ' ' LYS . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.59 HG21 HD13 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.527 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.902 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 234' ' ' GLU . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.635 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo -53.02 156.44 9.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 2.4 p -120.9 137.94 27.13 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.224 -171.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 14.2 Cg_exo -70.37 178.79 4.58 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.025 2.483 . . . . 0.0 112.561 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 58.94 28.19 17.26 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.061 0.545 . . . . 0.0 111.986 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.4 p -106.36 45.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.359 0.599 . . . . 0.0 111.702 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.33 -9.54 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.694 0.759 . . . . 0.0 109.377 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -117.82 116.66 3.52 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.812 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -81.95 137.72 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 51.0 mm -63.13 124.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.152 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -79.43 91.73 5.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.52 125.26 25.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.097 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.09 107.56 14.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.476 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.72 108.56 19.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.0 p -92.98 154.21 18.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.232 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.446 -179.01 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 46.8 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 1' ' ' GLN . 1.1 m-20 68.23 -179.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.639 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 219' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.3 pt -79.74 136.49 23.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.908 0.385 . . . . 0.0 110.536 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 148' ' ' THR . 24.3 t70 -150.04 128.36 5.93 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.874 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.44 -13.12 32.66 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.437 2.091 . . . . 0.0 113.53 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.83 13.96 24.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 145' ' ' ASP . 9.6 t -108.25 -2.52 19.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.808 0.813 . . . . 0.0 108.983 168.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 151' ' ' ARG . 75.1 mtp -78.2 83.37 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.418 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt 65.4 2.49 1.98 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.5 0.72 . . . . 0.0 111.661 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.722 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.531 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.739 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.637 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -126.64 161.4 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.8 -2.49 26.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.389 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -124.21 11.88 8.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.579 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.42 107.7 19.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -81.69 -11.03 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.348 2.699 . . . . 0.0 111.759 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -111.04 146.88 17.72 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.87 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.953 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.533 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 187' ' ' PRO . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.505 HG11 ' CG1' ' A' ' 219' ' ' ILE . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.548 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.4 ' O ' HG22 ' A' ' 215' ' ' VAL . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.548 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.505 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.531 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.816 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.466 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.766 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.547 ' HG2' HG11 ' A' ' 244' ' ' VAL . 24.5 Cg_exo -63.4 86.64 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 95.1 t -139.95 95.03 8.73 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.98 121.54 9.65 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.676 2.25 . . . . 0.0 112.812 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -100.15 -2.07 35.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.555 0.693 . . . . 0.0 109.869 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 265' ' ' GLN . 2.3 m -106.34 78.63 1.3 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.323 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.6 -23.58 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.099 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.22 -51.36 13.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.703 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.87 145.02 30.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 21.6 mt -81.69 66.86 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.759 0.79 . . . . 0.0 110.385 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.782 ' HB2' HG21 ' A' ' 260' ' ' THR . 73.1 mm-40 -105.08 83.04 1.93 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.943 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 267' ' ' GLU . 96.4 mttt -123.94 70.24 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.648 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 266' ' ' LYS . 35.9 tt0 71.51 133.15 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.919 0.762 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 54.8 t30 69.59 -68.67 0.19 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.256 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.9 m 53.02 79.89 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.987 0.804 . . . . 0.0 111.406 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.523 -178.055 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.637 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 8.4 tp-100 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.857 0.361 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -93.34 170.16 9.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.305 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.739 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.8 mt -110.15 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.651 0.262 . . . . 0.0 110.489 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.85 108.07 39.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.33 -13.05 23.09 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.569 2.179 . . . . 0.0 111.303 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -93.47 15.96 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.619 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -72.67 -22.36 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.139 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -86.43 60.68 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.823 0.82 . . . . 0.0 110.392 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp -80.48 88.58 5.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.662 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.641 HD21 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.466 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.636 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.633 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 13.2 t-20 -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.655 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.51 173.77 11.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -72.83 -11.24 60.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.56 -166.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.0 t -136.08 28.75 3.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.109 0.481 . . . . 0.0 110.426 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -121.19 97.42 47.7 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.71 -16.28 18.78 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.039 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -105.56 146.01 16.01 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.586 ' HG3' HG11 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.934 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.934 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.56 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.438 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.545 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.728 HG21 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 219' ' ' ILE . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.65 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.657 ' SD ' HG12 ' A' ' 215' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.657 HG12 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.633 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.636 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.466 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.641 ' HE3' HD21 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.423 ' HD2' HG13 ' A' ' 244' ' ' VAL . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.527 ' HB2' HG12 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.527 HG12 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.728 ' HG2' HG21 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 259' ' ' PHE . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.628 ' O ' HG22 ' A' ' 257' ' ' VAL . 58.3 Cg_endo -72.38 152.93 55.6 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 256' ' ' PRO . 1.8 m 61.13 158.76 0.11 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.87 1.268 . . . . 0.0 112.56 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.43 143.28 17.13 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.756 2.304 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' A' ' 255' ' ' LEU . 61.8 m-85 -83.03 68.91 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.412 0.625 . . . . 0.0 110.293 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.8 t -90.05 32.04 0.94 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.762 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.64 -12.11 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -87.43 41.5 3.09 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.15 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.84 -157.49 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 53.5 mt -68.54 96.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.38 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -83.76 70.26 10.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.534 0.683 . . . . 0.0 109.469 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -114.48 83.04 1.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.859 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -85.92 114.53 22.9 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -88.58 -0.9 57.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.431 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.6 p -122.05 63.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.408 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.655 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 3.6 pt20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.988 0.423 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 2.2 m-20 -136.01 168.36 19.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.6 pt -124.7 106.56 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.287 0.565 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.6 112.43 65.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.235 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.22 -15.86 22.62 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.511 2.141 . . . . 0.0 112.283 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.71 38.09 0.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.072 0.463 . . . . 0.0 111.087 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.4 t -78.9 -27.39 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt 43.68 94.7 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.417 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt -67.65 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.95 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.519 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.506 ' ND2' ' HG2' ' B' ' 4' ' ' ARG . 28.1 t-20 -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 12.6 t60 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 1.004 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . 20.1 m-20 -133.84 155.96 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -80.96 12.71 3.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.939 0.876 . . . . 0.0 109.955 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.6 m -127.26 12.63 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.555 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 1.004 ' HG2' ' HB2' ' A' ' 171' ' ' ASP . 34.0 mmtp -115.01 140.68 25.88 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.143 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.83 -20.6 19.65 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.793 2.328 . . . . 0.0 113.404 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -162.55 -169.05 25.38 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.764 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' A' ' 212' ' ' HIS . 0.1 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.762 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.773 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.762 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 87.2 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.45 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.893 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.606 ' HA ' ' NE2' ' A' ' 177' ' ' GLN . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.893 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.45 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 236' ' ' ASP . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 259' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.535 HD21 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo -77.61 -155.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.32 152.38 96.54 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.58 -163.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.398 2.732 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.2 p90 -100.51 4.4 43.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.525 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 29.3 m -66.89 146.37 54.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 260' ' ' THR . 12.4 m120 79.83 -3.74 1.99 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.062 0.851 . . . . 0.0 110.456 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.73 -0.27 75.67 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -68.6 137.25 54.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.9 mt -75.73 94.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.69 135.48 49.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.459 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.95 17.21 24.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.485 0.659 . . . . 0.0 109.533 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.17 138.62 31.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.273 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -143.72 85.05 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.714 0.768 . . . . 0.0 110.874 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.2 t -156.28 118.19 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.617 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.85 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 64.42 -176.39 0.17 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.523 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.494 ' HG1' ' HE2' ' A' ' 212' ' ' HIS . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.506 ' HG2' ' ND2' ' A' ' 167' ' ' ASN . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.937 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.2 OUTLIER -83.95 151.48 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -111.64 93.93 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.427 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.02 -22.05 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.244 1.963 . . . . 0.0 112.051 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -88.22 -1.17 57.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.709 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.2 t -70.62 -18.76 62.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mtp -81.02 72.89 8.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 235' ' ' THR . 13.9 tp -74.77 80.75 2.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 -172.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.42 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.762 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.615 ' HD2' ' HB3' ' B' ' 1' ' ' GLN . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.548 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -101.06 152.97 19.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -94.15 15.76 16.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.819 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.8 m -119.41 -62.67 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 132.76 28.27 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.83 135.79 6.87 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.507 2.138 . . . . 0.0 112.394 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 133.03 168.13 11.87 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.854 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.573 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.6 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.762 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.423 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 96.0 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.421 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.733 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.733 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.685 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.421 HG23 HH11 ' A' ' 198' ' ' ARG . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.551 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.468 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.551 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.664 HG23 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.494 ' HB2' HG22 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.562 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo -62.03 170.02 6.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.82 98.86 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.115 0.566 . . . . 0.0 110.89 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.79 167.46 21.21 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.733 2.289 . . . . 0.0 112.453 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.405 ' O ' HG22 ' A' ' 260' ' ' THR . 33.9 p90 -115.98 29.61 7.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 261' ' ' ASN . 0.5 OUTLIER 72.79 173.77 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.921 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.459 ' N ' HG23 ' A' ' 260' ' ' THR . 67.1 t30 77.95 -11.98 1.13 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.725 0.81 . . . . 0.0 110.357 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -170.97 77.93 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.679 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.56 110.74 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.424 0.631 . . . . 0.0 109.961 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.02 120.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.741 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -74.81 121.04 21.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.384 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -79.24 135.68 36.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.973 0.415 . . . . 0.0 111.106 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.37 150.41 22.63 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -87.83 17.17 5.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.027 0.441 . . . . 0.0 111.318 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -92.23 120.34 32.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.434 -177.047 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.615 ' HB3' ' HD2' ' A' ' 169' ' ' HIS . 55.9 mt-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.752 0.311 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 57.97 -103.15 0.17 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.873 0.869 . . . . 0.0 112.843 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -87.57 118.45 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.821 0.343 . . . . 0.0 110.227 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -87.82 117.3 68.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.109 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.5 -7.67 15.89 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.587 2.192 . . . . 0.0 111.877 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -89.11 17.81 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.484 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -83.65 -16.09 46.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.546 0.689 . . . . 0.0 109.401 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.5 mtt -103.9 76.3 1.36 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.583 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt -81.67 -83.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.629 ' HG2' HD21 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG12 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.878 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' B' ' 4' ' ' ARG . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.588 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.42 152.34 19.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -95.09 59.28 2.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.824 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.4 p -169.55 -65.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.174 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -83.39 146.84 51.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.01 0.433 . . . . 0.0 111.582 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -88.48 120.74 1.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.172 2.581 . . . . 0.0 112.427 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.86 127.03 1.13 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.607 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.951 ' HG3' HG11 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.878 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.405 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 203' ' ' ASN . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.686 ' SD ' HG12 ' A' ' 215' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.508 ' O ' HG22 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.55 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.951 HG11 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 212' ' ' HIS . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.566 ' HB3' HD11 ' A' ' 154' ' ' LEU . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.435 ' HA ' HD13 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.405 ' HB3' HG12 ' A' ' 244' ' ' VAL . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.687 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.548 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.629 HD21 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.531 ' HG3' HG11 ' A' ' 244' ' ' VAL . 37.6 Cg_endo -72.2 108.32 2.46 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 4.7 m -149.01 129.45 6.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.076 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 31.4 Cg_exo -61.35 109.66 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.972 2.448 . . . . 0.0 112.635 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -107.29 104.57 14.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.265 0.555 . . . . 0.0 110.792 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 262' ' ' GLY . 27.2 m 72.5 -74.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.126 175.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' THR . 6.1 m-20 69.14 -21.79 0.15 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.278 0.631 . . . . 0.0 112.2 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 260' ' ' THR . . . -80.97 58.05 4.82 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.561 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -117.59 113.98 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 110.019 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.84 75.01 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.69 0.757 . . . . 0.0 110.812 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -130.62 32.02 4.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.987 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -63.15 128.91 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.009 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -55.52 110.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.655 0.597 . . . . 0.0 111.905 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -117.61 73.99 0.91 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.906 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.4 t -84.13 62.35 7.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.297 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.083 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.008 0.432 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 -119.72 -171.48 2.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.975 -172.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.791 -0.523 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.97 80.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 20.4 m-20 -66.45 118.6 55.23 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.177 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.33 -19.8 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.761 2.307 . . . . 0.0 110.839 170.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -108.78 35.66 3.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.505 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 11.3 t -96.88 -8.11 31.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.348 0.594 . . . . 0.0 109.823 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.9 mtt -79.12 131.93 36.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt -77.84 87.98 4.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.669 ' HD2' HD21 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.852 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 38.3 t70 -128.15 168.48 15.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -78.66 -37.56 41.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.869 0.366 . . . . 0.0 110.34 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 m -84.65 -16.0 43.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.194 0.521 . . . . 0.0 110.23 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 69.2 mmtt -120.76 80.41 32.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.111 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.66 -33.05 22.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.84 2.36 . . . . 0.0 111.912 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.47 132.5 18.34 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.597 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.42 HG13 HD11 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 180' ' ' ARG . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 189' ' ' GLU . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 179' ' ' ILE . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.442 ' HA2' ' OE1' ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 214' ' ' ASP . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.775 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.529 ' CG1' HG11 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.472 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.53 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.586 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 22.8 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.669 HD21 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo -94.31 -169.31 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 5.1 p -124.85 122.44 25.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 120.814 0.34 . . . . 0.0 110.296 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 23.5 Cg_exo -64.52 152.3 82.23 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.74 2.293 . . . . 0.0 111.708 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -85.87 9.72 15.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 110.948 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 80.4 m -154.57 114.2 3.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.685 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.89 -16.75 26.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.541 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 86.7 -63.09 4.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.73 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.22 152.97 23.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.73 125.86 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.8 118.23 5.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.374 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -100.7 114.24 27.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.345 0.593 . . . . 0.0 111.108 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 270' ' ' ARG . 78.2 tt0 -109.78 127.96 54.99 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -65.53 -31.38 72.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.89 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.2 p -123.49 65.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 267' ' ' GLU . 15.5 tpp180 . . . . . 0 C--O 1.243 0.762 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.882 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.528 0.204 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.57 -77.25 0.08 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.491 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.987 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.9 mt -88.05 84.93 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 146' ' ' PRO . 14.3 m-20 -56.9 118.44 23.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.271 -174.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 145' ' ' ASP . 25.1 Cg_endo -63.04 -23.22 73.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.797 2.331 . . . . 0.0 111.874 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.36 19.66 6.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -75.23 -10.8 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.666 0.746 . . . . 0.0 109.228 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 76.5 mtp -101.68 98.39 8.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.779 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? -92.51 87.31 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.824 ' HG3' HD21 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HB3' HG12 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.54 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.712 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -117.29 156.33 27.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -103.76 -20.49 13.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.6 m -96.63 -40.99 8.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -109.18 139.74 21.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.0 -11.92 7.38 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.916 2.41 . . . . 0.0 113.172 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.52 135.75 27.35 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.014 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.719 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.54 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.769 ' HG2' HD12 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.588 HG12 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.445 HG21 HD13 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.712 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.55 HG23 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.54 ' HB3' HD21 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.769 HD12 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.6 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.634 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 258' ' ' PRO . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.54 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.824 HD21 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 94.4 Cg_endo -82.19 176.56 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.34 101.01 44.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.69 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.536 ' HG3' ' CE1' ' A' ' 238' ' ' PHE . 62.6 Cg_endo -73.01 133.86 20.48 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.352 2.035 . . . . 0.0 112.518 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -95.44 2.87 54.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.728 0.775 . . . . 0.0 109.423 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.548 HG23 HG13 ' A' ' 264' ' ' ILE . 5.6 m -105.09 77.87 1.35 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -61.79 -33.98 75.07 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 260' ' ' THR . . . -129.56 -113.28 1.63 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -129.41 143.26 50.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.069 0.462 . . . . 0.0 110.492 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.617 HG22 ' HG2' ' A' ' 266' ' ' LYS . 49.4 mt -101.41 128.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -79.72 88.84 5.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.851 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.617 ' HG2' HG22 ' A' ' 264' ' ' ILE . 34.7 mmtp -123.63 117.51 25.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.48 61.25 3.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.966 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.03 45.37 21.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.541 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.5 p -69.16 118.06 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.527 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.708 -178.5 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' B' ' 2' ' ' ASP . 19.2 pt20 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.743 ' H ' ' HG3' ' B' ' 1' ' ' GLN . 22.7 m-20 55.15 -163.94 0.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 174.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.1 mt -88.12 89.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 148' ' ' THR . 13.6 m-20 -114.42 75.92 3.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.953 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 -22.41 14.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.14 1.893 . . . . 0.0 111.956 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -112.66 35.01 4.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.663 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 145' ' ' ASP . 14.5 t -78.03 -21.78 50.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.777 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -79.78 89.54 5.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.25 -78.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.437 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.795 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HB3' HG12 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.539 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.942 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.489 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 -138.69 166.06 25.34 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.9 -11.83 12.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 p -100.5 -23.1 14.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 110.803 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -100.11 136.26 20.16 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.45 102.16 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.359 2.706 . . . . 0.0 112.179 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 128.77 -172.77 19.44 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.486 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.605 ' HG3' HG21 ' A' ' 215' ' ' VAL . 24.6 mm-40 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.797 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.942 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 219' ' ' ILE . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.491 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.491 HG13 HG11 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.572 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.435 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.521 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.56 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB2' HG12 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 200' ' ' VAL . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.487 ' HG2' HG11 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.55 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.795 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.98 142.92 42.13 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.458 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 11.7 m -60.79 122.17 66.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.117 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 16.5 Cg_exo -67.13 145.53 73.38 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.91 2.406 . . . . 0.0 111.428 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -140.4 11.55 2.33 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.513 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.1 m 63.85 86.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.425 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -68.87 -33.37 73.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.867 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.24 -139.88 3.01 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.735 -1.221 . . . . 0.0 113.638 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -93.01 153.25 18.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.133 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 48.2 mm -86.21 84.23 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -78.48 157.49 28.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.369 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -105.02 24.76 11.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -89.64 123.51 33.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.024 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -105.84 90.73 3.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 43.1 m -129.98 43.7 3.08 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.399 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.704 -178.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -126.67 -175.88 3.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.448 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.946 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 21.4 mt 52.35 54.03 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 26.6 m-20 -75.45 110.74 11.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.472 -171.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 145' ' ' ASP . 3.4 Cg_exo -74.59 -23.91 14.27 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.799 2.333 . . . . 0.0 112.307 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.69 29.79 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.153 0.502 . . . . 0.0 111.237 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.771 HG23 ' HG3' ' A' ' 149' ' ' MET . 9.0 t -85.63 -20.49 29.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.771 ' HG3' HG23 ' A' ' 148' ' ' THR . 56.5 mtt -123.22 84.69 2.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.309 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.9 -79.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.03 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.643 ' HG2' HD21 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.52 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.854 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.608 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.74 174.25 11.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.19 38.97 0.88 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -150.65 -33.59 0.16 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.607 0.242 . . . . 0.0 111.003 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.87 117.53 53.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.13 0.491 . . . . 0.0 111.154 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.03 -29.95 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.143 2.562 . . . . 0.0 111.748 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.93 141.82 38.73 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.862 ' HG3' HG21 ' A' ' 215' ' ' VAL . 31.6 mm-40 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 179' ' ' ILE . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.454 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 219' ' ' ILE . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.751 ' SD ' HG12 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.862 HG21 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.854 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.559 ' HB3' HD21 ' A' ' 154' ' ' LEU . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 248' ' ' GLN . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.636 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.37 177.86 1.9 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.69 147.98 94.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.203 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.36 151.0 85.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.834 2.356 . . . . 0.0 111.69 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -87.45 10.89 16.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.857 -176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 88.6 m -64.66 132.48 49.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 260' ' ' THR . 74.2 m-20 76.63 -9.01 1.57 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.448 0.699 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.06 55.02 3.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.83 141.87 46.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.985 0.421 . . . . 0.0 110.718 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.5 124.23 39.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.382 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -69.73 133.6 47.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.358 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -97.45 138.43 34.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.548 ' HG3' HD22 ' A' ' 268' ' ' ASN . 9.0 tp10 67.75 143.8 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.722 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 267' ' ' GLU . 32.3 m-80 61.72 40.81 12.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.412 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.7 m -80.85 58.38 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.652 . . . . 0.0 109.419 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.993 -174.419 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 -127.25 176.86 7.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.094 -174.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.569 HG22 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.724 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.33 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 148' ' ' THR . 10.9 m-20 -117.08 152.89 49.42 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -171.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.25 -14.56 9.43 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.75 2.3 . . . . 0.0 113.216 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.13 33.6 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.361 0.601 . . . . 0.0 111.425 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 151' ' ' ARG . 10.2 t -137.89 39.38 2.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.727 1.251 . . . . 0.0 109.375 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.626 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 24.7 ptp -60.15 -33.64 72.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.926 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.626 ' HG ' ' HG3' ' A' ' 149' ' ' MET . 68.5 mt -113.59 26.63 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.912 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 14.6 t60 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -142.65 160.37 40.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -89.8 -17.19 28.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.609 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -100.98 -23.14 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.043 0.449 . . . . 0.0 110.149 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.04 122.23 56.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.01 142.48 12.4 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.796 2.331 . . . . 0.0 112.144 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.78 -160.17 32.33 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.892 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 198' ' ' ARG . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.551 ' HA ' ' HB1' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.605 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.584 ' HB2' HD12 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.513 ' HE3' ' HB ' ' A' ' 202' ' ' VAL . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' B' ' 2' ' ' ASP . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.559 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.912 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.516 ' HB3' HD21 ' A' ' 154' ' ' LEU . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.408 ' HD1' HG13 ' A' ' 244' ' ' VAL . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.421 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.77 166.14 7.09 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.11 117.0 50.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.059 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 163.72 35.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.774 2.316 . . . . 0.0 112.129 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -86.18 35.35 0.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.434 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.7 m 57.52 53.9 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.525 0.678 . . . . 0.0 111.447 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -99.41 -28.44 13.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.675 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 71.48 -90.21 0.45 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.271 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -110.69 -179.74 3.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.784 0.434 . . . . 0.0 110.124 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 38.5 mt -114.99 63.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 7.1 tp-100 -84.08 112.74 20.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.887 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -85.17 88.32 7.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 41.9 mt-10 -82.3 141.07 33.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.989 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 t30 63.28 99.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.927 0.767 . . . . 0.0 110.881 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -140.89 93.91 2.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.639 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.492 -179.885 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -81.73 -83.2 0.12 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.114 -0.394 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.4 mt -77.34 94.46 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -57.03 113.23 5.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.643 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.7 -14.88 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.04 2.493 . . . . 0.0 110.978 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.8 14.18 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.981 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.1 t -81.79 -2.37 50.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 110.057 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -67.04 107.33 2.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.708 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt -96.33 -95.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.541 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD3' ' CE2' ' A' ' 239' ' ' PHE . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.98 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.32 152.47 40.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -86.69 71.39 10.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.612 0.72 . . . . 0.0 109.216 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.2 m -151.47 -39.29 0.12 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.982 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -158.83 156.82 27.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.97 159.19 11.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.2 2.6 . . . . 0.0 111.352 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.85 90.94 1.67 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.098 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.481 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.98 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 189' ' ' GLU . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 ' CG1' ' A' ' 219' ' ' ILE . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.735 ' SD ' HG12 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.735 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.511 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 234' ' ' GLU . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 233' ' ' ARG . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.538 ' HA ' HD13 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.638 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.508 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.418 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 255' ' ' LEU . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.42 150.29 57.86 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.1 t 56.84 86.7 0.16 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.2 119.13 6.08 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.748 2.298 . . . . 0.0 111.524 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -84.01 3.09 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.111 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 2.9 m 67.95 166.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.452 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 77.42 -23.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.587 0.755 . . . . 0.0 111.348 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.23 3.38 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.463 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.11 149.71 26.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.88 129.35 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.91 136.83 39.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -103.54 65.51 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.39 151.85 19.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.15 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -161.19 96.73 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.749 0.785 . . . . 0.0 110.726 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.7 p -63.97 -28.42 69.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.864 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.552 175.29 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.476 ' HB3' HD21 ' A' ' 167' ' ' ASN . 2.9 m-20 -137.61 178.47 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.591 ' HD2' ' H ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.3 mt 68.29 99.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.48 0.657 . . . . 0.0 111.767 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -115.98 96.12 46.19 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.47 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.83 -51.95 0.44 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.028 2.485 . . . . 0.0 113.615 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.05 31.78 0.96 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -88.15 -24.58 23.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.804 0.811 . . . . 0.0 108.906 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 93.9 mmm -97.44 66.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt -78.11 -84.91 0.07 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 164' ' ' TYR . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.483 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.68 174.12 6.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -50.86 -52.93 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.724 0.64 . . . . 0.0 110.483 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 t -143.33 72.29 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.404 0.621 . . . . 0.0 109.802 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -63.23 145.82 96.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.745 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.08 -15.5 18.41 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.202 2.601 . . . . 0.0 111.899 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -177.72 171.97 44.61 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.513 ' HG3' HG11 ' A' ' 215' ' ' VAL . 15.6 mm100 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.68 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.519 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.733 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.519 HG12 ' CE ' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 215' ' ' VAL . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 225' ' ' GLU . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.57 ' HA ' HD13 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.802 ' HA ' ' HE ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.671 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.468 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo -70.48 122.13 8.63 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 18.9 m -54.37 144.07 43.45 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.533 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 6.0 Cg_exo -79.43 106.13 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.964 2.443 . . . . 0.0 111.651 173.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -98.31 23.58 8.22 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.397 0.618 . . . . 0.0 110.226 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.9 m -86.33 72.52 10.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.712 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -75.53 -30.51 59.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.418 0.628 . . . . 0.0 110.304 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -100.29 66.95 0.54 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.481 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.71 137.92 53.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.3 mt -87.48 87.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.122 0.486 . . . . 0.0 109.843 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -95.44 151.5 19.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.128 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -107.09 98.73 8.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.101 0.477 . . . . 0.0 110.086 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 129.45 38.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.824 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 62.61 54.55 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.647 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 63.2 m -150.26 110.11 4.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.127 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.205 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 62.11 -168.3 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.483 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.0 146.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -112.75 98.81 46.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.754 0.312 . . . . 0.0 110.396 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.49 -15.15 37.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.377 2.051 . . . . 0.0 112.015 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.13 20.32 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 149' ' ' MET . 14.8 t -79.25 -18.38 52.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.452 0.644 . . . . 0.0 109.485 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.546 ' HG3' HG23 ' A' ' 148' ' ' THR . 51.8 mtt -116.56 119.12 34.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.351 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? -83.85 69.78 10.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.632 ' HG2' HD21 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB2' HD21 ' A' ' 229' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.686 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' B' ' 5' ' ' LEU . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 12.9 t70 -140.98 165.61 27.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -51.74 -56.87 11.25 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.606 0.566 . . . . 0.0 111.536 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -101.09 34.02 2.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.463 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.519 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 70.3 mmtt -112.86 100.0 49.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.655 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.36 -0.87 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.415 . . . . 0.0 111.869 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.54 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . -123.81 143.46 14.93 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.691 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG3' HG11 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.665 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.859 ' HB ' HD12 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.531 HG12 ' HE3' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.656 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.734 ' SD ' HG12 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.54 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 214' ' ' ASP . 74.2 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 216' ' ' VAL . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 211' ' ' GLN . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.734 HG12 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.561 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.686 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.859 HD12 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.51 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.442 ' HB2' HG12 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 53.8 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo -54.46 123.5 13.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.37 131.06 33.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.294 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.81 106.93 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.599 2.199 . . . . 0.0 111.747 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.28 41.17 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.7 m -116.89 62.85 0.72 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.648 0.737 . . . . 0.0 109.51 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.45 -16.22 17.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.218 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.52 74.04 0.92 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.683 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.08 144.45 55.25 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.742 0.417 . . . . 0.0 110.938 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.9 mt -85.21 67.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.692 0.758 . . . . 0.0 109.956 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -118.65 111.15 18.17 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.33 126.45 29.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.698 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.71 159.13 42.85 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -140.02 170.25 16.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.618 0.247 . . . . 0.0 111.034 -175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.5 t 63.32 79.86 0.25 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.071 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.249 176.919 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -111.0 -176.49 2.97 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 39.9 pt -116.25 172.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.271 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 1.6 m-20 -100.97 99.78 11.33 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.727 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 18.0 Cg_exo -65.46 -22.55 59.02 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.425 2.084 . . . . 0.0 110.614 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -110.69 35.13 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.596 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 11.9 t -69.74 -27.27 64.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 110.055 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 56.8 mtm -103.18 92.49 4.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? -75.0 79.39 2.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.568 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.562 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.557 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.562 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 22.2 t-20 -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -111.44 167.56 10.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 172' ' ' LYS . 9.1 mmpt? -66.65 -29.29 69.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.193 0.521 . . . . 0.0 110.035 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.9 m -91.1 -8.19 49.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.215 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -122.32 87.05 48.26 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.942 -176.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -22.01 10.53 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.187 2.591 . . . . 0.0 112.163 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . -76.55 117.1 4.86 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.61 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.449 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 189' ' ' GLU . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 183' ' ' ASP . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.573 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.564 ' HB2' HD12 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 219' ' ' ILE . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 219' ' ' ILE . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.683 ' SD ' HG12 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.683 HG12 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.571 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.557 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.516 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB3' HD11 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.427 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 27.6 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.22 158.48 39.59 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 4.4 m -96.17 121.11 61.4 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.99 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 14.5 Cg_exo -68.17 128.28 17.29 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.803 2.335 . . . . 0.0 111.579 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -92.12 50.67 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.208 0.528 . . . . 0.0 109.962 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 261' ' ' ASN . 10.7 m 57.42 -96.03 0.06 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.348 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 260' ' ' THR . 5.7 t-20 70.04 -43.49 0.54 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.063 0.545 . . . . 0.0 110.86 -174.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 260' ' ' THR . . . 157.17 -154.07 25.22 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.57 173.04 12.75 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.61 97.48 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.24 111.53 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.95 0.781 . . . . 0.0 111.039 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -121.61 50.11 1.45 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.92 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.51 80.28 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.699 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -103.2 21.69 15.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 48.2 t -91.27 108.82 20.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.298 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.958 176.575 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.46 164.02 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.663 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.545 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 167' ' ' ASN . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.678 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 219' ' ' ILE . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 2.9 t-20 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.457 ' HA3' ' ND2' ' A' ' 203' ' ' ASN . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.606 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.445 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.587 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.689 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo . . . . . 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.42 0.629 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.46 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.515 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.805 0.114 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.541 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.688 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.691 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 219' ' ' ILE . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 210' ' ' LYS . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.482 HG12 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.586 HG21 HD13 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 220' ' ' ARG . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.681 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.601 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 244' ' ' VAL . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.681 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.688 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.66 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.425 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.149 0.5 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.577 HG22 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.692 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' B' ' 5' ' ' LEU . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.76 ' HG3' HG11 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.504 HG13 HD11 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.9 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.501 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.504 HD11 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.431 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.635 ' HG2' HD12 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.563 HG11 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 207' ' ' MET . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.501 ' O ' HG22 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.563 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.692 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.577 ' HG2' HG22 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.635 HD12 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 233' ' ' ARG . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.431 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.78 ' HE ' ' HA ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.518 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.669 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.7 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 121.284 0.564 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.625 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.789 0.105 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.865 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.597 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.576 HG11 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.682 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 215' ' ' VAL . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.734 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.576 ' CG1' HG11 ' A' ' 202' ' ' VAL . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.578 ' HB3' HD11 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.686 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.628 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.522 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.1 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.63 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD23 HD13 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.534 ' HG2' HG21 ' A' ' 215' ' ' VAL . 1.4 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.814 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.706 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.64 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.413 ' O ' HG22 ' A' ' 215' ' ' VAL . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.64 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.706 HG12 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.498 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.42 ' CB ' HG23 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.818 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 151' ' ' ARG . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.553 ' HG2' HG11 ' A' ' 244' ' ' VAL . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 4' ' ' ARG . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.694 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.902 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.587 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.694 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.818 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.456 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 179' ' ' ILE . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG11 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.471 ' HA ' ' CG ' ' A' ' 210' ' ' LYS . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.59 HG21 HD13 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.527 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.902 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 234' ' ' GLU . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.635 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo . . . . . 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 219' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.285 0.565 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.722 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.531 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.739 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.953 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.533 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 187' ' ' PRO . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.505 HG11 ' CG1' ' A' ' 219' ' ' ILE . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.548 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.4 ' O ' HG22 ' A' ' 215' ' ' VAL . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.548 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.505 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.531 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.816 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.466 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.766 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.547 ' HG2' HG11 ' A' ' 244' ' ' VAL . 24.5 Cg_exo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.739 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.502 0.667 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.641 HD21 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.466 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.636 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.633 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.586 ' HG3' HG11 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.934 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.934 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.56 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.438 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.545 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.728 HG21 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 219' ' ' ILE . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.65 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.657 ' SD ' HG12 ' A' ' 215' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.657 HG12 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.633 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.636 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.466 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.641 ' HE3' HD21 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.423 ' HD2' HG13 ' A' ' 244' ' ' VAL . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.527 ' HB2' HG12 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.527 HG12 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.728 ' HG2' HG21 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 256' ' ' PRO . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.435 ' HG3' HG11 ' A' ' 244' ' ' VAL . 58.3 Cg_endo . . . . . 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.417 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.27 0.081 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.519 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 44.3 t-80 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 112.764 -0.135 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.686 ' N ' HE21 ' A' ' 177' ' ' GLN . 0.0 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.762 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.773 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.762 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 196' ' ' GLN . 15.4 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.45 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.893 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.494 ' HE2' ' HG1' ' B' ' 3' ' ' THR . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.893 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.45 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 236' ' ' ASP . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.535 HD21 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.25 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.494 ' HG1' ' HE2' ' A' ' 212' ' ' HIS . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 235' ' ' THR . 13.9 tp . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.42 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.762 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 167' ' ' ASN . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.548 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.573 ' HG2' HG21 ' A' ' 215' ' ' VAL . 2.2 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.762 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.423 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 21.8 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.421 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.733 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.733 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.685 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.551 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.468 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.551 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.664 HG23 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.494 ' HB2' HG22 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.562 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.629 ' HG2' HD21 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG12 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.878 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' B' ' 4' ' ' ARG . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.588 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.951 ' HG3' HG11 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.878 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.405 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 203' ' ' ASN . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.686 ' SD ' HG12 ' A' ' 215' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.508 ' O ' HG22 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.55 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.951 HG11 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 212' ' ' HIS . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.566 ' HB3' HD11 ' A' ' 154' ' ' LEU . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.435 ' HA ' HD13 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.405 ' HB3' HG12 ' A' ' 244' ' ' VAL . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.687 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.548 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.629 HD21 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.531 ' HG3' HG11 ' A' ' 244' ' ' VAL . 37.6 Cg_endo . . . . . 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 . . . . . 0 CA--C 1.517 -0.321 0 CA-C-O 120.656 0.265 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.669 ' HD2' HD21 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.852 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 167' ' ' ASN . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.597 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.42 HG13 HD11 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 180' ' ' ARG . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 189' ' ' GLU . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 179' ' ' ILE . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.896 ' HA2' HE22 ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 214' ' ' ASP . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.775 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.529 ' CG1' HG11 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.472 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.53 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.496 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.896 HE22 ' HA2' ' A' ' 204' ' ' GLY . 63.6 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.669 HD21 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.824 ' HG3' HD21 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HB3' HG12 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.54 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.712 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.796 ' HA ' HE21 ' A' ' 177' ' ' GLN . 0.0 OUTLIER -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.719 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.54 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 196' ' ' GLN . 20.1 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.769 ' HG2' HD12 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.588 HG12 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.445 HG21 HD13 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.712 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.55 HG23 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.54 ' HB3' HD21 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.769 HD12 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.6 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.634 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.54 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.824 HD21 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 94.4 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 168' ' ' LEU . 22.7 m-20 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.795 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HB3' HG12 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.539 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.942 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.489 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.605 ' HG3' HG21 ' A' ' 215' ' ' VAL . 13.7 mm100 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.797 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.942 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 219' ' ' ILE . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.491 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.491 HG13 HG11 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.572 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.435 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.521 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.56 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB2' HG12 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 200' ' ' VAL . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.487 ' HG2' HG11 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.55 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.795 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.448 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.326 0.108 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.643 ' HG2' HD21 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.52 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.854 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.608 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.862 ' HG3' HG21 ' A' ' 215' ' ' VAL . 31.6 mm-40 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 179' ' ' ILE . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.454 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 219' ' ' ILE . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.751 ' SD ' HG12 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.862 HG21 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.854 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.559 ' HB3' HD21 ' A' ' 154' ' ' LEU . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 248' ' ' GLN . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.636 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-O 121.152 0.501 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.569 HG22 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.724 ' H ' ' HD2' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 68.5 mt . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.912 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.52 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.52 ' N ' HD22 ' A' ' 167' ' ' ASN . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.469 ' HD2' ' OD1' ' B' ' 2' ' ' ASP . 11.1 t-160 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.777 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 198' ' ' ARG . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HA ' ' HD2' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.551 ' HA ' ' HB1' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.605 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.584 ' HB2' HD12 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.513 ' HE3' ' HB ' ' A' ' 202' ' ' VAL . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' B' ' 2' ' ' ASP . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.559 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.912 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.516 ' HB3' HD21 ' A' ' 154' ' ' LEU . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.456 ' HD3' ' H ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.408 ' HD1' HG13 ' A' ' 244' ' ' VAL . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.421 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD3' ' CE2' ' A' ' 239' ' ' PHE . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.98 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.481 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.98 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 189' ' ' GLU . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 ' CG1' ' A' ' 219' ' ' ILE . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.735 ' SD ' HG12 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.735 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.511 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 234' ' ' GLU . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 233' ' ' ARG . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.538 ' HA ' HD13 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.638 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.508 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.418 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 255' ' ' LEU . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.476 ' HB3' HD21 ' A' ' 167' ' ' ASN . 2.9 m-20 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 164' ' ' TYR . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.483 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.513 ' HG3' HG11 ' A' ' 215' ' ' VAL . 15.6 mm100 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.68 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.519 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.733 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.519 HG12 ' CE ' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 3.3 t-20 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.769 ' HA ' ' HE2' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 215' ' ' VAL . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.454 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.57 ' HA ' HD13 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.802 ' HE ' ' HA ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 254' ' ' PRO . 36.8 m80 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.41 ' O ' ' HD2' ' A' ' 250' ' ' HIS . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.671 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.468 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo . . . . . 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.107 0.479 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.483 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.632 ' HG2' HD21 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB2' HD21 ' A' ' 229' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.686 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' B' ' 5' ' ' LEU . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.54 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . . . . . . 0 N--CA 1.441 -0.976 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG3' HG11 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.665 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HA ' ' HD3' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.859 ' HB ' HD12 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.531 HG12 ' HE3' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.656 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.734 ' SD ' HG12 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.54 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 214' ' ' ASP . 25.0 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 216' ' ' VAL . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 211' ' ' GLN . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.734 HG12 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.561 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.686 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.859 HD12 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.51 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.442 ' HB2' HG12 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 8.7 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.568 ' HA ' ' NE ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.562 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.557 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.562 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.449 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 189' ' ' GLU . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 183' ' ' ASP . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.573 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.564 ' HB2' HD12 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 219' ' ' ILE . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 219' ' ' ILE . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.683 ' SD ' HG12 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.683 HG12 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.571 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.557 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.516 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB3' HD11 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.427 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.1 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.663 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.02 131.02 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.874 0.369 . . . . 0.0 110.055 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.603 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 45.7 m-20 -103.69 119.09 55.77 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.211 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -26.07 77.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.223 2.615 . . . . 0.0 113.637 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.4 34.7 4.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.378 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 7.3 t -78.01 -25.52 48.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.443 0.639 . . . . 0.0 109.478 176.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 63.6 mtt -88.49 76.47 8.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.32 80.74 9.1 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.501 0.667 . . . . 0.0 110.967 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 43.0 mtt180 -131.9 146.29 61.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.331 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 229' ' ' LEU . 27.7 Cg_endo -63.52 141.68 81.41 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.628 2.218 . . . . 0.0 112.206 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.06 139.88 30.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 227' ' ' LYS . 60.9 tp -110.53 116.64 31.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.66 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.59 129.55 54.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.275 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.7 m -117.32 116.99 28.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.748 0.309 . . . . 0.0 110.198 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 187' ' ' PRO . 1.3 pmm? -135.51 154.94 51.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.021 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 17.2 pttm -127.55 157.39 40.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.8 mttt -54.07 117.88 3.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.535 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.91 -78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.983 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -87.49 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.758 2.305 . . . . 0.0 112.723 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 t -119.28 21.25 12.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.791 0.805 . . . . 0.0 109.312 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 156.79 -139.47 6.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.582 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.545 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 59.1 m-85 -103.96 -13.43 16.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.042 0.449 . . . . 0.0 110.91 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 101.82 22.79 9.82 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.134 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.9 p90 -129.43 155.19 46.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.537 0.669 . . . . 0.0 111.39 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.65 120.7 42.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.962 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 167' ' ' ASN . 97.0 mt -95.43 131.95 41.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.678 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 21.5 t-80 -107.14 144.07 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.1 t -129.28 140.27 51.49 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -137.11 163.68 30.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.217 0.532 . . . . 0.0 111.656 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -95.79 47.49 1.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 23.0 t -162.84 -48.43 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.415 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -100.24 97.59 6.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.43 166.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 173' ' ' SER . 5.3 Cg_exo -79.05 -16.79 12.3 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.111 2.541 . . . . 0.0 112.708 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.76 166.53 34.23 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 212' ' ' HIS . 1.0 OUTLIER -98.42 140.5 32.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.764 0.792 . . . . 0.0 111.792 -176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 16.5 p90 -139.99 153.45 46.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.239 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -76.87 115.25 18.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 74.6 ttt180 -83.02 -44.91 14.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.0 110.645 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.4 m -150.09 150.97 32.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.603 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 189' ' ' GLU . 37.5 t -127.34 141.17 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.81 132.65 22.6 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.235 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -41.54 -50.41 4.73 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.234 2.623 . . . . 0.0 113.088 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.36 64.71 6.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 63.4 p -140.0 149.93 60.4 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.276 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 25.6 Cg_endo -62.88 -26.77 74.56 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.949 2.432 . . . . 0.0 111.867 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.53 -49.36 71.58 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 110.721 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.3 tp10 -64.52 -39.83 94.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.8 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.888 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.4 p -81.47 -6.81 59.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.425 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.34 25.72 8.12 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.402 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.2 tp -86.3 149.41 25.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.258 0.529 . . . . 0.0 109.655 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -132.35 177.89 7.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.063 0.458 . . . . 0.0 110.598 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.53 152.81 22.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 75.27 3.62 4.06 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.95 0.782 . . . . 0.0 111.38 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 57.3 m-20 -76.23 143.61 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 44.3 mtm105 -109.7 146.07 35.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.049 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.32 123.79 47.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.279 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.36 -34.06 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.565 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.4 mt-10 -142.26 141.92 32.53 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 219' ' ' ILE . 11.8 p -134.74 124.14 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.061 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 2.9 t-20 60.09 36.81 21.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.832 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.39 -2.35 83.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.223 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.77 142.46 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 22.2 m -92.22 127.58 37.75 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.499 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 215' ' ' VAL . 29.7 mmt -89.27 58.73 4.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.361 0.601 . . . . 0.0 110.446 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.16 81.81 7.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.366 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.58 75.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 214' ' ' ASP . 71.8 mmtt -74.05 153.1 39.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.03 0.443 . . . . 0.0 111.2 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -97.18 -175.91 3.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.029 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 4.9 t60 -59.61 -44.54 93.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.16 -32.88 85.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.485 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 210' ' ' LYS . 20.1 m-20 -68.51 -46.72 68.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 207' ' ' MET . 19.4 m -64.99 -38.17 82.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.686 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.24 -41.64 86.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.2 t -57.79 -42.98 85.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.595 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.86 92.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 202' ' ' VAL . 67.3 mt -70.87 -46.04 70.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.771 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -65.43 -33.6 76.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.249 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.8 -15.43 63.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.457 ' HA3' ' ND2' ' A' ' 203' ' ' ASN . . . -78.74 -3.09 86.97 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.137 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.93 -91.69 1.7 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.495 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.97 8.51 4.44 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.465 0.65 . . . . 0.0 109.453 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.1 tt0 -149.32 151.34 33.98 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.237 -176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.606 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 12.8 t -146.79 156.41 43.11 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.329 0.585 . . . . 0.0 111.491 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 154' ' ' LEU . 98.5 mttt -118.35 124.47 47.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.4 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' A' ' 157' ' ' MET . 4.3 mm? -109.74 122.71 48.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.918 0.389 . . . . 0.0 111.296 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 201' ' ' GLU . 8.5 mt -102.56 119.22 38.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.22 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 16.8 m -127.39 148.19 32.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 30.2 m -134.59 143.6 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.919 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -91.36 164.71 13.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.15 -34.8 58.39 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.427 0.558 . . . . 0.0 111.968 -173.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -59.93 -44.21 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.189 0.519 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.3 m -76.37 -39.12 54.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.92 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 14.8 t70 -58.17 -50.6 72.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.915 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -61.63 -34.62 75.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.59 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.8 t80 -63.8 -46.69 84.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.847 0.356 . . . . 0.0 111.269 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.42 -36.34 81.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 47.0 mtpt -61.17 -48.31 82.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.119 0.485 . . . . 0.0 110.767 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 21.1 ptmt -69.38 -17.53 63.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 85.7 m -100.74 6.32 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 65.86 33.71 7.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.738 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 256' ' ' PRO . 16.9 m -135.06 151.13 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.413 0.625 . . . . 0.0 112.406 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 49.0 mm -83.21 133.09 48.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.593 171.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 13.4 Cg_exo -69.26 60.72 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.694 2.263 . . . . 0.0 112.984 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.445 ' HA ' ' OE1' ' A' ' 201' ' ' GLU . 7.3 p -71.55 158.82 35.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.507 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 71.2 mt-30 -56.23 -26.15 50.18 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.147 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.6 -27.81 69.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -78.24 -35.71 47.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.747 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -74.29 -31.15 62.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -90.47 -41.82 11.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.26 -116.44 3.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.559 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.96 150.24 8.33 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.024 2.483 . . . . 0.0 114.453 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.587 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.0 tp -113.26 147.51 37.54 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.49 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.689 ' HG3' HG21 ' A' ' 244' ' ' VAL . 64.3 Cg_endo -72.49 174.16 12.07 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.766 2.311 . . . . 0.0 112.324 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.13 152.47 67.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.348 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.97 170.51 15.47 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.485 2.124 . . . . 0.0 111.408 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 55.78 49.01 17.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -71.24 39.51 0.06 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.311 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -92.44 -20.64 20.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -75.14 -36.99 44.07 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.495 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.58 114.38 17.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.81 88.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.919 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.625 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 6.4 tp-100 -66.8 132.64 48.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.473 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -85.32 66.65 9.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.489 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.625 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 50.6 mt-10 -102.43 119.94 39.67 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.761 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.95 151.45 45.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.9 t 70.87 169.45 0.32 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.838 0.711 . . . . 0.0 109.925 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.542 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 169' ' ' HIS . 0.9 OUTLIER 61.8 -173.72 0.14 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.757 0.789 . . . . 0.0 112.627 171.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 89.8 m -145.46 118.8 8.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.564 171.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -104.83 138.26 41.36 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.242 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 164' ' ' TYR . 41.2 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.947 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.5 mt -91.49 77.37 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.34 113.33 64.73 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.713 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.07 -26.75 50.25 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.767 2.311 . . . . 0.0 112.264 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -88.14 45.0 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.313 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.23 -25.9 12.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.48 ' HG3' HD23 ' A' ' 150' ' ' LEU . 26.2 ptt? -92.57 -178.34 4.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.559 -174.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 149' ' ' MET . 4.6 mm? 59.73 51.11 6.45 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.72 0.637 . . . . 0.0 111.032 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -134.0 136.23 25.92 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HB3' HG12 ' A' ' 231' ' ' VAL . 54.9 Cg_endo -68.41 147.7 71.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.856 2.371 . . . . 0.0 112.172 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.2 130.39 35.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.326 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 227' ' ' LYS . 62.2 tp -96.15 107.25 19.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.353 0.597 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.4 m -98.5 107.06 19.42 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.278 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.7 m -107.1 112.53 25.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.872 0.368 . . . . 0.0 110.023 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.46 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -125.9 141.6 51.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.601 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 3.6 ptmm? -108.26 144.4 35.81 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.558 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -85.02 121.2 27.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.471 0.653 . . . . 0.0 110.5 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.38 -89.83 2.1 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.431 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -66.49 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.209 2.606 . . . . 0.0 112.638 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -152.66 22.8 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.052 0.453 . . . . 0.0 110.244 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.515 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 172.44 -172.5 44.94 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.743 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 71.2 m-85 -98.17 -28.99 13.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.005 0.431 . . . . 0.0 110.112 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.795 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.18 15.66 6.0 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.894 171.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.53 164.35 25.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.486 0.643 . . . . 0.0 111.087 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 39.3 t30 -129.23 130.08 45.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.98 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.87 120.64 38.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.573 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 68.0 t60 -103.89 141.93 35.29 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 p -133.63 140.55 47.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 8.0 t70 -139.62 160.72 39.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.027 0.442 . . . . 0.0 110.348 -171.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 172' ' ' LYS . 28.2 mtmt -88.05 -16.41 33.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.03 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.5 t -107.39 -5.4 17.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.4 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 30.6 mmtp -114.02 138.75 22.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.655 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 2.2 Cg_endo -81.14 106.55 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.065 2.51 . . . . 0.0 113.481 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.19 49.48 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.096 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG2' HG21 ' A' ' 215' ' ' VAL . 26.0 mp0 -98.31 141.18 31.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.573 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 9.3 p90 -139.67 156.09 47.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.122 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.55 113.78 12.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 25.4 tpt180 -72.32 -48.66 40.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.539 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.3 m -159.35 152.04 21.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.667 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 189' ' ' GLU . 34.3 t -125.25 141.73 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -89.0 132.67 37.3 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.377 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -43.45 -49.89 7.25 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.222 2.614 . . . . 0.0 113.608 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.12 70.0 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.508 0.67 . . . . 0.0 110.171 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.795 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.7 p -137.37 146.96 56.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.352 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.3 Cg_endo -59.53 -28.4 87.38 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.162 2.575 . . . . 0.0 111.755 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.65 71.37 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.004 0.431 . . . . 0.0 110.355 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.4 tp10 -61.46 -42.29 98.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.64 72.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.09 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 80.3 p -81.79 -0.84 45.08 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.772 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.46 24.82 17.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.217 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.86 146.4 24.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.541 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 31.8 mmt180 -135.76 176.79 8.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.0 111.043 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -91.72 150.73 20.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.233 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 74.52 10.0 4.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.184 0.928 . . . . 0.0 111.377 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 28.9 m-20 -96.73 152.59 18.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 171.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -109.49 150.78 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.781 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -97.46 126.62 50.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.123 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.688 HG21 ' HG2' ' A' ' 246' ' ' PRO . 33.9 m -104.18 -18.16 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.369 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.691 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.9 mm-40 -155.74 138.92 15.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.849 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 219' ' ' ILE . 95.5 t -130.11 115.93 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.758 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.32 22.4 9.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.279 0.362 . . . . 0.0 111.97 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.38 9.93 80.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.869 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.0 t -90.74 140.74 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.82 117.53 19.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.011 -168.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 200' ' ' VAL . 17.7 mmt -97.75 51.33 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.324 0.583 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.83 101.37 10.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.174 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.64 20.15 69.34 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.791 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -70.33 152.43 44.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.292 0.568 . . . . 0.0 111.214 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -115.69 -170.88 1.87 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.186 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -54.81 -46.61 74.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.337 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.42 -37.75 79.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.082 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 210' ' ' LYS . 12.1 m-20 -61.69 -46.89 87.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.216 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.482 HG12 ' SD ' ' A' ' 207' ' ' MET . 34.0 m -67.44 -38.89 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 -45.02 85.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.728 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.2 t -62.49 -38.83 91.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.392 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.7 85.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.041 0.448 . . . . 0.0 110.902 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.586 HG21 HD13 ' B' ' 5' ' ' LEU . 63.6 mt -71.08 -44.65 74.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.26 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 220' ' ' ARG . 11.4 mmt180 -60.39 -34.57 74.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.43 -16.31 64.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.641 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.18 74.58 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.424 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.07 -78.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.747 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.32 6.28 3.56 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.363 0.602 . . . . 0.0 109.637 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.3 tt0 -149.87 148.66 29.41 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.312 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 14.3 t -148.18 149.19 31.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.248 0.546 . . . . 0.0 110.645 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 154' ' ' LEU . 60.1 mttt -118.95 113.84 21.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.739 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.0 mp -109.97 129.65 55.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 201' ' ' GLU . 14.2 mt -101.84 119.6 39.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.15 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.36 149.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 152' ' ' PRO . 19.3 m -122.83 149.49 26.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.207 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 155.35 34.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.9 ppt_? -57.81 -41.4 82.11 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.504 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 11.1 pt-20 -72.6 -35.23 67.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.061 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 59.7 m -61.09 -40.74 94.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 0.0 110.073 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.82 -48.63 79.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.261 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.681 ' HA ' ' CD ' ' A' ' 240' ' ' LYS . 56.0 mm-40 -58.84 -38.85 79.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.646 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.601 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 31.9 t80 -69.04 -47.95 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.821 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.411 ' HD1' HG23 ' A' ' 244' ' ' VAL . 66.2 m-85 -68.83 -40.58 79.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.681 ' CD ' ' HA ' ' A' ' 237' ' ' GLU . 12.6 ptmt -66.74 -33.94 76.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.677 0.275 . . . . 0.0 110.905 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.0 ptmm? -74.03 -17.54 60.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.06 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 244' ' ' VAL . 37.4 m -101.94 0.52 35.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.126 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 261' ' ' ASN . 23.4 mtp-105 63.89 26.78 14.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 242' ' ' CYS . 27.6 m -113.14 166.34 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.0 mt -115.08 122.97 32.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.688 ' HG2' HG21 ' A' ' 200' ' ' VAL . 57.3 Cg_endo -74.25 63.66 5.29 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.557 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.66 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 15.1 t -77.8 -179.91 6.27 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.4 mt-30 -61.09 -26.49 67.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.0 111.62 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.17 -27.37 69.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.431 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -86.02 -33.54 21.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.47 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.3 pp -75.96 -31.24 58.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.078 0.466 . . . . 0.0 110.438 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -85.36 -45.27 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.07 -135.17 6.24 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.065 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.48 154.8 21.29 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.944 2.43 . . . . 0.0 113.543 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.95 150.51 39.46 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.631 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.0 144.33 18.73 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.541 2.161 . . . . 0.0 112.326 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.13 130.37 92.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.26 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.47 ' HB3' ' HE1' ' A' ' 238' ' ' PHE . 67.7 Cg_endo -74.34 172.41 16.13 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.737 2.291 . . . . 0.0 113.072 -176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 61.36 35.91 17.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.592 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.26 63.97 0.82 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.564 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 243' ' ' ARG . 51.5 m-80 -76.67 -31.57 57.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 66.79 -90.11 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.827 172.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.75 135.4 54.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.188 0.518 . . . . 0.0 112.035 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 264' ' ' ILE . 4.1 mp -84.21 84.95 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 171.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -94.18 151.93 19.1 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.17 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 60.96 90.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.122 0.889 . . . . 0.0 111.582 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 70.06 96.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.014 0.911 . . . . 0.0 112.06 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -109.39 -14.66 14.39 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.572 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 20.5 m -136.37 156.06 49.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.747 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.168 176.082 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.239 0.542 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.425 ' CG ' ' HD1' ' A' ' 169' ' ' HIS . 1.8 m-20 -129.92 169.11 15.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.415 -176.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -151.98 116.43 5.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.18 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 17.0 ptt180 -102.97 145.97 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 219' ' ' ILE . 68.3 mt . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.068 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mt -84.39 74.74 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -95.12 103.74 12.89 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.183 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.23 -22.45 19.0 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.084 1.856 . . . . 0.0 111.999 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.1 30.62 6.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -89.26 -8.47 53.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.734 0.778 . . . . 0.0 108.951 172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 20.9 ptm -92.82 70.53 4.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.716 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.1 tp -81.68 81.9 7.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.569 0.699 . . . . 0.0 109.752 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 255' ' ' LEU . 46.1 mtp180 -141.07 154.11 67.74 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.717 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 26.1 Cg_endo -64.18 147.74 91.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.754 2.303 . . . . 0.0 110.981 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -97.14 130.71 44.37 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.603 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 227' ' ' LYS . 59.1 tp -92.84 110.51 21.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.924 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.01 109.34 22.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.813 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.577 HG22 ' HG2' ' A' ' 227' ' ' LYS . 1.4 p -110.51 121.21 44.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -143.87 156.1 44.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.682 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.692 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 21.5 mttp -115.2 155.44 27.19 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 22.4 pttm -99.41 138.77 36.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.811 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.38 -120.92 0.53 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 -63.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.283 1.989 . . . . 0.0 111.389 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 t -144.49 35.77 1.19 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.045 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -151.62 139.6 7.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.681 -1.247 . . . . 0.0 113.959 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' B' ' 5' ' ' LEU . 88.7 m-85 -96.53 -29.69 13.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 126.67 12.74 3.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.797 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.76 179.26 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.404 0.621 . . . . 0.0 110.841 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -135.23 125.8 26.91 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 167' ' ' ASN . 67.3 mt -94.75 124.02 38.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 65.3 t-80 -103.64 138.87 39.69 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -111.98 140.1 46.92 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 5.3 t70 -155.99 170.36 22.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -112.37 -6.44 14.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.614 0.245 . . . . 0.0 110.519 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.6 p -84.75 -54.4 4.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.02 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 91.5 mttt -81.01 134.65 52.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.095 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 174' ' ' LYS . 11.0 Cg_endo -86.79 100.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.12 2.547 . . . . 0.0 112.234 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.81 176.07 14.47 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.693 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.76 ' HG3' HG11 ' A' ' 215' ' ' VAL . 83.1 mm-40 -93.83 140.97 29.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.8 p90 -139.01 147.56 42.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.868 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.504 HG13 HD11 ' A' ' 193' ' ' LEU . 41.7 mm -76.9 126.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.118 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 6.4 tmm_? -77.32 -51.08 11.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.724 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 74.1 m -160.64 161.13 32.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.571 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 189' ' ' GLU . 39.1 t -119.21 142.22 35.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.9 t70 -87.29 132.42 41.31 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.107 -173.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -44.92 -58.33 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.425 2.75 . . . . 0.0 113.725 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -96.49 65.44 2.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.553 0.692 . . . . 0.0 110.719 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.9 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 60.4 p -129.9 147.93 67.51 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.607 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.5 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.5 Cg_endo -63.27 -22.98 72.44 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.434 2.09 . . . . 0.0 111.888 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.3 69.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.169 0.509 . . . . 0.0 110.39 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.501 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.2 tp10 -65.12 -37.9 88.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.295 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.3 -31.89 72.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.898 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.8 p -82.22 -10.81 59.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.07 24.24 10.64 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.985 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.504 HD11 HG13 ' A' ' 179' ' ' ILE . 59.4 tp -79.71 137.36 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.041 0.421 . . . . 0.0 110.037 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 8.5 tpp180 -125.39 151.67 45.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.945 0.403 . . . . 0.0 110.439 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -71.93 156.81 38.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.03 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 76.92 -8.82 1.62 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 50.6 m-20 -80.29 148.48 30.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.92 0.39 . . . . 0.0 110.234 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.431 ' HD3' ' OD2' ' A' ' 236' ' ' ASP . 4.8 ptm180 -103.57 143.06 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.743 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.97 133.31 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.3 -34.98 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.604 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.635 ' HG2' HD12 ' A' ' 229' ' ' LEU . 8.5 pt-20 -155.24 152.51 29.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.563 HG11 ' CG1' ' A' ' 219' ' ' ILE . 86.0 t -131.26 119.01 42.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.419 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 62.25 20.55 11.84 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.247 0.342 . . . . 0.0 111.71 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.72 2.08 70.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.623 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.29 129.13 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.7 p -89.82 119.5 30.26 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.818 -173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.478 ' HB3' ' HE2' ' A' ' 207' ' ' MET . 2.1 ptp -108.58 32.54 4.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.501 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -72.28 80.49 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.565 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 100.62 9.89 45.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.103 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 75.0 mmtt -85.35 171.68 11.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -99.9 179.05 4.63 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.33 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.501 ' O ' HG22 ' A' ' 215' ' ' VAL . 38.9 t60 -60.98 -40.58 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.695 0.283 . . . . 0.0 110.994 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.31 -32.16 81.81 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.434 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -68.31 -45.04 74.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.913 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 177' ' ' GLN . 8.7 m -68.75 -36.82 76.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.158 -176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.06 -39.37 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 21.9 t -63.78 -39.04 93.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.174 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.4 86.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.971 0.415 . . . . 0.0 110.765 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.563 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.6 mt -70.63 -46.96 67.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.172 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -67.19 -31.28 71.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.939 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.31 33.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.208 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -80.98 -7.51 88.5 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.661 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.94 -90.54 1.6 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.475 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -118.07 0.78 11.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.33 0.586 . . . . 0.0 109.638 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.692 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.6 mt-10 -135.9 164.38 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.321 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 12.5 t -160.84 146.51 14.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.131 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.577 ' HG2' HG22 ' A' ' 156' ' ' THR . 90.2 mttt -111.89 116.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.525 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.98 124.4 51.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.638 0.256 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.635 HD12 ' HG2' ' A' ' 201' ' ' GLU . 12.6 mt -97.75 118.64 34.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.418 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 16.0 m -123.46 152.74 28.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.651 175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.8 m -121.82 132.08 71.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.94 160.92 19.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.89 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 233' ' ' ARG . 10.7 ptt180 -51.55 -42.52 61.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.96 -37.28 69.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.721 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.5 m -68.21 -43.56 77.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.421 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.431 ' OD2' ' HD3' ' A' ' 198' ' ' ARG . 12.7 t70 -56.07 -48.98 75.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.945 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.92 -41.91 97.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.44 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.683 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.5 t80 -65.22 -48.39 73.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.621 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -68.15 -36.88 80.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.535 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -68.47 -27.46 66.18 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.138 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 41.7 pttt -72.98 -23.15 60.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.003 0.43 . . . . 0.0 110.018 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.9 -5.53 47.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.103 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.78 ' HE ' ' HA ' ' A' ' 243' ' ' ARG . 0.2 OUTLIER 61.82 40.1 13.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.297 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 256' ' ' PRO . 10.5 p -137.86 154.16 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.899 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.31 128.47 33.19 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.858 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.518 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 59.6 Cg_endo -73.57 64.68 4.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.131 2.554 . . . . 0.0 113.601 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 249' ' ' GLU . 1.2 p -74.79 170.81 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -55.54 -24.3 31.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 111.818 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 247' ' ' SER . 13.2 pt-20 -61.32 -26.33 67.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.854 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -81.53 -16.16 52.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 152' ' ' PRO . 12.6 mt -74.96 -43.69 52.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.543 0.687 . . . . 0.0 109.926 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -97.51 -0.11 46.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.896 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -113.41 -176.93 19.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.509 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.89 147.82 19.36 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.144 2.563 . . . . 0.0 112.224 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 151' ' ' ARG . 98.1 mt -86.34 142.99 35.95 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.669 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.7 Cg_endo -76.77 124.56 7.58 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.057 2.505 . . . . 0.0 112.935 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 256' ' ' PRO . 1.1 m 63.67 134.47 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 125.053 1.341 . . . . 0.0 112.015 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.95 116.09 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.343 2.028 . . . . 0.0 112.913 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -101.46 18.69 19.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.822 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 262' ' ' GLY . 6.1 m -65.81 136.66 56.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.861 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 260' ' ' THR . 26.9 t-20 76.13 -21.4 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.727 0.642 . . . . 0.0 110.594 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 260' ' ' THR . . . -97.03 23.86 33.86 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 172.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -70.55 160.04 33.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.838 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 264' ' ' ILE . 3.5 mp -71.42 111.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.389 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.84 156.1 28.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.236 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -113.68 133.93 55.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.312 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.75 126.51 16.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.372 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 63.73 91.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.834 0.826 . . . . 0.0 111.147 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 55.1 m -138.81 91.53 2.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.316 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.517 -0.754 . . . . 0.0 109.523 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.563 0.697 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.79 166.57 21.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.082 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.2 m -137.39 119.99 16.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.643 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 129.43 36.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.926 0.394 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' TYR . 37.3 mt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.182 -0.913 . . . . 0.0 108.707 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 20.9 mt 59.15 52.48 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.959 0.885 . . . . 0.0 109.003 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -97.34 124.13 50.16 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.469 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.47 -11.79 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.5 2.134 . . . . 0.0 112.093 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -98.95 18.06 18.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.122 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -81.07 -13.26 58.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.719 0.771 . . . . 0.0 109.183 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.403 ' O ' ' HG3' ' A' ' 149' ' ' MET . 21.9 ptt? -129.02 94.6 3.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.869 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.83 -68.61 0.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.56 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 3.1 tpp180 68.54 127.63 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.661 0.6 . . . . 0.0 112.419 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.5 Cg_endo -73.25 152.4 50.13 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.34 2.027 . . . . 0.0 111.138 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 6.8 ptm85 -113.9 151.6 31.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.559 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 229' ' ' LEU . 2.3 tm? -114.79 109.1 17.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.501 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.87 129.86 42.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.33 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.3 m -117.99 113.7 22.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -123.8 155.32 38.17 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.612 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 32.3 mttm -119.37 156.84 29.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 97.9 mttt -64.96 119.27 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.621 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.29 -74.75 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.406 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.95 -75.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.696 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.5 t -134.83 21.63 3.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 152.82 -134.17 4.36 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.333 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.625 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 71.6 m-85 -101.99 -15.72 16.71 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 0.0 111.526 -173.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.02 14.01 10.43 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.632 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 53.7 p90 -130.41 179.42 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.319 0.58 . . . . 0.0 111.126 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -136.53 125.73 24.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.654 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.2 mt -95.02 123.94 38.79 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 66.4 t-80 -110.43 141.55 43.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t -123.74 148.23 46.78 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.43 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 18.6 t70 -148.36 158.86 44.36 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -90.47 -11.53 40.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.214 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.2 p -127.82 18.85 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.493 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 48.5 mmtm -108.54 134.91 20.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.06 97.62 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 113.095 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.51 177.96 34.06 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.199 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HG3' HG11 ' A' ' 215' ' ' VAL . 18.3 mm-40 -95.29 141.07 29.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.7 150.18 44.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.532 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 199' ' ' ILE . 39.7 mm -77.19 127.99 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 29.7 tpt180 -93.56 -38.76 11.21 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.416 -175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -153.5 151.64 30.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.789 0.328 . . . . 0.0 111.193 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.64 141.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.9 136.49 21.58 Favored Pre-proline 0 C--N 1.321 -0.631 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.496 -173.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -38.39 -52.3 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.06 3.173 . . . . 0.0 114.106 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -107.43 72.23 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.918 0.866 . . . . 0.0 110.228 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.865 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 97.1 p -132.15 147.59 66.39 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.42 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.597 ' HB2' ' HB2' ' A' ' 157' ' ' MET . 76.6 Cg_exo -49.76 -41.26 46.78 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.599 2.866 . . . . 0.0 112.168 172.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.68 79.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.938 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.96 -38.41 90.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.248 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.37 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.89 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 p -82.96 -19.4 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 111.181 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.36 27.25 5.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.314 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 13.0 tp -75.13 154.58 37.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.998 0.399 . . . . 0.0 109.987 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.614 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 9.7 tpp180 -136.58 165.83 24.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.647 0.261 . . . . 0.0 110.563 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.17 26.41 6.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -139.23 16.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.614 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.3 m-20 -108.15 153.28 23.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.692 -173.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -111.8 152.14 28.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.537 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 179' ' ' ILE . 37.5 mt -104.02 131.42 52.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.5 m -104.22 -24.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 0.0 111.316 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -145.15 131.79 19.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.576 HG11 ' CG1' ' A' ' 219' ' ' ILE . 98.8 t -119.32 114.44 44.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.758 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 58.08 23.7 10.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.03 -5.67 66.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -88.34 132.17 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 10.8 p -72.89 117.2 14.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.068 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.682 ' SD ' HG12 ' A' ' 215' ' ' VAL . 6.4 tpp -97.8 62.52 1.63 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.772 0.796 . . . . 0.0 109.911 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -77.15 47.27 0.54 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.955 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.44 57.36 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -76.93 169.91 17.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.003 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -68.34 171.44 7.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 215' ' ' VAL . 4.3 t60 -59.59 -48.22 82.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.416 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.93 -39.23 97.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.232 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -61.64 -46.89 87.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.734 HG11 ' HG3' ' A' ' 177' ' ' GLN . 23.8 m -63.87 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.764 0.316 . . . . 0.0 110.714 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.56 -42.36 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 0.0 110.632 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.0 m -63.35 -39.89 95.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.36 98.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.02 0.438 . . . . 0.0 110.688 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.576 ' CG1' HG11 ' A' ' 202' ' ' VAL . 84.2 mt -70.64 -45.52 73.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.598 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.38 -31.71 72.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.54 -11.68 12.09 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.79 -13.79 82.02 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.085 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.31 -95.97 1.92 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -120.76 20.06 11.73 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 50.0 mt-10 -146.07 165.22 29.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.622 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.2 t -155.79 139.14 15.75 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.578 ' HB3' HD11 ' A' ' 154' ' ' LEU . 95.1 mttt -104.01 114.0 27.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.25 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.8 mt -109.63 115.8 30.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.001 0.429 . . . . 0.0 109.851 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD23 ' A' ' 154' ' ' LEU . 25.0 tp -97.49 117.74 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.595 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.9 m -123.29 157.97 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.082 0.467 . . . . 0.0 111.741 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 152' ' ' PRO . 17.3 m -129.2 133.71 65.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.859 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.26 164.34 18.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.788 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HG3' ' CD ' ' A' ' 234' ' ' GLU . 13.8 ptt180 -53.88 -45.21 70.97 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 19.2 mp0 -68.15 -32.94 73.56 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.2 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.2 m -68.72 -38.07 79.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.876 0.369 . . . . 0.0 110.464 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.9 -49.78 76.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.189 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 234' ' ' GLU . 12.0 pt-20 -68.97 -33.68 74.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.329 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.686 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.0 t80 -60.99 -48.09 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.256 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.95 -35.54 76.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 17.7 pttm -66.94 -26.27 66.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.715 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 59.7 pttt -68.94 -24.36 64.27 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 81.4 m -103.27 3.65 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.075 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 52.74 44.33 30.34 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.902 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' A' ' 256' ' ' PRO . 9.2 p -125.82 139.31 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.29 0.567 . . . . 0.0 110.733 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 34.0 mt -75.72 132.61 74.6 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.096 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 9.7 Cg_exo -71.58 53.26 1.76 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.093 2.528 . . . . 0.0 113.041 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 m -59.62 156.23 13.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.117 0.484 . . . . 0.0 111.184 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.628 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 52.5 mt-30 -51.76 -25.63 7.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.936 -170.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 10.0 pt-20 -63.5 -27.99 69.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 59.1 m80 -74.12 -34.9 64.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 2.9 pp -75.33 -31.99 60.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.95 -43.43 68.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.946 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.37 -91.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.815 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 93.3 Cg_endo -81.56 146.68 15.33 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.746 2.298 . . . . 0.0 115.163 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.1 mt -118.07 149.75 46.15 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.454 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.522 ' HG3' HG11 ' A' ' 244' ' ' VAL . 73.1 Cg_endo -78.63 151.28 25.13 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.007 1.805 . . . . 0.0 112.906 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.96 144.7 28.27 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.948 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.32 107.31 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.835 2.356 . . . . 0.0 112.297 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -108.34 77.41 1.1 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.884 0.85 . . . . 0.0 109.069 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -77.48 74.83 4.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.733 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.77 -33.87 60.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 84.95 -50.22 4.36 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.596 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.42 6.05 7.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.381 0.61 . . . . 0.0 112.317 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.6 mt -91.69 91.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.105 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -111.23 168.74 9.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.7 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -149.78 100.08 2.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.133 0.492 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.63 176.77 7.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.37 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.0 m120 55.66 44.18 26.89 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 110.325 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.9 p -116.52 170.32 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 270' ' ' ARG . 60.4 mtt-85 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.985 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 70.46 -179.67 0.23 Allowed 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 124.199 0.937 . . . . 0.0 111.569 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.5 m -145.04 125.35 13.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.722 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -94.92 140.48 29.88 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.844 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 118.652 -0.69 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.6 153.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.727 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -110.58 103.95 55.12 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.524 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.28 -20.17 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.788 2.325 . . . . 0.0 111.32 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -80.62 19.28 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.26 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -78.82 -17.06 56.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.636 0.731 . . . . 0.0 109.47 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 62.2 mtm -85.88 56.39 3.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.857 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.37 86.58 6.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.884 0.85 . . . . 0.0 110.461 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.63 ' HG2' ' HA ' ' A' ' 251' ' ' LEU . 2.1 mpp_? -125.68 146.49 55.14 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.714 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 239' ' ' PHE . 26.8 Cg_endo -63.49 149.7 90.4 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.601 2.201 . . . . 0.0 112.376 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 230' ' ' VAL . 38.1 ttm180 -88.08 131.34 34.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.3 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD23 HD13 ' A' ' 229' ' ' LEU . 1.8 tm? -111.7 106.65 15.51 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 74.6 m -99.63 129.22 45.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.6 m -118.43 112.87 20.52 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -127.04 141.85 51.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 110.807 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 13.0 mtpp -106.23 155.11 19.81 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 8.3 ptmt -70.1 142.43 52.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.136 0.493 . . . . 0.0 110.75 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.82 -102.05 2.56 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.94 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.91 -67.85 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.284 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.1 t -148.14 28.24 0.92 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.43 0.633 . . . . 0.0 109.493 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . -178.1 -165.36 32.79 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.498 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 88.9 m-85 -107.59 -18.02 13.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.878 0.339 . . . . 0.0 111.278 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.95 11.48 7.62 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.958 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 43.5 p90 -130.81 158.34 40.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 112.053 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.22 125.28 52.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.767 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 75.6 mt -93.76 127.48 39.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -132.46 144.09 50.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.1 p -131.32 139.25 49.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.256 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -113.62 152.46 30.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.22 -11.91 59.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.3 m -96.62 -5.38 39.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.445 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.54 144.58 29.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.395 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.53 104.85 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.807 2.338 . . . . 0.0 112.756 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 -161.75 20.66 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.847 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.534 ' HG2' HG21 ' A' ' 215' ' ' VAL . 1.4 mp0 -113.28 143.3 44.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.475 . . . . 0.0 110.567 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -138.83 157.08 46.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 199' ' ' ILE . 40.0 mm -73.8 119.34 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.459 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -52.03 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.269 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.8 t -164.3 152.74 12.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' GLU . 21.7 t -117.39 142.44 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 10.4 t70 -89.13 130.5 44.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 73.1 Cg_exo -50.88 -26.84 19.02 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.565 2.843 . . . . 0.0 113.032 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.84 71.68 0.92 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.584 0.707 . . . . 0.0 109.886 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.814 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 83.1 p -153.45 150.29 23.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.7 Cg_endo -62.04 -27.08 78.92 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.15 2.567 . . . . 0.0 111.817 173.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.31 71.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 13.3 tp10 -60.37 -41.26 93.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.144 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.45 75.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.878 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 51.8 p -81.21 -0.87 42.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.358 . . . . 0.0 111.587 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.82 25.06 23.76 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.03 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.6 141.03 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 197' ' ' ASP . 25.3 mmt180 -133.61 178.02 7.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.122 0.486 . . . . 0.0 111.02 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.13 144.98 38.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.784 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 74.18 8.59 4.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.947 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 194' ' ' ARG . 4.2 m-20 -80.16 137.73 36.75 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -103.28 143.61 32.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.0 110.565 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.44 HD11 HD11 ' A' ' 179' ' ' ILE . 46.1 mt -98.92 130.78 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.918 -176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.9 t -99.49 -43.55 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.546 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -133.41 140.46 47.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 219' ' ' ILE . 86.8 t -125.42 113.57 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 58.97 23.28 11.34 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.27 0.356 . . . . 0.0 111.874 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.22 60.65 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.224 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.4 138.77 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 74.0 m -92.46 133.8 35.57 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 -174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.706 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.8 mmt -90.4 47.11 1.4 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.172 0.511 . . . . 0.0 110.639 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 40.2 mt-10 -80.91 89.76 5.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.605 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.12 26.64 74.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.722 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.64 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 52.3 mmtt -67.49 138.53 56.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.258 0.551 . . . . 0.0 111.689 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -70.13 170.36 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.087 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.413 ' O ' HG22 ' A' ' 215' ' ' VAL . 7.4 t60 -61.18 -41.75 97.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.817 0.341 . . . . 0.0 110.18 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.59 -32.4 71.11 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.64 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -63.84 -45.9 87.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.706 HG12 ' SD ' ' A' ' 207' ' ' MET . 20.6 m -63.88 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.953 0.406 . . . . 0.0 110.479 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.54 -35.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.131 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.4 t -64.4 -45.35 88.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.03 81.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.052 0.453 . . . . 0.0 110.824 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.498 HG13 HG11 ' A' ' 202' ' ' VAL . 77.7 mt -70.73 -46.34 69.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.566 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.37 -33.78 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.04 -11.28 60.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.524 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.05 -22.99 72.77 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.971 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.85 -89.67 0.56 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.724 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 52.2 m-20 -132.15 10.22 4.52 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.112 0.958 . . . . 0.0 108.434 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 8.2 tt0 -149.27 152.73 36.43 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 113.833 -1.53 . . . . 0.0 108.909 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.42 ' CB ' HG23 ' A' ' 219' ' ' ILE . 13.5 t -139.81 130.96 26.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.356 0.598 . . . . 0.0 110.566 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -98.22 115.72 28.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.135 174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 66.6 mt -109.02 120.65 43.16 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.537 HD13 HD23 ' A' ' 154' ' ' LEU . 23.0 tp -95.88 117.47 30.65 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 153' ' ' ARG . 30.5 m -124.87 152.59 31.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.632 -176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.8 m -121.88 131.52 72.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.213 0.53 . . . . 0.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.48 165.21 25.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.34 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 27.7 ptt180 -51.57 -45.49 63.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 3.8 mt-10 -71.96 -41.34 67.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.4 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.1 m -67.77 -41.72 82.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.319 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.21 -49.22 77.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.189 0.518 . . . . 0.0 110.267 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 41.1 mt-10 -62.03 -32.64 73.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.219 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.818 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 64.2 t80 -65.35 -48.59 72.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.658 0.266 . . . . 0.0 111.372 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 51.3 m-85 -68.7 -42.52 77.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.79 0.329 . . . . 0.0 111.239 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 10.3 ptmm? -68.04 -26.9 66.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.342 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 0.1 OUTLIER -70.18 -23.73 63.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 110.047 179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.17 1.17 54.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.727 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 59.21 33.28 22.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.863 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.553 HG11 ' HG2' ' A' ' 256' ' ' PRO . 8.3 p -117.04 160.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.301 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.5 mt -100.01 124.8 42.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.171 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 142.97 57.6 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.79 2.327 . . . . 0.0 111.595 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 34.0 t -147.65 162.48 39.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.297 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 69.4 mt-30 -59.32 -35.28 73.52 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.595 0.56 . . . . 0.0 110.622 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.23 -26.71 67.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.347 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.01 -36.69 64.49 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.223 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 151' ' ' ARG . 3.5 pp -75.0 -30.7 61.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.368 0.604 . . . . 0.0 109.695 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.74 -50.02 47.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.891 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.01 -108.58 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.666 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.2 159.24 15.26 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.06 2.507 . . . . 0.0 114.192 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' A' ' 151' ' ' ARG . 85.9 mt -118.73 173.49 3.36 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.843 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.553 ' HG2' HG11 ' A' ' 244' ' ' VAL . 31.2 Cg_exo -60.44 156.31 42.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.158 1.905 . . . . 0.0 111.589 174.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 25.0 t 62.42 82.75 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.193 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.71 137.2 53.03 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.295 2.663 . . . . 0.0 113.159 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -119.22 6.41 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.608 0.718 . . . . 0.0 109.343 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 38.1 p -99.2 107.9 20.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.301 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -68.11 -36.99 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -84.69 78.48 2.0 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.226 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.56 142.96 42.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.953 0.406 . . . . 0.0 111.216 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 264' ' ' ILE . 4.2 mp -76.14 87.4 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.542 0.687 . . . . 0.0 110.152 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -76.19 158.66 31.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.52 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -73.1 84.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.091 0.472 . . . . 0.0 109.824 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.84 104.89 0.49 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.865 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -91.49 145.42 24.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.7 p -120.91 112.72 19.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.083 0.468 . . . . 0.0 111.141 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 177.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.516 0.198 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 1.1 m-20 -62.88 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.343 0.592 . . . . 0.0 111.168 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 27.8 m -124.92 119.22 28.16 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.41 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 4' ' ' ARG . 10.2 tpt180 -93.3 114.6 27.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 164' ' ' TYR . 86.0 mt . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.392 -0.813 . . . . 0.0 108.806 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.606 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 58.8 mt -87.37 111.77 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -86.53 107.07 12.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.146 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 0.9 OUTLIER -85.23 -44.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.908 2.405 . . . . 0.0 111.757 175.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -86.71 24.11 1.53 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.425 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.3 t -83.34 -19.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.462 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 72.5 mtm 41.56 69.25 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.334 -1.303 . . . . 0.0 112.588 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 89.3 mt -76.16 86.72 3.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.853 0.835 . . . . 0.0 109.562 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.462 ' HE ' ' HB3' ' A' ' 149' ' ' MET . 50.7 mtt180 -108.62 147.86 36.6 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.383 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.537 ' HB3' HG12 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -69.44 134.13 27.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.576 2.184 . . . . 0.0 111.384 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -89.83 132.66 35.14 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.46 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' A' ' 227' ' ' LYS . 42.5 tp -96.05 106.96 19.21 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.991 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 34.6 m -94.39 126.12 39.46 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.8 m -120.38 114.35 21.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.224 0.535 . . . . 0.0 110.616 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.694 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.3 pmm? -133.0 153.63 51.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.477 -177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.902 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 21.4 pttm -128.42 155.87 44.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.603 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 96.6 mttt -55.12 126.4 24.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.008 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.03 -77.25 1.34 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.67 -74.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.986 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.0 t -137.43 6.31 2.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.587 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . -161.14 -160.75 10.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.415 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.694 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 43.0 m-85 -106.04 -21.43 13.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.03 0.443 . . . . 0.0 110.493 -172.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 108.43 18.26 9.83 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.556 -0.83 . . . . 0.0 114.309 171.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.0 p90 -130.46 158.66 39.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.012 0.906 . . . . 0.0 111.454 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 9.0 t30 -123.75 127.43 48.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.4 mt -95.14 122.48 37.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.815 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 77.9 t60 -104.04 142.14 34.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.163 0.506 . . . . 0.0 110.276 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 177' ' ' GLN . 18.2 t -141.9 141.39 33.01 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.579 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.586 ' H ' ' HB2' ' A' ' 174' ' ' LYS . 50.1 m-20 -109.62 165.17 11.88 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -72.14 -7.56 49.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.622 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.8 p -121.91 16.99 10.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.553 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.586 ' HB2' ' H ' ' A' ' 171' ' ' ASP . 32.2 mmtp -128.78 100.96 20.75 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.43 -33.48 6.89 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.595 2.197 . . . . 0.0 112.417 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -74.04 149.96 41.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.136 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.451 ' OE1' ' HB2' ' A' ' 170' ' ' SER . 81.1 mm-40 -111.25 139.77 46.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.079 0.466 . . . . 0.0 110.768 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 14.3 p90 -141.01 152.94 45.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.48 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 199' ' ' ILE . 23.2 mm -75.02 118.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -79.49 -47.64 15.26 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.4 m -150.79 151.04 31.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.134 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 189' ' ' GLU . 50.8 t -130.86 137.6 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 170.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.51 137.74 21.51 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.45 -28.68 8.94 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.904 3.069 . . . . 0.0 113.488 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -110.88 71.27 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.41 0.624 . . . . 0.0 110.036 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.818 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 86.0 p -147.17 144.85 20.33 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.537 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -49.45 -41.58 43.46 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.45 2.766 . . . . 0.0 112.235 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.16 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.779 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 182' ' ' VAL . 16.7 tp10 -63.15 -38.23 90.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 109.672 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.94 78.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.591 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.456 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 25.7 p -82.1 -13.27 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.488 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.22 36.15 4.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.998 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.8 tp -95.35 148.15 22.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 194' ' ' ARG . 21.8 mmm180 -135.89 176.43 8.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.398 0.618 . . . . 0.0 111.769 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -87.51 156.16 19.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.502 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 45.8 mt-30 76.35 -7.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.789 0.836 . . . . 0.0 111.349 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 230' ' ' VAL . 5.8 m-20 -80.34 140.59 36.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.209 174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 147.88 26.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 179' ' ' ILE . 37.4 mt -96.52 128.48 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.971 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.77 -36.72 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.123 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 229' ' ' LEU . 46.5 mt-10 -140.74 142.24 34.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG11 ' CG1' ' A' ' 219' ' ' ILE . 76.6 t -132.85 120.47 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.347 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 55.47 30.23 14.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.258 0.551 . . . . 0.0 111.211 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.32 -10.45 67.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.845 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.2 t -92.54 133.08 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.755 0.312 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 46.7 t -92.26 134.67 34.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.006 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.471 ' HA ' ' CG ' ' A' ' 210' ' ' LYS . 3.6 ptp -121.51 17.23 11.29 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -71.92 85.62 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.1 4.54 18.4 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 24.7 mmmt -100.39 165.81 11.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.92 -175.67 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.667 0.27 . . . . 0.0 111.647 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 215' ' ' VAL . 34.2 t60 -59.67 -47.01 87.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.72 85.26 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.194 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 5.7 m-20 -68.69 -46.08 69.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.573 0.225 . . . . 0.0 110.893 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 212' ' ' HIS . 11.8 m -66.44 -37.45 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.802 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 212' ' ' HIS . 90.0 t -66.89 -41.15 87.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.152 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.5 m -61.02 -38.55 86.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.22 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.0 110.83 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.59 HG21 HD13 ' B' ' 5' ' ' LEU . 69.5 mt -70.76 -42.91 77.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.181 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.23 -33.88 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.185 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.32 -11.07 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.756 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.77 -3.27 88.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.899 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.58 -97.02 1.69 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.527 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 18.7 m-20 -126.08 15.22 7.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.673 0.749 . . . . 0.0 109.259 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.902 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 40.3 mt-10 -133.61 163.95 28.28 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.862 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 15.3 t -160.77 142.93 12.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.514 0.673 . . . . 0.0 112.259 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 154' ' ' LEU . 44.1 mttm -107.55 115.71 30.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.229 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 mt -109.91 124.48 51.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.724 0.297 . . . . 0.0 110.781 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 201' ' ' GLU . 6.9 mt -97.35 118.32 33.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.216 174.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 24.5 m -118.08 148.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.035 0.445 . . . . 0.0 110.845 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.9 m -122.6 131.56 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.48 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 13.4 t70 -69.97 160.38 32.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.29 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 234' ' ' GLU . 37.1 ptt85 -56.14 -41.64 75.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.682 0.277 . . . . 0.0 110.727 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 233' ' ' ARG . 45.5 mt-10 -72.61 -30.27 64.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.034 0.445 . . . . 0.0 110.715 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 36.5 m -65.59 -46.95 77.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.78 -49.29 78.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.322 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 10.8 pt-20 -62.9 -34.9 78.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.71 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 81.0 t80 -64.34 -46.86 81.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 0.0 110.765 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 50.7 m-85 -68.95 -40.09 79.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.672 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 14.2 pttm -66.47 -25.81 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 19.9 pttp -62.77 -24.19 67.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 110.6 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.66 4.03 23.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.135 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 53.14 40.04 30.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.162 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 256' ' ' PRO . 7.5 p -110.7 136.44 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.748 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.83 122.38 87.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 152' ' ' PRO . 72.4 Cg_endo -79.1 61.9 8.31 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.687 2.258 . . . . 0.0 113.081 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.9 m -70.44 171.82 9.45 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.635 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 66.2 mt-30 -52.15 -30.25 25.77 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.31 -27.63 69.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -83.92 -29.24 27.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -73.98 -31.73 63.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.304 0.573 . . . . 0.0 110.008 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -93.41 -45.24 7.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.897 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.1 -127.26 5.32 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.059 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.94 155.28 8.55 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.02 2.48 . . . . 0.0 113.941 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 2.5 tp -104.53 145.15 30.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.249 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 6.7 Cg_endo -53.02 156.44 9.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.202 2.602 . . . . 0.0 114.89 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 2.4 p -120.9 137.94 27.13 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.224 -171.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 14.2 Cg_exo -70.37 178.79 4.58 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.025 2.483 . . . . 0.0 112.561 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 58.94 28.19 17.26 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.061 0.545 . . . . 0.0 111.986 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.4 p -106.36 45.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.359 0.599 . . . . 0.0 111.702 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -91.33 -9.54 44.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.694 0.759 . . . . 0.0 109.377 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -117.82 116.66 3.52 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.812 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -81.95 137.72 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 51.0 mm -63.13 124.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.152 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.43 91.73 5.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.52 125.26 25.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.097 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.09 107.56 14.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.476 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.72 108.56 19.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.0 p -92.98 154.21 18.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.232 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.446 -179.01 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' B' ' 2' ' ' ASP . 46.8 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 1' ' ' GLN . 1.1 m-20 68.23 -179.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.639 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 97.8 m -148.0 117.76 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.807 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -110.0 103.17 11.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.494 0.664 . . . . 0.0 110.12 178.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 219' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.245 0.818 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.33 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.3 pt -79.74 136.49 23.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.908 0.385 . . . . 0.0 110.536 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 148' ' ' THR . 24.3 t70 -150.04 128.36 5.93 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.874 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.44 -13.12 32.66 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.437 2.091 . . . . 0.0 113.53 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.83 13.96 24.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 145' ' ' ASP . 9.6 t -108.25 -2.52 19.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.808 0.813 . . . . 0.0 108.983 168.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 151' ' ' ARG . 75.1 mtp -78.2 83.37 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.418 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 mt 65.4 2.49 1.98 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.5 0.72 . . . . 0.0 111.661 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.722 ' HG3' ' HA ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER -92.55 122.25 64.68 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HB3' HG12 ' A' ' 231' ' ' VAL . 12.3 Cg_endo -56.44 127.79 27.4 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.681 2.254 . . . . 0.0 111.581 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -83.68 138.52 33.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 229' ' ' LEU . 29.0 tp -106.23 115.61 30.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.151 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 44.4 m -90.56 103.02 15.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.8 m -98.48 113.3 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.689 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -136.93 158.02 45.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.546 -174.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 57.2 pttt -133.23 151.16 51.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.821 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.531 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 20.8 ptmt -75.52 125.68 29.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.445 0.64 . . . . 0.0 110.085 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.41 -85.71 0.85 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.784 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.24 -62.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.966 1.778 . . . . 0.0 111.399 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -161.6 28.72 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.565 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -158.98 162.95 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.483 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.5 m-85 -100.99 -25.96 13.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.147 0.499 . . . . 0.0 110.136 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.99 15.05 8.77 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.889 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.61 172.69 11.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.506 0.653 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.739 ' HB2' ' HG3' ' B' ' 4' ' ' ARG . 40.8 t30 -137.1 123.11 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.77 120.46 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-80 -106.35 142.88 35.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.637 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 11.3 t -132.23 140.57 48.72 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -126.64 161.4 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.148 0.499 . . . . 0.0 111.049 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.8 -2.49 26.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.389 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -124.21 11.88 8.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.579 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.42 107.7 19.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -81.69 -11.03 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.348 2.699 . . . . 0.0 111.759 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -111.04 146.88 17.72 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.87 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.19 142.1 28.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.151 0.5 . . . . 0.0 110.48 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 17.5 p90 -138.67 150.16 45.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.56 -173.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 199' ' ' ILE . 41.2 mm -75.45 112.53 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HG3' ' HB2' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -81.32 -43.84 18.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 -176.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.6 m -147.08 149.95 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.88 0.372 . . . . 0.0 110.948 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.2 t -133.28 142.49 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 14.5 t70 -97.07 135.23 22.07 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 75.8 Cg_exo -52.93 -27.24 34.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.319 2.679 . . . . 0.0 112.949 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.57 65.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 109.665 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.953 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.1 p -142.65 145.93 36.2 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.25 0.547 . . . . 0.0 110.837 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.533 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.27 -24.12 78.26 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.986 2.457 . . . . 0.0 111.844 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -64.85 -50.66 65.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 110.41 173.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.5 -37.26 84.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.942 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 187' ' ' PRO . . . -63.84 -31.63 72.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.125 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.1 p -85.29 -19.51 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 111.121 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.23 18.57 6.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.082 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 179' ' ' ILE . 13.3 tp -83.2 144.42 29.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -140.58 160.41 40.08 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.122 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.3 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.837 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 77.42 -2.8 2.53 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.896 0.748 . . . . 0.0 111.135 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -82.08 145.51 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -110.48 142.8 41.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 179' ' ' ILE . 42.8 mt -98.89 135.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.115 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 246' ' ' PRO . 5.8 p -105.74 -39.03 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.876 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -138.55 146.8 42.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.505 HG11 ' CG1' ' A' ' 219' ' ' ILE . 80.2 t -130.23 115.12 31.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 89.2 m-20 61.02 19.88 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.254 0.346 . . . . 0.0 111.822 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.08 -0.99 62.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.884 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.21 136.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 21.1 p -85.17 134.79 34.15 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.603 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.548 ' SD ' HG12 ' A' ' 215' ' ' VAL . 32.8 mmt -81.31 31.16 0.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 0.0 110.954 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.96 -3.66 52.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.084 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.74 74.05 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 171.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 65.03 -50.18 0.34 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.233 1.013 . . . . 0.0 113.408 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.36 148.9 51.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.709 0.766 . . . . 0.0 111.057 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.4 ' O ' HG22 ' A' ' 215' ' ' VAL . 45.2 t60 -60.57 -32.39 71.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.535 -169.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.36 -39.18 97.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.491 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.94 -46.12 82.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.567 0.222 . . . . 0.0 111.589 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.548 HG12 ' SD ' ' A' ' 207' ' ' MET . 17.9 m -64.72 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.821 0.343 . . . . 0.0 110.823 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.62 -41.53 85.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.353 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 31.7 m -59.73 -39.83 86.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.957 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.22 -43.87 95.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.204 0.526 . . . . 0.0 110.962 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.505 ' CG1' HG11 ' A' ' 202' ' ' VAL . 70.8 mt -71.14 -43.78 74.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.471 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.95 -34.57 76.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.029 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.94 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.741 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.74 -9.73 86.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.362 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.3 -92.64 1.5 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.099 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.531 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 21.3 m-20 -115.56 3.98 14.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.733 0.301 . . . . 0.0 110.345 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.816 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.2 mt-10 -136.61 156.03 49.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.173 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.466 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 13.3 t -160.1 136.73 9.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.562 0.696 . . . . 0.0 111.171 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 88.3 mttt -104.86 118.96 37.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.292 175.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.99 116.47 32.01 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 154' ' ' LEU . 23.7 tp -96.33 118.1 32.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.74 148.52 21.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.176 0.513 . . . . 0.0 111.017 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.2 m -123.78 139.69 49.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 162.18 27.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.294 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -52.81 -43.59 66.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.585 0.175 . . . . 0.0 111.239 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HA ' ' HG2' ' A' ' 237' ' ' GLU . 0.7 OUTLIER -71.08 -28.77 64.58 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 120.762 0.315 . . . . 0.0 111.622 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.8 m -70.91 -47.69 57.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.327 0.584 . . . . 0.0 109.895 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.77 -47.66 85.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -62.18 -34.51 76.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.766 ' HA ' ' HE2' ' A' ' 241' ' ' LYS . 61.4 t80 -64.96 -47.41 77.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -68.14 -36.52 79.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.48 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 14.6 pttp -63.77 -25.06 68.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.842 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 238' ' ' PHE . 57.7 mttm -61.29 -33.24 73.25 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 109.987 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 244' ' ' VAL . 38.3 m -97.7 0.06 46.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.575 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 56.37 42.55 27.53 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 256' ' ' PRO . 14.7 p -126.6 142.62 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.46 0.648 . . . . 0.0 110.589 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 35.8 mt -75.68 129.36 81.76 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.05 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 200' ' ' VAL . 9.5 Cg_exo -72.01 58.34 2.78 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.122 2.548 . . . . 0.0 112.891 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.3 p -68.66 161.45 28.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.887 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.2 mt-30 -54.0 -23.68 14.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.324 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.58 -27.33 69.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.112 0.482 . . . . 0.0 110.542 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -85.69 -29.97 23.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.75 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 3.8 pp -74.24 -36.13 63.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 110.229 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -96.45 -17.14 20.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.254 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.18 -136.37 7.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -96.87 163.2 1.05 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.508 2.805 . . . . 0.0 113.513 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 256' ' ' PRO . 64.7 mt -97.73 145.25 29.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.506 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.547 ' HG2' HG11 ' A' ' 244' ' ' VAL . 24.5 Cg_exo -63.4 86.64 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.354 2.703 . . . . 0.0 113.769 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 95.1 t -139.95 95.03 8.73 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.98 121.54 9.65 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.676 2.25 . . . . 0.0 112.812 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -100.15 -2.07 35.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.555 0.693 . . . . 0.0 109.869 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 265' ' ' GLN . 2.3 m -106.34 78.63 1.3 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.323 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.6 -23.58 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.099 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.22 -51.36 13.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.703 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.87 145.02 30.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 21.6 mt -81.69 66.86 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.759 0.79 . . . . 0.0 110.385 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.782 ' HB2' HG21 ' A' ' 260' ' ' THR . 73.1 mm-40 -105.08 83.04 1.93 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.943 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 267' ' ' GLU . 96.4 mttt -123.94 70.24 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.648 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 266' ' ' LYS . 35.9 tt0 71.51 133.15 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.919 0.762 . . . . 0.0 111.337 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 54.8 t30 69.59 -68.67 0.19 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.256 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.9 m 53.02 79.89 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.987 0.804 . . . . 0.0 111.406 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.523 -178.055 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.637 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 8.4 tp-100 . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.857 0.361 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -93.34 170.16 9.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.305 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.4 m -152.33 119.34 5.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.779 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.739 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 7.5 ttp180 -92.46 144.96 24.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 164' ' ' TYR . 66.3 mt . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.8 mt -110.15 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.651 0.262 . . . . 0.0 110.489 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.85 108.07 39.39 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.33 -13.05 23.09 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.569 2.179 . . . . 0.0 111.303 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -93.47 15.96 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.619 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -72.67 -22.36 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.139 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -86.43 60.68 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.823 0.82 . . . . 0.0 110.392 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp -80.48 88.58 5.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.662 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 251' ' ' LEU . 18.8 ptp180 -114.38 160.87 31.23 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.511 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 246' ' ' PRO . 46.6 Cg_endo -67.56 164.27 31.68 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.744 2.296 . . . . 0.0 113.073 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -105.95 132.42 52.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.82 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.641 HD21 ' HE3' ' A' ' 227' ' ' LYS . 58.9 tp -100.33 112.66 25.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.583 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.7 m -99.9 115.03 28.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.1 m -113.53 112.31 23.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.022 0.439 . . . . 0.0 110.592 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.466 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.23 158.0 33.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.149 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.636 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 10.9 ptpt -131.88 143.9 50.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.938 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.633 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 13.4 ptmm? -77.85 131.04 37.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.201 0.524 . . . . 0.0 111.031 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.16 -76.49 0.99 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.462 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.01 -73.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.368 2.045 . . . . 0.0 111.932 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.0 t -154.39 34.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.86 176.25 43.02 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.945 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 83.3 m-85 -96.02 -31.12 13.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.44 . . . . 0.0 110.355 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 116.62 17.07 6.16 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.653 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -130.27 150.75 51.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.502 0.651 . . . . 0.0 111.15 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -111.55 122.81 48.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.41 131.39 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.554 0.216 . . . . 0.0 110.682 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 178' ' ' PHE . 84.3 t60 -114.69 141.82 47.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.581 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.655 ' HB3' ' HG3' ' B' ' 1' ' ' GLN . 4.8 t -133.29 146.07 51.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.51 173.77 11.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.072 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -72.83 -11.24 60.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.56 -166.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.0 t -136.08 28.75 3.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.109 0.481 . . . . 0.0 110.426 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -121.19 97.42 47.7 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.47 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.71 -16.28 18.78 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.039 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -105.56 146.01 16.01 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.586 ' HG3' HG11 ' A' ' 215' ' ' VAL . 30.9 mm-40 -91.63 142.32 27.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.077 0.465 . . . . 0.0 110.235 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 169' ' ' HIS . 17.2 p90 -138.61 156.35 47.53 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.789 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 199' ' ' ILE . 31.1 mm -83.42 120.56 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.137 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 61.9 ttt180 -73.12 -48.36 36.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.141 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.43 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 9.3 t -161.58 152.03 17.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.932 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 189' ' ' GLU . 40.3 t -126.23 143.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.934 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 10.9 t70 -75.27 127.09 87.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 84.9 Cg_exo -48.74 -31.7 20.03 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 124.099 3.199 . . . . 0.0 114.757 -171.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -125.89 29.42 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.302 0.572 . . . . 0.0 111.008 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.934 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 94.5 p -83.52 159.3 61.65 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.898 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.56 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -60.61 -33.83 93.04 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.557 2.171 . . . . 0.0 111.593 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -59.5 -50.22 74.75 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.47 ' HB2' HG12 ' A' ' 182' ' ' VAL . 13.1 tp10 -62.48 -38.9 91.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.167 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.27 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.308 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.438 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 93.1 p -81.49 -0.53 42.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.319 -177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.62 24.13 16.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.521 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 15.1 tp -89.33 155.04 19.61 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.545 ' HB3' ' OD1' ' A' ' 197' ' ' ASP . 15.0 tpt180 -144.89 150.36 36.93 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.075 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 181' ' ' SER . . . -79.26 25.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -128.63 4.06 5.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.839 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 194' ' ' ARG . 2.6 m-20 -110.55 156.23 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 112.255 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 22.4 mtp-105 -109.35 143.15 39.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 179' ' ' ILE . 59.2 mt -99.0 128.11 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.728 HG21 ' HG2' ' A' ' 246' ' ' PRO . 22.1 m -104.95 -25.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.811 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE2' ' HA ' ' A' ' 206' ' ' CYS . 15.3 mm-40 -149.33 141.94 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.16 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 219' ' ' ILE . 99.4 t -127.93 114.92 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.669 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.87 13.58 5.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.17 7.97 61.86 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.824 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.6 137.57 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.65 ' HA ' ' OE2' ' A' ' 201' ' ' GLU . 29.3 m -77.01 118.54 19.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.98 -169.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.657 ' SD ' HG12 ' A' ' 215' ' ' VAL . 18.8 mmt -94.9 44.93 1.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.33 -93.38 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.467 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.84 52.09 3.89 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 207' ' ' MET . 0.7 OUTLIER -97.55 162.34 13.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.181 0.515 . . . . 0.0 111.482 -175.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -113.56 169.39 9.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 215' ' ' VAL . 63.0 t60 -55.2 -39.79 70.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 118.131 0.423 . . . . 0.0 110.704 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.03 -39.8 94.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.477 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.24 -40.37 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.58 0.229 . . . . 0.0 111.193 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.657 HG12 ' SD ' ' A' ' 207' ' ' MET . 4.5 m -65.72 -39.81 85.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.139 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.47 -36.11 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.231 0.539 . . . . 0.0 109.961 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.2 t -61.38 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.37 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -43.0 99.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.009 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 202' ' ' VAL . 70.0 mt -67.6 -45.84 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.403 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.936 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.79 -14.24 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.2 -32.71 85.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.592 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.15 65.13 1.33 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.311 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.633 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 2.1 m-20 64.87 14.2 9.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.372 0.669 . . . . 0.0 110.974 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.636 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.9 mt-10 -142.54 159.1 42.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.796 175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.466 HG23 ' SD ' ' A' ' 157' ' ' MET . 12.5 t -159.11 143.34 15.35 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.549 0.69 . . . . 0.0 111.495 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.641 ' HE3' HD21 ' A' ' 154' ' ' LEU . 19.0 mtpp -116.3 113.67 23.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.105 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 57.2 mt -109.32 126.01 52.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.859 0.361 . . . . 0.0 110.507 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 201' ' ' GLU . 12.4 mt -97.91 119.51 36.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.607 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 27.8 m -117.28 148.42 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 111.06 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 35.9 m -133.18 146.77 31.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 33.9 t70 -93.44 164.98 12.99 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.18 -35.2 64.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.363 0.529 . . . . 0.0 111.779 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 15.0 pt-20 -65.62 -39.55 91.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.039 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 1.3 m -69.12 -41.5 77.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.541 0.686 . . . . 0.0 109.695 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.0 -45.78 91.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.785 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 17.2 pt-20 -70.31 -33.49 71.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.302 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 53.0 t80 -66.93 -48.52 68.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.279 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.423 ' HD2' HG13 ' A' ' 244' ' ' VAL . 50.6 m-85 -69.37 -36.51 76.91 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 20.0 pttp -63.25 -27.33 69.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.612 0.244 . . . . 0.0 111.248 -176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 pttp -73.01 -17.56 61.44 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.593 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.527 ' HB2' HG12 ' A' ' 244' ' ' VAL . 81.2 m -107.66 3.22 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.331 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 55.99 28.53 12.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.682 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.527 HG12 ' HB2' ' A' ' 242' ' ' CYS . 11.9 p -114.12 140.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.46 0.648 . . . . 0.0 110.894 -174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.66 128.23 75.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.651 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.728 ' HG2' HG21 ' A' ' 200' ' ' VAL . 59.9 Cg_endo -73.49 59.48 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 112.131 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 201' ' ' GLU . 8.0 t -80.7 -177.1 6.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.216 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 77.3 mt-30 -60.69 -23.44 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.98 -27.27 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.0 111.12 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.05 -29.2 23.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.777 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.8 pp -76.76 -31.56 57.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.502 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.31 -42.58 15.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.752 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.87 11.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.05 -173.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.504 2.803 . . . . 0.0 113.25 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 259' ' ' PHE . 96.6 mt -119.52 157.87 50.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.966 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.628 ' O ' HG22 ' A' ' 257' ' ' VAL . 58.3 Cg_endo -72.38 152.93 55.6 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.502 2.134 . . . . 0.0 112.245 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 256' ' ' PRO . 1.8 m 61.13 158.76 0.11 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 124.87 1.268 . . . . 0.0 112.56 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.43 143.28 17.13 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.756 2.304 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.533 ' HZ ' ' HB2' ' A' ' 255' ' ' LEU . 61.8 m-85 -83.03 68.91 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.412 0.625 . . . . 0.0 110.293 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.8 t -90.05 32.04 0.94 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.762 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.64 -12.11 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -87.43 41.5 3.09 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.15 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.84 -157.49 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 53.5 mt -68.54 96.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.258 0.551 . . . . 0.0 110.38 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -83.76 70.26 10.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.534 0.683 . . . . 0.0 109.469 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -114.48 83.04 1.82 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.859 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -85.92 114.53 22.9 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -88.58 -0.9 57.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.431 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.6 p -122.05 63.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.408 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.655 ' HG3' ' HB3' ' A' ' 170' ' ' SER . 3.6 pt20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.988 0.423 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -136.01 168.36 19.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.989 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 31.3 m -156.46 120.1 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.659 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 21.5 ptt180 -96.93 116.07 28.54 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.607 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 219' ' ' ILE . 69.8 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.273 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.6 pt -124.7 106.56 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.287 0.565 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.6 112.43 65.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.235 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.22 -15.86 22.62 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.511 2.141 . . . . 0.0 112.283 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.71 38.09 0.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.072 0.463 . . . . 0.0 111.087 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.4 t -78.9 -27.39 43.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 mmt 43.68 94.7 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.417 ' HB3' ' OG1' ' A' ' 235' ' ' THR . 93.1 mt -67.65 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.95 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' A' ' 251' ' ' LEU . 33.1 mtm180 64.05 149.02 0.11 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.54 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HB3' HG12 ' A' ' 231' ' ' VAL . 5.8 Cg_exo -72.96 154.98 53.27 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.759 2.306 . . . . 0.0 111.893 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -84.71 130.64 34.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -107.29 104.08 13.6 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.2 m -103.3 129.32 50.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.6 m -127.36 118.69 24.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.583 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.519 ' HG3' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -126.48 146.21 50.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.791 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 33.2 mttm -99.43 156.23 17.13 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -99.39 118.44 36.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.677 0.751 . . . . 0.0 110.499 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.81 -90.89 1.85 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.995 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.27 -68.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.79 2.326 . . . . 0.0 112.719 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -147.54 21.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 174.9 -172.44 45.47 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.57 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.519 ' HB3' ' HG3' ' A' ' 157' ' ' MET . 95.9 m-85 -98.5 -28.86 13.41 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 129.54 2.45 5.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.457 172.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.16 179.26 5.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.713 0.757 . . . . 0.0 111.236 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -137.71 125.12 21.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.7 mt -95.27 124.78 39.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.631 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 44.3 t-80 -110.09 144.09 39.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.7 m -134.38 140.41 46.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.561 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 1.004 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . 20.1 m-20 -133.84 155.96 48.9 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -80.96 12.71 3.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.939 0.876 . . . . 0.0 109.955 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.6 m -127.26 12.63 7.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.555 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 1.004 ' HG2' ' HB2' ' A' ' 171' ' ' ASP . 34.0 mmtp -115.01 140.68 25.88 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.143 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.83 -20.6 19.65 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.793 2.328 . . . . 0.0 113.404 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -162.55 -169.05 25.38 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.764 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.686 ' N ' HE21 ' A' ' 177' ' ' GLN . 0.0 OUTLIER -93.57 142.65 27.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 0.0 110.73 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.4 p90 -138.96 152.51 47.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.334 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 199' ' ' ILE . 36.7 mm -75.27 111.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 8.1 tpt180 -72.17 -51.7 20.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 75.4 m -162.1 150.24 14.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.358 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 165' ' ' GLY . 0.7 OUTLIER -133.74 141.7 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -98.48 139.01 20.86 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.368 -167.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.762 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.8 Cg_exo -38.52 -44.84 2.25 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.495 2.797 . . . . 0.0 113.858 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -87.47 66.37 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.477 0.656 . . . . 0.0 110.262 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.773 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.3 p -155.31 148.57 18.4 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.871 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 28.4 Cg_endo -63.1 -24.08 73.31 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.54 2.827 . . . . 0.0 112.433 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.64 75.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.351 0.596 . . . . 0.0 109.856 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.762 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 9.8 tp10 -62.54 -42.52 99.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.973 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.922 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.1 p -82.57 -5.47 58.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.809 0.337 . . . . 0.0 111.656 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.87 29.04 12.3 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.024 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 9.5 tp -81.13 148.91 29.37 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 193' ' ' LEU . 9.0 tpp180 -131.59 149.19 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.222 0.534 . . . . 0.0 110.884 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 181' ' ' SER . . . -76.3 154.17 35.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.203 176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 196' ' ' GLN . 15.4 mt-30 75.87 4.55 3.86 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.0 0.813 . . . . 0.0 111.141 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.36 148.27 22.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 0.0 110.789 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.45 HH22 ' CG ' ' A' ' 236' ' ' ASP . 24.2 ptt85 -103.8 149.41 25.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.489 0.661 . . . . 0.0 110.958 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 179' ' ' ILE . 46.2 mt -100.82 136.28 33.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.534 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.46 -37.21 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.037 0.446 . . . . 0.0 110.591 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 229' ' ' LEU . 5.4 tt0 -145.78 147.83 32.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.084 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 72.9 t -133.88 118.41 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.596 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.84 26.54 13.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.677 0.391 . . . . 0.0 112.022 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.01 61.24 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.48 131.26 65.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 210' ' ' LYS . 21.9 t -78.36 134.68 37.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.013 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 37.4 mmt -90.41 -10.67 43.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.794 0.331 . . . . 0.0 110.571 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.15 101.94 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.98 17.42 14.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.126 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.893 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 25.3 mmmt -113.18 157.32 21.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.043 0.449 . . . . 0.0 110.889 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -95.24 -178.52 4.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.479 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.494 ' HE2' ' HG1' ' B' ' 3' ' ' THR . 18.4 t60 -60.63 -46.25 90.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.34 -30.55 77.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.254 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.893 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 8.2 m-20 -68.47 -46.9 68.49 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.011 0.125 . . . . 0.0 111.306 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 212' ' ' HIS . 16.9 m -66.72 -37.3 79.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.837 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.53 -39.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 110.184 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.0 m -64.73 -38.83 92.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.158 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.28 86.19 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.002 0.43 . . . . 0.0 110.624 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 73.9 mt -70.85 -46.61 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.605 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.09 -32.12 73.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.621 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.99 -13.79 29.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.674 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.12 71.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.707 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.88 -75.79 0.27 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.498 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.5 5.19 2.92 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.819 0.818 . . . . 0.0 108.902 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.4 tt0 -150.56 154.06 36.89 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.504 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.7 t -148.74 147.5 28.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.28 0.562 . . . . 0.0 111.596 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -107.14 116.12 31.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.944 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.57 130.73 55.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 201' ' ' GLU . 15.7 mt -105.28 119.11 38.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.427 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.16 151.55 22.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.3 m -122.11 137.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.091 0.472 . . . . 0.0 111.941 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.06 150.44 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -62.42 -27.88 69.41 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.595 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -71.3 -44.44 65.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.404 0.621 . . . . 0.0 109.626 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 150' ' ' LEU . 87.8 m -64.85 -44.09 90.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.476 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.45 ' CG ' HH22 ' A' ' 198' ' ' ARG . 35.0 t70 -60.79 -43.62 97.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.72 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -58.71 -41.76 87.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 72.8 t80 -63.47 -46.79 84.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.528 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -69.38 -46.43 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.765 0.317 . . . . 0.0 111.513 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 236' ' ' ASP . 2.4 pttm -68.3 -25.55 65.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.495 -172.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 259' ' ' PHE . 17.4 pttm -62.39 -25.54 67.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.062 0.458 . . . . 0.0 110.157 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 69.0 m -102.17 -0.83 32.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.09 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 60.54 35.26 20.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.74 128.64 68.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.429 0.633 . . . . 0.0 110.002 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 30.2 mt -74.3 125.71 89.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.777 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 152' ' ' PRO . 34.0 Cg_exo -57.87 138.08 84.22 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.771 2.314 . . . . 0.0 111.95 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 m -157.38 165.1 36.67 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.858 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -63.71 -31.23 72.33 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.403 0.439 . . . . 0.0 110.693 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.19 -26.29 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.946 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -82.39 -45.35 14.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 4.1 pp -74.7 -30.68 61.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -89.65 -27.37 20.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.48 -124.18 3.22 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -90.04 140.7 3.43 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.943 2.429 . . . . 0.0 113.726 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.535 HD21 ' HG2' ' A' ' 151' ' ' ARG . 94.3 mt -93.08 167.62 13.87 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.676 174.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 67.0 Cg_endo -77.61 -155.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 121.969 1.779 . . . . 0.0 111.59 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.32 152.38 96.54 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.58 -163.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.398 2.732 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.2 p90 -100.51 4.4 43.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.525 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 29.3 m -66.89 146.37 54.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.147 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 260' ' ' THR . 12.4 m120 79.83 -3.74 1.99 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.062 0.851 . . . . 0.0 110.456 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.73 -0.27 75.67 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -68.6 137.25 54.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.9 mt -75.73 94.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.69 135.48 49.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.459 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.95 17.21 24.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.485 0.659 . . . . 0.0 109.533 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.17 138.62 31.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.273 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -143.72 85.05 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.714 0.768 . . . . 0.0 110.874 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.2 t -156.28 118.19 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.617 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.85 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 72.1 m-20 64.42 -176.39 0.17 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.523 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.494 ' HG1' ' HE2' ' A' ' 212' ' ' HIS . 79.1 m -147.39 120.34 8.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.653 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -95.59 131.53 41.71 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 164' ' ' TYR . 58.1 mt . . . . . 0 C--O 1.242 0.695 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.937 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.2 OUTLIER -83.95 151.48 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -111.64 93.93 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.427 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.02 -22.05 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.244 1.963 . . . . 0.0 112.051 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -88.22 -1.17 57.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.709 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.2 t -70.62 -18.76 62.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mtp -81.02 72.89 8.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 235' ' ' THR . 13.9 tp -74.77 80.75 2.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.701 0.763 . . . . 0.0 110.712 -172.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 50.6 mtt180 -130.32 137.25 30.42 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.705 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HB3' ' CG1' ' A' ' 231' ' ' VAL . 18.0 Cg_endo -60.48 142.3 97.65 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 111.807 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.42 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 50.5 ttt180 -92.52 136.52 33.15 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 227' ' ' LYS . 2.8 mt -96.14 112.95 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.332 0.587 . . . . 0.0 110.772 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 228' ' ' LEU . 61.0 m -99.44 102.84 14.54 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.165 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.5 m -102.64 116.15 32.02 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.7 ptp -136.08 151.86 50.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 46.4 pttt -128.88 142.63 50.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.884 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 19.1 ptpt -69.53 140.6 53.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 -171.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.45 -84.18 0.83 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.12 -68.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 121.951 1.768 . . . . 0.0 111.263 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 5.3 t -151.27 14.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.515 0.674 . . . . 0.0 109.242 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.05 162.52 24.51 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.88 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 86.7 m-85 -104.0 -19.17 14.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.359 . . . . 0.0 110.877 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.762 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.99 16.83 8.81 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.724 171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 164' ' ' TYR . 41.5 p90 -130.07 158.16 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.696 0.76 . . . . 0.0 111.578 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.78 123.23 49.84 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.376 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 167' ' ' ASN . 77.0 mt -95.18 133.97 38.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.612 0.244 . . . . 0.0 110.54 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.615 ' HD2' ' HB3' ' B' ' 1' ' ' GLN . 39.9 t-80 -132.3 144.2 50.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 0.0 110.041 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.548 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 15.9 p -133.57 140.75 47.35 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -101.06 152.97 19.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.237 0.542 . . . . 0.0 111.331 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -94.15 15.76 16.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.819 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.8 m -119.41 -62.67 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 132.76 28.27 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.83 135.79 6.87 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.507 2.138 . . . . 0.0 112.394 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 133.03 168.13 11.87 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.854 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.573 ' HG2' HG21 ' A' ' 215' ' ' VAL . 2.2 mp0 -118.54 140.99 49.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 169' ' ' HIS . 20.3 p90 -139.59 156.93 46.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.997 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 199' ' ' ILE . 42.3 mm -74.17 112.7 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 7.1 tpm_? -82.53 -35.93 26.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.3 t -160.35 150.65 18.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.676 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.4 t -133.14 143.19 40.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 5.3 m-20 -98.88 132.8 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 74.4 Cg_exo -51.26 -28.39 26.23 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.704 2.936 . . . . 0.0 113.459 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.69 73.84 1.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.762 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 84.0 p -152.07 147.73 20.27 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.189 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.4 Cg_endo -60.01 -24.67 77.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.176 2.584 . . . . 0.0 111.712 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.423 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -66.63 -49.91 64.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 14.4 tp10 -66.19 -39.03 89.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.12 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.58 -29.56 69.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.663 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -82.23 -19.84 38.9 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.735 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 112.53 25.32 4.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.912 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 HG13 ' A' ' 179' ' ' ILE . 12.6 tp -88.71 145.57 25.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -138.21 161.33 37.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -64.55 151.4 44.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.802 173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 21.8 mt-30 79.45 -2.02 2.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.984 0.803 . . . . 0.0 111.55 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.31 151.74 27.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.941 0.401 . . . . 0.0 110.322 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.421 HH11 HG23 ' A' ' 231' ' ' VAL . 7.6 ptm180 -117.98 143.48 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.244 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 179' ' ' ILE . 39.1 mt -106.5 135.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.212 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 m -104.43 -35.62 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.295 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.733 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 43.8 mt-10 -147.11 146.71 30.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 12.9 m -123.94 131.25 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 170.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 10.7 p30 45.78 25.15 0.26 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 0.0 113.454 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.82 -8.18 42.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.907 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.5 t -93.07 126.53 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.733 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 26.5 p -86.88 124.52 33.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.685 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 3.9 ptp -113.51 25.36 11.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.468 0.651 . . . . 0.0 110.55 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -61.0 98.29 0.07 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.117 173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.22 26.67 57.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.628 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.685 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.7 mmtp -94.91 163.91 13.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 111.23 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -88.49 179.57 6.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.316 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 215' ' ' VAL . 19.2 t60 -57.66 -49.93 74.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.92 85.77 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.1 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 12.2 t70 -68.29 -46.22 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.765 0.282 . . . . 0.0 111.126 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 177' ' ' GLN . 16.1 m -64.18 -37.75 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.811 0.339 . . . . 0.0 110.8 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.63 -48.74 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.126 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 9.5 t -60.4 -38.52 84.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.06 84.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 226' ' ' THR . 68.5 mt -71.44 -39.17 70.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.48 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -58.23 -39.02 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -74.59 -10.98 60.07 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.095 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.64 60.83 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.514 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.62 67.39 1.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.302 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 46.7 m-20 65.9 2.17 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.643 0.777 . . . . 0.0 111.856 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 50.2 mt-10 -148.55 159.3 44.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.178 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 219' ' ' ILE . 10.2 t -162.11 150.34 14.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.157 0.503 . . . . 0.0 111.185 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 96.1 mttt -110.02 127.16 54.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 10.8 mp -108.25 121.69 45.41 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.142 0.496 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 201' ' ' GLU . 17.5 mt -97.27 117.93 32.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.529 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.11 147.3 25.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 110.917 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 152' ' ' PRO . 10.6 m -139.19 132.67 38.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.063 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.551 ' OD2' ' HG2' ' A' ' 234' ' ' GLU . 26.5 t70 -71.08 163.07 28.33 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.468 ' HD3' ' OD2' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -56.52 -41.67 77.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.956 0.343 . . . . 0.0 111.685 -173.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.551 ' HG2' ' OD2' ' A' ' 232' ' ' ASP . 11.9 pt-20 -72.56 -24.62 61.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.761 0.315 . . . . 0.0 111.064 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.664 HG23 ' HG ' ' A' ' 150' ' ' LEU . 4.9 m -72.7 -43.25 63.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 109.719 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.25 -47.67 84.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.415 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 8.3 pt-20 -62.75 -34.23 76.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.341 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 48.0 t80 -61.95 -44.98 95.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.925 0.393 . . . . 0.0 111.188 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -69.96 -42.8 72.69 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.371 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 13.6 ptmm? -68.18 -30.87 70.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 22.1 ptmt -69.3 -21.56 63.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.945 0.403 . . . . 0.0 110.169 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.494 ' HB2' HG22 ' A' ' 244' ' ' VAL . 38.2 m -100.94 2.4 40.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.433 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 57.13 34.58 25.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.635 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 242' ' ' CYS . 17.8 m -118.24 147.12 21.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 51.2 mm -79.79 126.16 80.79 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.753 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.0 Cg_exo -74.01 52.57 2.67 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.86 2.373 . . . . 0.0 112.073 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -80.74 -176.45 5.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.416 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -61.2 -23.89 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.155 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -62.56 -28.56 69.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.733 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -90.02 -34.29 16.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.82 -31.67 61.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.06 0.457 . . . . 0.0 110.32 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -89.15 -46.92 8.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -99.99 -126.8 5.82 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.117 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.57 169.26 8.21 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.079 2.519 . . . . 0.0 113.684 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.562 ' HG ' ' HD2' ' A' ' 256' ' ' PRO . 5.1 tp -122.03 148.62 52.05 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.672 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.562 ' HD2' ' HG ' ' A' ' 255' ' ' LEU . 23.7 Cg_endo -62.03 170.02 6.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.625 2.217 . . . . 0.0 112.238 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.82 98.86 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.115 0.566 . . . . 0.0 110.89 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.79 167.46 21.21 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.733 2.289 . . . . 0.0 112.453 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.405 ' O ' HG22 ' A' ' 260' ' ' THR . 33.9 p90 -115.98 29.61 7.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 261' ' ' ASN . 0.5 OUTLIER 72.79 173.77 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.921 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.459 ' N ' HG23 ' A' ' 260' ' ' THR . 67.1 t30 77.95 -11.98 1.13 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.725 0.81 . . . . 0.0 110.357 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -170.97 77.93 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.679 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.56 110.74 3.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.424 0.631 . . . . 0.0 109.961 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.02 120.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.741 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -74.81 121.04 21.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.384 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -79.24 135.68 36.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.973 0.415 . . . . 0.0 111.106 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.37 150.41 22.63 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -87.83 17.17 5.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.027 0.441 . . . . 0.0 111.318 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -92.23 120.34 32.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.434 -177.047 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.615 ' HB3' ' HD2' ' A' ' 169' ' ' HIS . 10.7 mt-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.752 0.311 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 212' ' ' HIS . 77.3 m-20 57.97 -103.15 0.17 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.873 0.869 . . . . 0.0 112.843 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 88.7 m -122.83 131.32 53.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.418 -168.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -109.69 116.73 32.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.3 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.87 176.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -87.57 118.45 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.821 0.343 . . . . 0.0 110.227 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -87.82 117.3 68.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.109 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.5 -7.67 15.89 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.587 2.192 . . . . 0.0 111.877 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -89.11 17.81 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.484 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -83.65 -16.09 46.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.546 0.689 . . . . 0.0 109.401 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 59.5 mtt -103.9 76.3 1.36 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.583 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 235' ' ' THR . 94.0 mt -81.67 -83.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.629 ' HG2' HD21 ' A' ' 255' ' ' LEU . 51.2 mtt180 66.93 135.31 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.424 0.69 . . . . 0.0 112.205 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HB3' HG12 ' A' ' 231' ' ' VAL . 30.3 Cg_endo -65.49 158.04 55.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.628 2.219 . . . . 0.0 112.264 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 32.4 mmm180 -97.0 132.0 43.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.149 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 227' ' ' LYS . 50.3 tp -102.34 111.75 24.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 m -96.4 101.56 13.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.845 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.6 m -103.54 113.38 26.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.957 0.408 . . . . 0.0 109.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 188' ' ' ALA . 16.8 ptp -131.08 151.75 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.005 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.96 131.11 56.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.114 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 224' ' ' ASP . 19.7 pttp -76.47 151.42 36.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.675 0.274 . . . . 0.0 110.717 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -80.28 -103.5 0.28 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 169.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 16.4 Cg_exo -68.6 -71.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.435 2.09 . . . . 0.0 110.66 172.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.5 t -137.54 8.9 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.879 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -111.29 135.26 12.69 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.024 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 159' ' ' LYS . 93.0 m-85 -99.55 -27.82 13.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.878 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 122.67 22.0 2.57 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.718 -0.754 . . . . 0.0 113.627 173.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -148.76 175.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.512 0.656 . . . . 0.0 110.59 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' B' ' 4' ' ' ARG . 2.4 t30 -130.52 133.28 46.13 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 79.3 mt -94.76 136.23 35.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.588 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 57.7 t-80 -132.22 139.35 48.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 16.0 m -132.18 139.85 48.52 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.42 152.34 19.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.013 0.435 . . . . 0.0 110.171 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -95.09 59.28 2.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.824 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.4 p -169.55 -65.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.174 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -83.39 146.84 51.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.01 0.433 . . . . 0.0 111.582 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -88.48 120.74 1.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.172 2.581 . . . . 0.0 112.427 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.86 127.03 1.13 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.607 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.951 ' HG3' HG11 ' A' ' 215' ' ' VAL . 73.7 mm-40 -96.85 140.32 31.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.941 0.401 . . . . 0.0 110.617 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -140.66 156.62 46.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.003 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 199' ' ' ILE . 39.9 mm -87.2 128.51 39.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 72.8 ttt180 -82.67 -51.19 7.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.63 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.1 m -153.45 158.07 40.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.761 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' A' ' 195' ' ' ALA . 59.7 t -132.29 142.57 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 22.6 m-20 -82.48 137.2 45.1 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.494 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 50.3 Cg_exo -56.35 -26.25 61.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.801 3.001 . . . . 0.0 112.696 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -124.38 75.18 1.37 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.194 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.878 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 99.4 p -139.41 144.72 41.08 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.197 0.522 . . . . 0.0 110.806 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 27.9 Cg_endo -63.14 -23.39 73.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.743 2.295 . . . . 0.0 111.419 173.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.405 ' HA ' ' CE ' ' A' ' 157' ' ' MET . . . -62.55 -50.2 72.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.455 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -61.81 -45.76 92.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.536 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.8 -29.04 69.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.2 p -81.52 -5.43 57.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.093 0.473 . . . . 0.0 110.631 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.04 12.1 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.563 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 179' ' ' ILE . 3.3 tm? -89.16 114.11 25.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 197' ' ' ASP . 18.2 tpt85 -111.94 145.77 38.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.925 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -77.47 20.94 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.177 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -124.37 6.12 8.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 194' ' ' ARG . 10.7 m-20 -114.91 168.32 10.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.293 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 198' ' ' ARG . 8.7 ttm180 -110.51 143.33 41.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.041 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.689 HD11 HD11 ' A' ' 179' ' ' ILE . 61.0 mt -96.94 125.06 50.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.657 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 246' ' ' PRO . 7.1 p -104.16 -39.39 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.349 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.2 mt-10 -135.22 150.3 50.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 111.06 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 203' ' ' ASN . 91.2 t -129.12 113.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 202' ' ' VAL . 10.9 p30 43.91 33.95 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.129 0.971 . . . . 0.0 112.923 -175.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.32 -9.93 59.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.575 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.61 139.87 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 6.8 p -90.33 134.58 34.22 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.686 ' SD ' HG12 ' A' ' 215' ' ' VAL . 19.1 mmt -105.16 19.13 21.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.515 0.674 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -76.91 103.91 7.11 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.504 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.27 62.45 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.375 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 214' ' ' ASP . 29.8 mmmt -102.43 151.82 21.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -93.56 178.49 5.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.508 ' O ' HG22 ' A' ' 215' ' ' VAL . 36.2 t60 -61.42 -42.81 99.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.52 -34.41 89.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.086 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.55 ' HB3' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-20 -67.04 -46.42 74.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.617 0.246 . . . . 0.0 111.008 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.951 HG11 ' HG3' ' A' ' 177' ' ' GLN . 11.1 m -65.39 -36.85 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 0.0 110.903 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 212' ' ' HIS . 86.0 t -67.19 -43.6 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.078 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.9 m -60.7 -38.55 85.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.56 92.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 111.234 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.6 -42.21 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.529 . . . . 0.0 111.291 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -64.85 -32.94 74.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.2 -16.84 64.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.8 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.49 -10.92 85.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.943 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.64 -93.43 1.14 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 121.259 -0.496 . . . . 0.0 111.945 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 3.9 m-20 -110.6 5.07 20.8 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.375 0.27 . . . . 0.0 110.756 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -140.84 162.3 35.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.151 0.5 . . . . 0.0 111.296 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.0 t -160.25 147.64 16.24 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.863 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.566 ' HB3' HD11 ' A' ' 154' ' ' LEU . 62.5 mttp -113.73 120.81 42.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.9 mt -109.33 127.3 54.21 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 201' ' ' GLU . 9.2 mt -97.45 118.65 34.43 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.509 176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -121.84 148.82 25.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.17 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 152' ' ' PRO . 11.1 m -122.21 131.82 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.059 0.457 . . . . 0.0 111.236 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 157.52 37.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.566 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -52.55 -41.6 63.68 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -70.58 -41.29 72.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.038 0.447 . . . . 0.0 110.259 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.435 ' HA ' HD13 ' A' ' 150' ' ' LEU . 87.0 m -64.35 -46.89 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.878 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 32.6 t70 -55.88 -47.91 76.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.792 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 241' ' ' LYS . 20.7 mm-40 -65.86 -34.24 77.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.494 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -61.41 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.859 0.361 . . . . 0.0 110.819 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.49 -32.82 73.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.275 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 236' ' ' ASP . 32.3 mmtp -56.15 -36.7 68.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.253 0.549 . . . . 0.0 110.386 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 46.8 mttm -68.84 -17.75 64.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.661 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.405 ' HB3' HG12 ' A' ' 244' ' ' VAL . 40.1 t -110.14 -4.25 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.289 0.566 . . . . 0.0 110.087 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 51.15 36.34 15.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.619 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.531 HG11 ' HG3' ' A' ' 256' ' ' PRO . 12.6 p -111.42 150.28 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.742 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.5 mm -74.67 130.41 81.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.687 ' HD2' HG21 ' A' ' 200' ' ' VAL . 7.9 Cg_exo -72.36 55.34 2.49 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.033 2.489 . . . . 0.0 112.217 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 p -68.38 166.09 17.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.806 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.548 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 97.5 mt-30 -54.21 -24.39 18.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.615 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.11 -27.97 69.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.193 0.52 . . . . 0.0 110.796 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -88.19 -19.85 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -75.09 -31.59 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.929 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -107.64 -37.35 6.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.773 0.321 . . . . 0.0 111.22 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.11 -154.92 25.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.718 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.08 152.97 21.74 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.846 2.364 . . . . 0.0 112.381 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.629 HD21 ' HG2' ' A' ' 151' ' ' ARG . 79.9 mt -88.16 142.78 32.06 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.129 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.531 ' HG3' HG11 ' A' ' 244' ' ' VAL . 37.6 Cg_endo -72.2 108.32 2.46 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.483 2.789 . . . . 0.0 114.697 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 4.7 m -149.01 129.45 6.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.076 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 31.4 Cg_exo -61.35 109.66 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.972 2.448 . . . . 0.0 112.635 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -107.29 104.57 14.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.265 0.555 . . . . 0.0 110.792 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 262' ' ' GLY . 27.2 m 72.5 -74.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.126 175.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' THR . 6.1 m-20 69.14 -21.79 0.15 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.278 0.631 . . . . 0.0 112.2 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 260' ' ' THR . . . -80.97 58.05 4.82 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.561 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -117.59 113.98 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 110.019 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.84 75.01 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.69 0.757 . . . . 0.0 110.812 -175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -130.62 32.02 4.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.987 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -63.15 128.91 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.009 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -55.52 110.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.655 0.597 . . . . 0.0 111.905 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -117.61 73.99 0.91 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.906 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 19.4 t -84.13 62.35 7.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.297 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.083 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.008 0.432 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 21.1 m-20 -119.72 -171.48 2.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.975 -172.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 43.0 m -150.26 137.65 19.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.429 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 167' ' ' ASN . 15.4 tpt180 -102.61 123.6 46.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.859 176.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.633 177.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.791 -0.523 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.1 mt -85.97 80.62 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 20.4 m-20 -66.45 118.6 55.23 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.177 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.33 -19.8 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.761 2.307 . . . . 0.0 110.839 170.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -108.78 35.66 3.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.505 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 11.3 t -96.88 -8.11 31.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.348 0.594 . . . . 0.0 109.823 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.9 mtt -79.12 131.93 36.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.3 mt -77.84 87.98 4.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.688 0.756 . . . . 0.0 109.646 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.669 ' HD2' HD21 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -138.6 135.94 18.42 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 -178.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.24 123.33 11.66 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.028 1.818 . . . . 0.0 111.084 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -85.55 134.54 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.48 102.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 73.0 m -94.72 130.41 41.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.03 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.1 m -125.79 114.23 18.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.975 0.416 . . . . 0.0 110.199 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.39 141.18 52.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.83 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.0 mttm -105.27 133.11 50.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.826 -177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 224' ' ' ASP . 12.6 ptmm? -65.22 144.43 57.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.248 0.547 . . . . 0.0 110.962 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.98 -124.11 5.08 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 172.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.84 -58.21 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.743 2.295 . . . . 0.0 112.691 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t -141.41 27.03 1.93 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.358 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 171.73 173.25 38.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.297 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.505 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 46.5 m-85 -98.39 -30.59 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.94 0.496 . . . . 0.0 110.021 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.852 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 132.3 10.67 2.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.995 -1.097 . . . . 0.0 114.1 174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -130.19 149.79 51.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.724 0.773 . . . . 0.0 111.662 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -106.72 127.51 53.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.476 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 167' ' ' ASN . 77.5 mt -101.68 128.67 47.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.2 -177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -133.51 142.43 48.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.581 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.8 p -122.53 144.86 48.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 38.3 t70 -128.15 168.48 15.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.567 0.222 . . . . 0.0 110.434 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -78.66 -37.56 41.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.869 0.366 . . . . 0.0 110.34 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 m -84.65 -16.0 43.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.194 0.521 . . . . 0.0 110.23 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' ASP . 69.2 mmtt -120.76 80.41 32.47 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.111 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.66 -33.05 22.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.84 2.36 . . . . 0.0 111.912 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.47 132.5 18.34 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.597 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.6 mp0 -67.31 140.99 57.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 0.0 111.206 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -139.27 153.74 47.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.149 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.42 HG13 HD11 ' A' ' 193' ' ' LEU . 47.5 mm -79.8 116.94 24.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 180' ' ' ARG . 37.3 ttt-85 -73.45 -49.0 29.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.021 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.1 p -157.52 151.38 24.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.452 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 189' ' ' GLU . 36.6 t -123.9 144.46 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.863 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 16.7 t70 -85.7 127.16 63.93 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.37 -28.19 42.6 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.458 2.772 . . . . 0.0 113.964 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -109.55 21.47 16.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.906 0.384 . . . . 0.0 110.696 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.863 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 59.8 p -94.49 149.65 36.92 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.374 0.607 . . . . 0.0 110.852 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.3 Cg_endo -61.48 -24.62 78.56 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.984 2.456 . . . . 0.0 111.876 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.29 -48.52 75.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.806 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.0 tp10 -61.58 -38.75 88.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.27 71.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' HE3' ' A' ' 157' ' ' MET . 53.9 p -81.34 -0.28 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.65 22.99 32.12 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 179' ' ' ILE . 7.2 tp -83.75 138.46 33.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -120.75 165.32 15.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.641 0.734 . . . . 0.0 111.985 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.77 25.17 1.32 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.796 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -135.7 7.88 3.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.192 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -93.41 150.69 20.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.905 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -113.97 146.12 40.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.547 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 179' ' ' ILE . 54.4 mt -98.81 127.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.135 0.493 . . . . 0.0 111.502 -172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.99 -46.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.708 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 229' ' ' LEU . 31.3 mt-10 -140.45 147.43 39.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 219' ' ' ILE . 96.0 t -129.26 114.19 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.406 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 91.4 m-20 58.28 23.15 10.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 174.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.896 ' HA2' HE22 ' A' ' 248' ' ' GLN . . . 104.19 -8.29 48.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.351 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.59 137.07 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 56.8 m -91.53 134.98 34.19 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.893 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 215' ' ' VAL . 38.6 mmt -93.47 3.28 55.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -172.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -21.09 62.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.983 0.42 . . . . 0.0 111.531 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -130.66 34.52 2.65 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' ASP . 68.0 mmtt -111.28 147.49 34.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.393 0.616 . . . . 0.0 112.094 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 214' ' ' ASP . 26.2 mp0 -102.04 -176.94 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -53.35 -45.48 69.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.222 0.326 . . . . 0.0 111.078 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.19 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.745 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.775 ' HB3' ' HD2' ' A' ' 210' ' ' LYS . 0.5 OUTLIER -68.18 -39.83 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -176.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 177' ' ' GLN . 23.3 m -67.34 -39.71 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.647 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.81 -39.91 82.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 109.97 176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.6 t -62.3 -39.49 93.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.837 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.36 83.38 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.094 0.473 . . . . 0.0 110.566 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.529 ' CG1' HG11 ' A' ' 202' ' ' VAL . 63.0 mt -70.84 -46.6 67.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.801 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.61 -31.81 71.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.118 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.87 -17.57 61.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.29 -20.44 62.49 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.59 -94.29 1.52 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.405 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.472 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 7.6 p-10 -103.36 -3.25 25.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.909 0.385 . . . . 0.0 110.446 -175.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 60.4 mt-10 -136.91 166.16 24.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.195 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.4 t -157.23 133.36 9.61 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.199 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -103.8 114.51 28.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.236 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 48.9 mt -110.08 130.59 55.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.405 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 201' ' ' GLU . 13.7 mt -97.8 119.23 36.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.148 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.79 147.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.59 133.89 61.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.67 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.82 164.11 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -58.13 -39.55 79.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.877 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -66.42 -44.8 81.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.213 0.53 . . . . 0.0 109.959 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.53 ' O ' ' HD1' ' A' ' 239' ' ' PHE . 69.6 m -63.09 -47.12 84.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.18 -49.26 76.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.748 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 pt-20 -67.62 -33.63 75.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.52 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 41.1 t80 -62.06 -40.7 96.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.174 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HD1' ' O ' ' A' ' 235' ' ' THR . 61.0 m-85 -67.7 -39.53 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.867 173.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 237' ' ' GLU . 9.1 pttm -67.27 -27.98 67.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.571 -172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.496 ' HB2' ' NZ ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -73.14 -19.32 61.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 109.94 177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 256' ' ' PRO . 26.3 m -96.48 -9.22 30.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.531 0.681 . . . . 0.0 109.888 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 57.67 44.37 20.78 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.597 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.73 151.39 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.867 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 46.2 mm -85.28 126.86 66.05 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 7.8 Cg_exo -72.1 62.6 3.33 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.962 2.441 . . . . 0.0 112.428 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.29 178.59 5.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.793 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.896 HE22 ' HA2' ' A' ' 204' ' ' GLY . 63.6 mt-30 -53.22 -30.74 39.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.054 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.63 -26.88 68.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.0 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 44.9 m80 -88.25 -21.72 24.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -173.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.0 pp -75.35 -30.33 60.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.716 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -89.14 -42.97 11.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.279 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.91 -138.42 9.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.427 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 4.2 Cg_exo -80.07 -173.51 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.553 2.836 . . . . 0.0 112.088 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.669 HD21 ' HD2' ' A' ' 151' ' ' ARG . 19.7 mt -107.93 -49.37 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.121 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 255' ' ' LEU . 2.0 Cg_endo -94.31 -169.31 0.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.404 2.736 . . . . 0.0 111.153 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 5.1 p -124.85 122.44 25.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 120.814 0.34 . . . . 0.0 110.296 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 23.5 Cg_exo -64.52 152.3 82.23 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.74 2.293 . . . . 0.0 111.708 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -85.87 9.72 15.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 110.948 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 80.4 m -154.57 114.2 3.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.685 176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.89 -16.75 26.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.541 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 86.7 -63.09 4.16 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.73 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.22 152.97 23.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.73 125.86 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.8 118.23 5.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.374 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -100.7 114.24 27.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.345 0.593 . . . . 0.0 111.108 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 270' ' ' ARG . 78.2 tt0 -109.78 127.96 54.99 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.53 -31.38 72.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.89 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.2 p -123.49 65.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.281 0.562 . . . . 0.0 110.785 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 267' ' ' GLU . 15.5 tpp180 . . . . . 0 C--O 1.243 0.762 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.882 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.528 0.204 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.57 -77.25 0.08 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.491 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.23 119.02 37.92 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -107.1 127.72 53.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.4 mt . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.987 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.9 mt -88.05 84.93 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 146' ' ' PRO . 14.3 m-20 -56.9 118.44 23.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.271 -174.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 145' ' ' ASP . 25.1 Cg_endo -63.04 -23.22 73.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.797 2.331 . . . . 0.0 111.874 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.36 19.66 6.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -75.23 -10.8 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.666 0.746 . . . . 0.0 109.228 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 76.5 mtp -101.68 98.39 8.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.779 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 235' ' ' THR . 2.7 mm? -92.51 87.31 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.0 109.788 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.824 ' HG3' HD21 ' A' ' 255' ' ' LEU . 7.7 ttt180 -135.19 127.16 17.89 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.454 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HB3' HG12 ' A' ' 231' ' ' VAL . 32.0 Cg_endo -62.83 144.7 94.03 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.766 2.311 . . . . 0.0 112.152 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.54 ' NH2' ' HA3' ' A' ' 192' ' ' GLY . 37.8 ttt180 -94.59 132.21 39.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.4 OUTLIER -94.7 111.56 23.33 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 58.8 m -104.42 108.95 20.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.417 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.0 m -109.52 113.52 26.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.017 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.719 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 1.2 pmm? -123.74 141.95 51.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.484 0.659 . . . . 0.0 110.797 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.712 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -107.97 149.16 28.72 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.79 177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -87.07 120.28 28.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.468 0.652 . . . . 0.0 109.623 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.52 -86.91 1.95 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.815 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 -66.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.756 2.304 . . . . 0.0 112.593 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.3 t -153.8 31.97 0.45 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.427 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 160.89 -173.5 37.38 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.742 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 95.0 m-85 -96.64 -28.55 14.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 0.0 110.144 -177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.752 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 106.79 19.38 9.73 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.598 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -130.61 150.75 51.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.676 0.751 . . . . 0.0 110.988 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -112.93 122.05 46.48 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.639 -178.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' B' ' 2' ' ' ASP . 91.4 mt -94.7 121.7 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 60.6 t-80 -103.4 140.84 36.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.3 t -107.21 144.58 33.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.0 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -117.29 156.33 27.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -103.76 -20.49 13.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.6 m -96.63 -40.99 8.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -109.18 139.74 21.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.0 -11.92 7.38 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.916 2.41 . . . . 0.0 113.172 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -69.52 135.75 27.35 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.014 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.796 ' HA ' HE21 ' A' ' 177' ' ' GLN . 0.0 OUTLIER -97.79 144.1 27.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.03 0.443 . . . . 0.0 110.557 -177.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 13.2 p90 -138.47 143.81 39.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.522 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mm -74.39 117.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.0 tmt_? -73.39 -49.83 25.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.051 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 m -159.59 152.9 22.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.44 143.15 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 24.2 t70 -88.62 131.98 40.17 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.407 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -39.36 -43.57 2.76 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.134 3.223 . . . . 0.0 114.314 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -119.47 71.98 0.89 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.29 0.567 . . . . 0.0 110.483 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.752 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 85.4 p -127.15 153.48 76.74 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.347 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.0 Cg_endo -61.1 -30.46 89.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.531 2.154 . . . . 0.0 111.914 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.719 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -62.15 -47.03 86.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.973 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.18 -38.79 84.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.507 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -81.43 -11.55 59.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 0.0 110.965 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.54 ' HA3' ' NH2' ' A' ' 153' ' ' ARG . . . 95.01 27.79 10.64 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.99 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.13 142.86 32.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 28.1 mmt180 -122.27 168.34 12.15 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.692 0.758 . . . . 0.0 111.153 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -85.99 153.0 22.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.102 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 196' ' ' GLN . 20.1 mt-30 69.94 16.26 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.696 0.622 . . . . 0.0 111.157 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 55.4 m-20 -93.42 170.24 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -123.29 146.18 48.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.07 123.99 50.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.45 -43.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.62 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.769 ' HG2' HD12 ' A' ' 229' ' ' LEU . 10.9 pt-20 -160.92 156.52 25.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.011 174.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 227' ' ' LYS . 94.4 t -117.86 114.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 85.3 m-20 69.61 -59.27 0.5 Allowed 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.937 0.773 . . . . 0.0 111.924 175.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.56 25.11 0.06 OUTLIER Glycine 0 C--N 1.314 -0.68 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.75 137.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 28.2 t -74.99 117.59 17.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.373 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 201' ' ' GLU . 7.6 tpp -110.58 74.36 0.87 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 110.72 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -81.74 14.47 2.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.503 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.5 69.07 1.41 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.833 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -117.83 -73.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.66 139.55 52.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -57.43 -32.2 66.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.639 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.48 -38.24 93.31 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.992 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.11 -46.24 74.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.588 HG12 ' SD ' ' A' ' 207' ' ' MET . 11.7 m -64.19 -41.35 92.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.71 -45.18 81.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.122 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 12.5 t -60.14 -41.37 92.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.71 92.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.445 HG21 HD13 ' B' ' 5' ' ' LEU . 65.1 mt -71.77 -46.76 59.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.684 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -66.81 -32.39 73.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.14 -15.11 55.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.675 0.274 . . . . 0.0 111.404 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -75.19 -18.67 80.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.133 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 80.39 -71.14 2.86 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.087 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.65 -4.91 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.712 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 46.0 mt-10 -141.51 158.64 43.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.695 0.284 . . . . 0.0 110.404 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.55 HG23 ' SD ' ' A' ' 157' ' ' MET . 9.5 t -151.27 139.17 19.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 111.241 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.54 ' HB3' HD21 ' A' ' 154' ' ' LEU . 84.5 mttt -107.51 113.67 27.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.402 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.7 mt -110.59 125.9 53.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.814 0.34 . . . . 0.0 110.364 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.769 HD12 ' HG2' ' A' ' 201' ' ' GLU . 11.8 mt -97.22 120.46 37.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.52 149.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.262 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 152' ' ' PRO . 16.3 m -122.44 142.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 233' ' ' ARG . 18.1 t70 -71.36 156.12 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.274 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 232' ' ' ASP . 0.1 OUTLIER -55.95 -46.85 78.42 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.86 -23.81 58.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.131 0.491 . . . . 0.0 111.076 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 150' ' ' LEU . 45.0 m -68.73 -42.05 78.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.757 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.12 -49.96 72.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.219 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.6 ' HA ' ' HE2' ' A' ' 240' ' ' LYS . 38.9 mt-10 -62.16 -34.79 77.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.61 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.634 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 51.5 t80 -65.1 -46.96 78.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.665 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.43 -46.15 67.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.908 0.385 . . . . 0.0 111.483 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 42.8 pttt -68.68 -26.37 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.884 -172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 17.4 ptpt -63.72 -27.3 69.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.907 0.385 . . . . 0.0 110.287 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 258' ' ' PRO . 11.3 t -99.71 1.5 43.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 109.677 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 63.32 24.18 14.12 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.64 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.56 160.08 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.943 0.401 . . . . 0.0 110.122 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 79.8 mt -104.15 126.09 32.6 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.659 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.8 56.78 2.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.423 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 175.96 4.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.99 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.54 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.1 mt-30 -56.48 -23.82 41.81 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 111.389 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.2 -27.01 68.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.166 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -89.0 -28.3 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -76.3 -31.49 58.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 110.251 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.6 -47.14 8.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -101.09 -156.81 27.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.697 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.29 159.94 46.0 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.981 2.454 . . . . 0.0 113.13 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.824 HD21 ' HG3' ' A' ' 151' ' ' ARG . 85.5 mt -88.28 160.18 46.07 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.041 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 94.4 Cg_endo -82.19 176.56 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.034 1.823 . . . . 0.0 113.084 -174.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.34 101.01 44.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.69 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.536 ' HG3' ' CE1' ' A' ' 238' ' ' PHE . 62.6 Cg_endo -73.01 133.86 20.48 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.352 2.035 . . . . 0.0 112.518 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -95.44 2.87 54.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.728 0.775 . . . . 0.0 109.423 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.548 HG23 HG13 ' A' ' 264' ' ' ILE . 5.6 m -105.09 77.87 1.35 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -61.79 -33.98 75.07 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.216 0.531 . . . . 0.0 110.211 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 260' ' ' THR . . . -129.56 -113.28 1.63 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -129.41 143.26 50.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.069 0.462 . . . . 0.0 110.492 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.617 HG22 ' HG2' ' A' ' 266' ' ' LYS . 49.4 mt -101.41 128.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -79.72 88.84 5.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.851 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.617 ' HG2' HG22 ' A' ' 264' ' ' ILE . 34.7 mmtp -123.63 117.51 25.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.48 61.25 3.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.966 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.03 45.37 21.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.541 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.5 p -69.16 118.06 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.527 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.708 -178.5 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' B' ' 2' ' ' ASP . 19.2 pt20 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.743 ' H ' ' HG3' ' B' ' 1' ' ' GLN . 22.7 m-20 55.15 -163.94 0.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 112.077 174.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -144.11 120.86 11.21 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.827 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -99.63 116.16 31.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 219' ' ' ILE . 91.7 mt . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.416 -175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.1 mt -88.12 89.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 148' ' ' THR . 13.6 m-20 -114.42 75.92 3.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.953 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 -22.41 14.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.14 1.893 . . . . 0.0 111.956 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -112.66 35.01 4.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.663 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 145' ' ' ASP . 14.5 t -78.03 -21.78 50.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.777 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -79.78 89.54 5.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.25 -78.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.437 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.795 ' HG2' HD21 ' A' ' 255' ' ' LEU . 56.2 mtm180 65.07 158.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 121.449 0.643 . . . . 0.0 112.556 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HB3' HG12 ' A' ' 231' ' ' VAL . 92.7 Cg_endo -83.22 164.89 14.89 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.838 2.358 . . . . 0.0 111.363 172.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -106.24 132.96 51.67 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.164 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.539 ' HA ' HD23 ' A' ' 229' ' ' LEU . 0.4 OUTLIER -87.7 115.0 24.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 30.4 m -108.34 110.36 21.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.31 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 77.2 m -110.01 114.01 27.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -122.6 141.45 51.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.522 0.677 . . . . 0.0 110.988 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 28.2 pttt -116.51 137.54 52.09 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.614 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 22.8 pttp -72.36 138.09 47.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.325 0.583 . . . . 0.0 111.424 -172.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.13 -86.36 1.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.519 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.15 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.477 2.118 . . . . 0.0 110.861 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.0 t -158.61 21.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . -138.53 156.36 24.06 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.958 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 25.2 m-85 -99.09 -25.99 14.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.161 0.505 . . . . 0.0 109.791 -175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.942 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 114.47 20.21 5.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.297 -0.954 . . . . 0.0 114.142 171.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -129.86 170.55 13.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.468 0.634 . . . . 0.0 111.026 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' OD1' ' HD3' ' A' ' 180' ' ' ARG . 2.0 t-20 -128.42 118.49 23.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.948 -173.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.66 120.54 36.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 57.5 t-80 -110.72 143.12 41.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.615 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.2 m -99.21 144.36 28.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.33 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.489 ' HB2' ' HZ ' ' A' ' 178' ' ' PHE . 4.4 t0 -138.69 166.06 25.34 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.9 -11.83 12.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 p -100.5 -23.1 14.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 110.803 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -100.11 136.26 20.16 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.45 102.16 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.359 2.706 . . . . 0.0 112.179 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 128.77 -172.77 19.44 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.486 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.605 ' HG3' HG21 ' A' ' 215' ' ' VAL . 13.7 mm100 -111.3 142.63 43.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.209 0.528 . . . . 0.0 111.333 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' A' ' 171' ' ' ASP . 14.1 p90 -137.95 146.11 42.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.107 -176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 199' ' ' ILE . 32.9 mm -81.72 113.93 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.765 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 18.6 ttt180 -71.84 -52.46 17.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.23 154.1 30.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.699 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 189' ' ' GLU . 73.6 t -132.15 141.42 45.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HB2' ' OG ' ' A' ' 186' ' ' SER . 33.5 m-20 -88.55 132.93 37.37 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.797 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 54.4 Cg_exo -55.25 -26.73 53.36 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.764 2.976 . . . . 0.0 114.067 -174.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -99.18 12.63 35.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.678 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.942 ' HB3' ' HA3' ' A' ' 165' ' ' GLY . 9.7 m -87.38 149.52 47.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.198 0.523 . . . . 0.0 111.361 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.0 Cg_endo -61.67 -26.49 80.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 111.491 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.64 -49.61 70.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 110.193 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 184' ' ' PRO . 10.6 tp10 -61.73 -38.88 89.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.012 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.42 73.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.691 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.9 p -81.7 -7.39 59.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.161 0.505 . . . . 0.0 110.831 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.97 35.05 9.29 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.325 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 179' ' ' ILE . 2.5 tm? -76.91 110.06 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.15 120.79 28.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.745 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -68.52 151.72 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.377 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 79.5 mt-30 78.71 7.36 2.22 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.04 0.838 . . . . 0.0 111.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -107.99 163.15 13.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.808 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -108.66 148.3 30.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.915 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 179' ' ' ILE . 18.0 mt -94.32 135.01 29.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.822 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 245' ' ' ILE . 26.8 m -103.63 -33.35 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 45.6 mt-10 -140.18 140.31 35.88 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.541 0.21 . . . . 0.0 110.653 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 219' ' ' ILE . 95.1 t -126.06 114.54 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.249 171.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 59.36 23.41 11.89 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.364 0.415 . . . . 0.0 112.019 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.22 11.24 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.205 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.36 146.06 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.33 116.69 29.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.491 ' HA ' ' HG3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -113.87 44.22 1.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.662 . . . . 0.0 110.082 174.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 91.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.593 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.52 9.61 83.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.763 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 207' ' ' MET . 29.2 mmmt -83.74 160.3 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -102.52 -171.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 216' ' ' VAL . 15.2 t60 -51.17 -53.42 34.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.002 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.86 85.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.753 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 210' ' ' LYS . 19.3 m-20 -65.05 -46.1 82.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.78 0.324 . . . . 0.0 111.064 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.605 HG21 ' HG3' ' A' ' 177' ' ' GLN . 18.8 m -69.46 -35.74 68.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 212' ' ' HIS . 85.6 t -63.02 -38.3 81.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 50.5 m -60.4 -38.9 85.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.46 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.72 91.83 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.107 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.491 HG13 HG11 ' A' ' 202' ' ' VAL . 74.6 mt -70.34 -46.79 69.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -59.53 -32.11 70.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.38 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.35 -34.73 70.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.437 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.98 68.95 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.4 -88.81 1.38 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.572 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 8.6 p-10 -100.07 -9.1 22.99 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.806 -0.232 . . . . 0.0 111.46 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 55.9 mt-10 -133.59 148.15 51.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.926 0.393 . . . . 0.0 110.768 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.435 ' CB ' HG23 ' A' ' 219' ' ' ILE . 11.6 t -148.04 142.02 25.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.361 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.521 ' HB3' HD21 ' A' ' 154' ' ' LEU . 67.5 mttm -111.67 114.64 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.296 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.09 131.15 55.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 201' ' ' GLU . 25.7 mt -104.74 119.57 39.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.102 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.53 161.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.56 HG12 ' HB3' ' A' ' 152' ' ' PRO . 27.7 m -121.99 152.25 25.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.22 160.69 30.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -53.84 -44.74 70.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.67 0.271 . . . . 0.0 111.042 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 237' ' ' GLU . 45.0 mt-10 -72.32 -32.1 66.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 77.0 m -60.79 -43.64 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.42 -49.26 76.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.812 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 234' ' ' GLU . 1.8 pp20? -61.97 -32.68 73.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 55.4 t80 -74.16 -47.71 34.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.511 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -67.55 -35.78 79.71 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 237' ' ' GLU . 63.3 pttt -60.47 -25.2 65.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.269 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 238' ' ' PHE . 63.1 mttp -62.09 -32.48 73.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB2' HG12 ' A' ' 244' ' ' VAL . 86.0 m -101.78 -4.08 26.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.686 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 57.5 30.94 19.5 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.853 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 242' ' ' CYS . 10.6 p -109.4 141.57 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.065 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.424 HG23 ' HB ' ' A' ' 200' ' ' VAL . 1.9 mp -75.87 132.16 74.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.487 ' HG2' HG11 ' A' ' 231' ' ' VAL . 19.1 Cg_exo -67.19 61.41 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.259 2.64 . . . . 0.0 112.206 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 t -63.76 159.04 20.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.179 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.55 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 37.8 mt-30 -53.66 -24.04 13.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.144 -1.389 . . . . 0.0 113.014 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.48 -27.3 69.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.937 0.398 . . . . 0.0 111.025 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -77.71 -14.0 59.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 18.1 mt -64.03 -43.65 94.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.473 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -110.32 -15.7 13.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.745 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.38 155.48 37.95 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.591 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.31 135.3 53.22 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.815 2.343 . . . . 0.0 112.053 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.795 HD21 ' HG2' ' A' ' 151' ' ' ARG . 88.5 mt -81.9 164.82 46.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.312 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.98 142.92 42.13 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.557 2.172 . . . . 0.0 111.565 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.458 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 11.7 m -60.79 122.17 66.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.117 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 16.5 Cg_exo -67.13 145.53 73.38 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.91 2.406 . . . . 0.0 111.428 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -140.4 11.55 2.33 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.513 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.1 m 63.85 86.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.425 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -68.87 -33.37 73.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.867 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.24 -139.88 3.01 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.735 -1.221 . . . . 0.0 113.638 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -93.01 153.25 18.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.133 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 48.2 mm -86.21 84.23 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.48 157.49 28.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.369 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -105.02 24.76 11.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -89.64 123.51 33.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.024 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -105.84 90.73 3.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 43.1 m -129.98 43.7 3.08 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.399 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.704 -178.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -126.67 -175.88 3.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.072 0.463 . . . . 0.0 111.096 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -146.04 131.88 19.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.155 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -101.24 143.72 30.96 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.448 ' HB3' ' HD1' ' A' ' 164' ' ' TYR . 73.0 mt . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.946 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 21.4 mt 52.35 54.03 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 26.6 m-20 -75.45 110.74 11.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.472 -171.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 145' ' ' ASP . 3.4 Cg_exo -74.59 -23.91 14.27 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.799 2.333 . . . . 0.0 112.307 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.69 29.79 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.153 0.502 . . . . 0.0 111.237 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.771 HG23 ' HG3' ' A' ' 149' ' ' MET . 9.0 t -85.63 -20.49 29.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.771 ' HG3' HG23 ' A' ' 148' ' ' THR . 56.5 mtt -123.22 84.69 2.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.309 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.9 -79.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.03 -178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.643 ' HG2' HD21 ' A' ' 255' ' ' LEU . 74.6 mtt-85 63.93 129.32 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.794 0.683 . . . . 0.0 111.596 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 3.4 Cg_exo -71.43 162.72 41.41 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.453 2.102 . . . . 0.0 111.089 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 153' ' ' ARG . 10.6 mmm180 -95.65 130.82 42.41 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.235 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 227' ' ' LYS . 0.6 OUTLIER -103.05 116.26 32.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -112.81 103.19 11.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.633 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 227' ' ' LYS . 6.4 m -104.47 112.72 25.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.634 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.52 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.2 pmm? -123.73 143.57 50.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.531 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.854 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 1.0 OUTLIER -106.67 146.58 30.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.924 178.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 224' ' ' ASP . 21.5 pttp -82.56 129.77 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.743 -176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -87.3 -91.39 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.935 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -61.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.211 1.941 . . . . 0.0 111.497 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.0 t -160.22 25.31 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -157.93 166.47 34.01 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.805 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 64.6 m-85 -103.53 -24.85 13.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 113.72 21.34 5.76 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.962 171.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 51.8 p90 -136.51 156.23 48.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.59 0.695 . . . . 0.0 111.523 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -118.93 122.17 41.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.41 124.54 38.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.69 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.608 ' HA ' ' OD1' ' B' ' 2' ' ' ASP . 84.8 t60 -113.15 144.09 43.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -133.56 159.3 40.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.736 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.74 174.25 11.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.671 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.19 38.97 0.88 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -150.65 -33.59 0.16 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.607 0.242 . . . . 0.0 111.003 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.87 117.53 53.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.13 0.491 . . . . 0.0 111.154 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.03 -29.95 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.143 2.562 . . . . 0.0 111.748 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -67.93 141.82 38.73 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.862 ' HG3' HG21 ' A' ' 215' ' ' VAL . 31.6 mm-40 -86.37 141.78 28.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.622 0.725 . . . . 0.0 111.813 -174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -136.38 147.77 47.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.06 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 13.1 mm -78.51 115.2 20.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.037 0.446 . . . . 0.0 110.402 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 4.5 tmm_? -67.37 -43.39 81.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.81 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 195' ' ' ALA . 29.0 t -170.17 158.01 6.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.987 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.91 142.01 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.59 134.43 27.9 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.35 -54.0 3.85 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.708 2.938 . . . . 0.0 113.557 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.92 64.0 2.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.76 0.79 . . . . 0.0 110.859 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 78.6 p -131.5 145.18 56.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.978 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 20.0 Cg_endo -61.64 -25.23 78.87 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.123 2.549 . . . . 0.0 112.102 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.46 -49.31 71.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.048 0.451 . . . . 0.0 110.269 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.04 -39.36 85.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.06 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.12 -32.68 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.813 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -82.45 -0.59 46.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.347 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.58 22.75 33.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.752 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 179' ' ' ILE . 2.6 tm? -83.7 118.92 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -107.6 159.91 16.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.228 0.537 . . . . 0.0 111.436 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -84.91 159.15 20.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.907 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 71.07 6.62 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.925 0.765 . . . . 0.0 111.107 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.93 152.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.809 0.337 . . . . 0.0 110.469 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 236' ' ' ASP . 31.7 mtm180 -102.97 146.15 28.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.9 mt -97.33 131.45 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.454 HG11 ' HG2' ' A' ' 246' ' ' PRO . 12.8 p -104.38 -27.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.099 0.476 . . . . 0.0 111.004 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 204' ' ' GLY . 18.4 tt0 -150.65 138.09 19.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.396 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.548 HG11 HG13 ' A' ' 219' ' ' ILE . 90.3 t -123.18 118.75 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.134 175.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 226' ' ' THR . 71.5 m-20 60.15 23.23 12.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 201' ' ' GLU . . . 90.34 8.45 66.24 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 80.9 t -104.04 130.51 54.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 27.0 t -76.53 123.64 26.38 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.505 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.751 ' SD ' HG12 ' A' ' 215' ' ' VAL . 2.2 tpp -97.54 1.89 49.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.156 0.503 . . . . 0.0 110.965 -172.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -76.39 100.16 5.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.435 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 106.69 -0.52 36.56 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.918 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 214' ' ' ASP . 13.2 mptt -88.88 153.92 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.461 0.304 . . . . 0.0 110.707 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 215' ' ' VAL . 38.9 mt-30 -105.6 -173.97 2.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.345 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 215' ' ' VAL . 10.7 t60 -55.15 -45.86 75.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.7 -33.4 85.94 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.414 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 40.2 m-20 -68.58 -43.9 75.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 111.225 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.862 HG21 ' HG3' ' A' ' 177' ' ' GLN . 4.6 m -64.12 -38.84 83.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.671 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.5 t -66.19 -35.65 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 109.919 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.1 m -65.34 -43.21 91.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.677 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.42 93.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.075 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.548 HG13 HG11 ' A' ' 202' ' ' VAL . 65.8 mt -70.78 -47.04 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -65.06 -32.21 73.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.9 -12.04 58.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.67 -21.4 72.07 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.655 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 91.09 -96.24 2.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 1.2 m-20 -109.05 -0.44 19.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.616 0.246 . . . . 0.0 110.798 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.854 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 45.4 mt-10 -139.72 161.88 36.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.041 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 9.6 t -153.75 140.13 18.66 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.797 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.559 ' HB3' HD21 ' A' ' 154' ' ' LEU . 65.4 mttm -103.87 113.67 27.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.928 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.22 117.92 34.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.813 0.34 . . . . 0.0 110.187 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 248' ' ' GLN . 7.0 mp -97.2 129.24 44.57 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.368 0.604 . . . . 0.0 111.203 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.8 m -130.91 153.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.65 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.2 m -127.4 131.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.829 0.347 . . . . 0.0 110.916 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.58 163.09 27.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.455 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -52.82 -42.31 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -63.08 -44.74 94.93 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.143 0.497 . . . . 0.0 110.548 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -66.58 -41.3 88.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.327 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 198' ' ' ARG . 14.9 t70 -56.99 -50.05 73.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.009 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.03 -42.06 97.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.636 ' HA ' ' HE3' ' A' ' 241' ' ' LYS . 42.4 t80 -63.95 -48.27 77.19 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.45 -40.28 81.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.306 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.4 -34.81 76.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.055 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' A' ' 238' ' ' PHE . 17.8 ptpt -72.87 -20.78 61.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.062 0.458 . . . . 0.0 110.581 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 57.5 m -97.73 -4.0 38.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.39 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 59.68 43.72 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.915 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.09 134.23 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 26.0 mt -78.33 122.14 84.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.054 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HG2' HG11 ' A' ' 200' ' ' VAL . 64.9 Cg_endo -75.38 66.37 6.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.835 2.357 . . . . 0.0 113.336 -176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.7 p -71.38 171.79 10.6 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.91 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 67.8 mt-30 -60.16 -27.45 67.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.707 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 254' ' ' PRO . 9.5 pt-20 -61.86 -29.46 70.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.511 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 254' ' ' PRO . 57.5 m80 -77.79 -40.29 41.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.378 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.663 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.5 pp -75.18 -30.84 60.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 0.0 110.63 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -86.25 -44.5 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.91 -108.51 2.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.617 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.536 ' O ' ' HA ' ' A' ' 250' ' ' HIS . 63.7 Cg_endo -88.74 158.93 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.228 2.618 . . . . 0.0 114.587 -173.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 151' ' ' ARG . 51.9 mt -118.39 163.94 22.84 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.751 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.37 177.86 1.9 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.492 2.128 . . . . 0.0 112.23 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.69 147.98 94.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.203 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.36 151.0 85.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.834 2.356 . . . . 0.0 111.69 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -87.45 10.89 16.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.857 -176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 261' ' ' ASN . 88.6 m -64.66 132.48 49.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 260' ' ' THR . 5.9 m120 76.63 -9.01 1.57 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.448 0.699 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -90.06 55.02 3.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.83 141.87 46.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.985 0.421 . . . . 0.0 110.718 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 69.1 mt -82.5 124.23 39.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.382 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -69.73 133.6 47.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.358 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -97.45 138.43 34.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.548 ' HG3' HD22 ' A' ' 268' ' ' ASN . 9.0 tp10 67.75 143.8 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.722 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 267' ' ' GLU . 32.3 m-80 61.72 40.81 12.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.412 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.7 m -80.85 58.38 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.652 . . . . 0.0 109.419 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.993 -174.419 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 79.1 m-20 -127.25 176.86 7.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.094 -174.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.569 HG22 ' HG ' ' B' ' 5' ' ' LEU . 54.3 m -133.25 119.86 20.36 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.032 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.724 ' H ' ' HD2' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -101.7 100.77 11.18 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.435 0.636 . . . . 0.0 109.692 177.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' B' ' 3' ' ' THR . 27.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.399 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.33 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 148' ' ' THR . 10.9 m-20 -117.08 152.89 49.42 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -171.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.25 -14.56 9.43 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.75 2.3 . . . . 0.0 113.216 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.13 33.6 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.361 0.601 . . . . 0.0 111.425 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 151' ' ' ARG . 10.2 t -137.89 39.38 2.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.727 1.251 . . . . 0.0 109.375 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.626 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 24.7 ptp -60.15 -33.64 72.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.926 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.626 ' HG ' ' HG3' ' A' ' 149' ' ' MET . 68.5 mt -113.59 26.63 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.562 0.696 . . . . 0.0 111.589 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.654 ' HG2' HD21 ' A' ' 255' ' ' LEU . 60.9 mtt85 -111.37 139.4 21.94 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.436 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 251' ' ' LEU . 19.2 Cg_exo -62.77 150.76 87.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.631 2.221 . . . . 0.0 111.847 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -84.21 131.05 34.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 227' ' ' LYS . 2.7 tm? -103.51 105.61 15.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.207 0.527 . . . . 0.0 109.91 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.17 123.93 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.827 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.0 m -118.03 115.34 24.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.956 0.408 . . . . 0.0 110.519 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.3 pmm? -124.04 145.61 49.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.917 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.912 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 11.3 ptmm? -113.53 154.95 26.24 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.801 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 224' ' ' ASP . 0.0 OUTLIER -79.71 122.14 26.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.63 0.728 . . . . 0.0 110.277 -178.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.29 -87.87 2.0 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.184 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.18 -65.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.452 2.102 . . . . 0.0 112.039 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.8 t -158.49 38.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 168.4 179.11 40.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.773 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.499 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 78.2 m-85 -99.07 -24.33 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.865 0.364 . . . . 0.0 110.67 -174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.63 15.91 7.25 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.917 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -131.11 148.99 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.792 0.796 . . . . 0.0 111.792 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.52 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.2 OUTLIER -107.51 124.05 49.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.195 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.52 ' N ' HD22 ' A' ' 167' ' ' ASN . 88.2 mt -94.26 142.1 27.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.738 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.469 ' HD2' ' OD1' ' B' ' 2' ' ' ASP . 11.1 t-160 -132.31 134.03 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.8 p -113.6 144.21 43.26 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -142.65 160.37 40.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.0 110.694 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -89.8 -17.19 28.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.609 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -100.98 -23.14 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.043 0.449 . . . . 0.0 110.149 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.04 122.23 56.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.764 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.01 142.48 12.4 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.796 2.331 . . . . 0.0 112.144 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.78 -160.17 32.33 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.892 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 215' ' ' VAL . 4.8 tp-100 -122.27 142.03 50.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 198' ' ' ARG . 7.8 p90 -138.72 148.58 44.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.215 0.531 . . . . 0.0 111.462 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 199' ' ' ILE . 37.2 mm -79.97 128.85 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.8 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HA ' ' HD2' ' A' ' 180' ' ' ARG . 19.4 tpt180 -87.3 -47.25 8.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.551 ' HA ' ' HB1' ' A' ' 195' ' ' ALA . 21.3 m -150.58 150.49 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.711 0.291 . . . . 0.0 111.019 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' GLU . 42.1 t -133.01 142.79 41.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.86 132.08 32.01 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 121.254 -0.178 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.39 -47.94 12.31 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.36 2.707 . . . . 0.0 113.472 -173.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -98.66 32.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.655 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.7 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 82.7 p -97.78 150.94 37.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 110.078 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 23.7 Cg_endo -62.07 -23.01 75.24 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.966 2.444 . . . . 0.0 112.011 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.89 63.11 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.067 0.46 . . . . 0.0 110.165 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 182' ' ' VAL . 11.0 tp10 -65.32 -38.55 90.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.921 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.12 75.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.192 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.1 p -81.78 -10.52 59.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.139 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.67 12.51 14.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.359 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 194' ' ' ARG . 7.9 tp -80.24 147.79 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.035 0.418 . . . . 0.0 110.245 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.605 ' HB2' ' OD2' ' A' ' 197' ' ' ASP . 25.8 mmt180 -123.14 171.42 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.911 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 181' ' ' SER . . . -99.93 22.22 11.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.12 8.24 2.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.299 . . . . 0.0 110.951 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 5.8 m-20 -99.15 158.41 15.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.629 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 236' ' ' ASP . 7.1 mtm180 -107.37 144.51 34.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.786 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.564 HD11 HD11 ' A' ' 179' ' ' ILE . 17.4 mt -99.25 129.99 48.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.75 -37.46 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.272 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.584 ' HB2' HD12 ' A' ' 229' ' ' LEU . 34.5 mt-10 -140.84 146.55 37.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.462 . . . . 0.0 110.875 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.591 HG11 ' CG1' ' A' ' 219' ' ' ILE . 55.5 t -128.59 114.89 35.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.523 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 58.87 28.26 17.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.051 0.453 . . . . 0.0 111.238 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.29 -12.55 68.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.107 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.16 126.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 208' ' ' GLU . 58.4 m -74.73 135.22 41.8 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.663 -174.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.513 ' HE3' ' HB ' ' A' ' 202' ' ' VAL . 32.0 mmt -82.2 17.21 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.888 -175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 206' ' ' CYS . 0.0 OUTLIER -91.81 31.54 1.21 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.613 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.92 -0.5 81.13 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.804 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 -59.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.574 1.149 . . . . 0.0 113.737 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -73.24 147.51 44.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.209 1.004 . . . . 0.0 111.7 -170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' B' ' 2' ' ' ASP . 13.1 t60 -59.81 -38.59 82.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.231 -172.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.01 -32.76 77.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.847 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.2 -43.14 87.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 177' ' ' GLN . 29.0 m -70.11 -39.82 77.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.687 0.279 . . . . 0.0 111.09 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.0 -36.66 76.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.086 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.8 t -57.75 -41.05 81.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.671 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.074 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.591 ' CG1' HG11 ' A' ' 202' ' ' VAL . 49.3 mt -71.03 -43.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -60.94 -34.96 75.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.278 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.29 -17.27 64.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.401 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.53 -17.46 76.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.646 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 82.23 -82.18 1.64 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.583 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.559 ' HA ' ' HD3' ' A' ' 159' ' ' LYS . 19.1 p-10 -122.56 -5.64 8.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.013 0.435 . . . . 0.0 110.792 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.912 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 52.1 mt-10 -140.15 161.79 36.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.71 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.437 HG23 ' SD ' ' A' ' 157' ' ' MET . 13.9 t -153.37 139.86 18.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.359 0.6 . . . . 0.0 111.539 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.516 ' HB3' HD21 ' A' ' 154' ' ' LEU . 93.7 mttt -105.75 116.67 32.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.1 mp -110.03 130.33 55.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 201' ' ' GLU . 31.8 mt -103.94 123.1 46.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.357 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.17 152.91 32.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 235' ' ' THR . 18.9 m -129.23 142.35 44.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.956 0.408 . . . . 0.0 111.492 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.36 163.4 27.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.781 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.456 ' HD3' ' H ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -53.99 -43.39 69.95 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.341 -178.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 233' ' ' ARG . 58.3 mp0 -63.12 -44.49 95.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.434 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 231' ' ' VAL . 3.3 m -64.44 -43.88 92.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.343 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 198' ' ' ARG . 20.8 t70 -59.74 -49.93 75.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.435 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 13.9 pt-20 -67.45 -34.1 76.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.645 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 42.8 t80 -63.66 -46.64 84.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.735 0.302 . . . . 0.0 111.233 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.408 ' HD1' HG13 ' A' ' 244' ' ' VAL . 52.1 m-85 -68.82 -46.0 69.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.934 0.397 . . . . 0.0 111.129 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 16.7 pttp -69.4 -27.71 65.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.976 -173.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 0.0 OUTLIER -65.77 -26.09 67.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.072 0.463 . . . . 0.0 110.323 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 244' ' ' VAL . 42.7 t -99.64 -0.78 39.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.83 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 53.49 30.49 10.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.481 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 242' ' ' CYS . 7.7 p -100.17 140.52 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.695 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 50.8 mm -72.89 123.87 90.08 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.896 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 6.6 Cg_exo -72.01 118.78 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.383 2.055 . . . . 0.0 110.149 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.0 p -141.6 170.26 16.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.421 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 44.3 mt-30 -63.19 -33.47 75.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.759 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.86 -26.2 68.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.938 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -81.32 -40.89 22.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 4.4 pp -74.9 -31.33 61.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.282 . . . . 0.0 111.419 -177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -101.68 6.97 42.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.494 0.664 . . . . 0.0 109.979 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.1 -156.92 6.98 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.55 149.06 20.98 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.063 2.508 . . . . 0.0 112.728 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.654 HD21 ' HG2' ' A' ' 151' ' ' ARG . 97.5 mt -97.09 165.58 15.51 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.621 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.77 166.14 7.09 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.287 1.991 . . . . 0.0 112.116 174.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 11.8 t -70.11 117.0 50.13 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.059 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.26 163.72 35.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.774 2.316 . . . . 0.0 112.129 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -86.18 35.35 0.64 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.434 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.7 m 57.52 53.9 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.525 0.678 . . . . 0.0 111.447 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -99.41 -28.44 13.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.675 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 71.48 -90.21 0.45 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.271 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -110.69 -179.74 3.84 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.784 0.434 . . . . 0.0 110.124 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 38.5 mt -114.99 63.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 267' ' ' GLU . 27.1 tp60 -84.08 112.74 20.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.887 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -85.17 88.32 7.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.822 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 265' ' ' GLN . 41.9 mt-10 -82.3 141.07 33.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.989 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 t30 63.28 99.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.927 0.767 . . . . 0.0 110.881 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -140.89 93.91 2.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.639 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.492 -179.885 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -81.73 -83.2 0.12 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.537 0.684 . . . . 0.0 110.647 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.411 ' H ' ' HB2' ' B' ' 2' ' ' ASP . 93.5 m -123.96 123.49 40.52 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.179 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -93.61 116.53 29.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.707 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 164' ' ' TYR . 84.1 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.114 -0.394 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.4 mt -77.34 94.46 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -57.03 113.23 5.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.643 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.7 -14.88 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.04 2.493 . . . . 0.0 110.978 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.8 14.18 32.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.981 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.1 t -81.79 -2.37 50.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 110.057 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -67.04 107.33 2.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.708 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 235' ' ' THR . 95.2 mt -96.33 -95.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.541 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 64.35 132.72 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.255 0.622 . . . . 0.0 111.463 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD3' ' CE2' ' A' ' 239' ' ' PHE . 30.7 Cg_endo -63.95 149.1 91.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.554 2.169 . . . . 0.0 112.229 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' A' ' 230' ' ' VAL . 39.8 ttt180 -93.54 134.87 35.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.466 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 229' ' ' LEU . 2.0 tm? -107.98 103.15 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 61.3 m -95.47 129.71 42.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.911 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.6 m -123.71 114.38 19.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.848 0.356 . . . . 0.0 110.517 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 226' ' ' THR . 1.1 pmm? -123.36 146.04 48.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.134 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 225' ' ' GLU . 16.2 ptmt -118.01 144.51 45.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.39 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.7 ptmm? -72.76 130.69 41.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.156 0.503 . . . . 0.0 110.212 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.71 -111.51 3.2 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.938 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.1 -55.05 2.13 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.683 2.255 . . . . 0.0 112.512 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.1 t -150.16 70.07 1.03 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.1 0.476 . . . . 0.0 110.648 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 111.75 -163.18 12.24 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.005 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 44.8 m-85 -103.11 -28.76 11.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.17 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.98 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 115.2 17.38 6.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.578 170.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -130.43 165.39 22.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.779 0.789 . . . . 0.0 110.874 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' B' ' 4' ' ' ARG . 2.6 t30 -127.37 125.07 40.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.24 131.98 40.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.566 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 12.1 t-160 -112.79 141.44 46.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.9 p -134.19 140.82 46.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.32 152.47 40.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.047 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -86.69 71.39 10.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.612 0.72 . . . . 0.0 109.216 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.2 m -151.47 -39.29 0.12 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.982 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -158.83 156.82 27.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.994 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.97 159.19 11.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.2 2.6 . . . . 0.0 111.352 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.85 90.94 1.67 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.098 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' A' ' 215' ' ' VAL . 25.5 mp0 -67.51 142.56 56.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.653 0.739 . . . . 0.0 111.953 -172.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.481 ' HB3' ' HD3' ' A' ' 198' ' ' ARG . 7.9 p90 -135.44 144.11 46.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.358 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 199' ' ' ILE . 23.5 mm -76.27 120.62 26.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.873 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 28.0 tpt180 -84.59 -47.32 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.683 -177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 m -147.27 150.27 34.49 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.999 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.34 135.39 58.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -79.92 136.78 54.17 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.55 -29.43 88.54 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.136 2.557 . . . . 0.0 111.725 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -103.87 68.01 0.9 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.489 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.98 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 74.5 p -145.11 146.78 31.98 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.204 0.526 . . . . 0.0 110.786 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 22.8 Cg_endo -61.94 -25.68 78.18 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.884 2.389 . . . . 0.0 111.69 171.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -64.35 -49.23 72.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -65.25 -37.01 85.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.917 -178.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.427 ' N ' ' HG3' ' A' ' 189' ' ' GLU . . . -66.43 -22.83 66.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.154 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -86.54 -0.65 56.53 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.244 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 98.51 7.42 55.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 179' ' ' ILE . 11.4 tp -83.12 136.68 34.37 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 189' ' ' GLU . 35.9 mmt180 -133.96 -171.4 2.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.916 0.388 . . . . 0.0 110.269 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -77.44 160.05 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.991 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 75.98 -11.37 1.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.065 0.546 . . . . 0.0 112.129 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -66.75 142.59 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.481 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 72.5 mmt-85 -102.85 148.19 25.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.677 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 179' ' ' ILE . 60.0 mt -109.4 125.56 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.926 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 m -104.51 -35.46 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.83 147.38 44.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 110.819 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.511 HG11 ' CG1' ' A' ' 219' ' ' ILE . 99.4 t -130.88 114.64 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.084 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 57.15 25.71 11.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.927 0.394 . . . . 0.0 111.936 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.33 0.16 65.51 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.968 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 t -96.64 138.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 35.4 t -92.42 134.32 35.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.735 ' SD ' HG12 ' A' ' 215' ' ' VAL . 17.2 mmt -99.24 33.07 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.886 0.374 . . . . 0.0 111.82 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -73.07 95.47 2.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.159 0.504 . . . . 0.0 111.0 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.13 29.05 69.23 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.714 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 207' ' ' MET . 71.1 mmtt -80.04 146.8 31.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.88 0.371 . . . . 0.0 110.773 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.11 -176.53 4.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.462 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -58.21 -49.88 75.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.285 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.2 77.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.953 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.86 -46.75 77.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.761 0.315 . . . . 0.0 111.357 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.735 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.6 m -67.1 -36.63 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.124 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.37 -40.01 85.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.065 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.6 t -63.19 -42.45 99.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.83 90.28 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.027 0.441 . . . . 0.0 111.413 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.511 ' CG1' HG11 ' A' ' 202' ' ' VAL . 72.8 mt -70.52 -47.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.401 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -66.44 -32.46 73.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.81 -17.47 64.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.303 . . . . 0.0 111.112 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -73.59 -15.16 79.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.67 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.25 -106.39 3.41 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.453 ' HA ' ' CD ' ' A' ' 159' ' ' LYS . 6.9 p-10 -113.84 8.67 17.41 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.57 0.7 . . . . 0.0 109.663 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 158' ' ' LYS . 43.5 mt-10 -135.07 147.82 49.69 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.478 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 157' ' ' MET . 11.3 t -142.21 135.41 28.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.496 0.665 . . . . 0.0 110.73 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -110.43 114.85 28.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.043 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.2 mt -108.54 126.73 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 109.863 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -96.46 117.98 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.8 m -121.85 151.59 25.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 110.849 -177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 152' ' ' PRO . 15.5 m -122.22 141.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.35 161.5 28.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 234' ' ' GLU . 23.3 ptt180 -54.69 -46.95 74.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.899 0.318 . . . . 0.0 111.773 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 233' ' ' ARG . 34.4 mt-10 -73.83 -31.64 63.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.538 ' HA ' HD13 ' A' ' 150' ' ' LEU . 34.1 m -66.57 -45.41 79.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.638 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t70 -57.67 -50.25 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.68 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.456 ' HA ' ' HZ3' ' A' ' 240' ' ' LYS . 48.3 mt-10 -58.86 -36.02 73.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.497 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 60.4 t80 -66.38 -46.7 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.411 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.508 ' CE2' ' HD3' ' A' ' 152' ' ' PRO . 53.8 m-85 -69.14 -36.77 77.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.326 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 27.8 mtmm -63.86 -44.26 93.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 13.8 ptmm? -69.45 -17.89 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 76.1 m -94.99 -1.69 51.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 243' ' ' ARG . 52.2 mtp180 60.81 39.42 17.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.288 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.79 139.49 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.973 0.416 . . . . 0.0 111.052 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.88 126.84 87.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.418 ' HB3' ' CG ' ' A' ' 239' ' ' PHE . 65.6 Cg_endo -75.71 54.44 3.98 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 113.366 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.1 m -59.53 156.21 13.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.68 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 68.0 mt-30 -51.72 -25.06 6.64 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.865 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.44 -26.79 68.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -81.47 -28.93 33.92 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.5 pp -73.16 -30.75 63.8 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.003 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -105.61 -39.19 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.278 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.35 -124.02 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.401 -175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.33 156.0 19.26 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.052 2.502 . . . . 0.0 113.642 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 255' ' ' LEU . 7.2 tp -128.22 141.48 41.46 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.665 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.42 150.29 57.86 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.497 2.131 . . . . 0.0 111.557 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.1 t 56.84 86.7 0.16 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.2 119.13 6.08 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.748 2.298 . . . . 0.0 111.524 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -84.01 3.09 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.111 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 2.9 m 67.95 166.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.452 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 58.7 t30 77.42 -23.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.587 0.755 . . . . 0.0 111.348 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.23 3.38 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.463 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.11 149.71 26.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.88 129.35 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.91 136.83 39.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -103.54 65.51 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.39 151.85 19.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.15 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -161.19 96.73 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.749 0.785 . . . . 0.0 110.726 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.7 p -63.97 -28.42 69.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.864 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.552 175.29 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.476 ' HB3' HD21 ' A' ' 167' ' ' ASN . 2.9 m-20 -137.61 178.47 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.085 0.469 . . . . 0.0 111.299 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m -154.08 124.61 7.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.721 174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -95.26 127.43 41.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.184 0.516 . . . . 0.0 110.312 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.886 -177.325 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.3 mt 68.29 99.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.48 0.657 . . . . 0.0 111.767 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -115.98 96.12 46.19 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.47 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.83 -51.95 0.44 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.028 2.485 . . . . 0.0 113.615 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.05 31.78 0.96 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.6 t -88.15 -24.58 23.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.804 0.811 . . . . 0.0 108.906 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 93.9 mmm -97.44 66.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 235' ' ' THR . 86.2 mt -78.11 -84.91 0.07 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' A' ' 255' ' ' LEU . 98.2 mtt180 63.32 152.76 0.11 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.439 0.637 . . . . 0.0 112.262 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.5 146.07 30.52 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.066 1.844 . . . . 0.0 111.939 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -87.95 130.7 34.86 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.413 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 58.7 tp -100.35 113.13 25.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.294 0.569 . . . . 0.0 110.775 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.9 m -105.04 122.13 45.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.294 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 227' ' ' LYS . 15.7 m -120.11 113.35 20.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 164' ' ' TYR . 20.4 ptp -134.69 153.06 52.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.426 -172.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 225' ' ' GLU . 20.7 pttp -133.5 156.13 48.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.909 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 53.9 mttm -55.98 127.84 32.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.857 -176.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -126.1 -82.65 0.46 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.542 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.08 -88.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.723 2.282 . . . . 0.0 112.77 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.7 t -107.3 9.57 29.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 109.569 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.483 ' HA3' ' OXT' ' B' ' 5' ' ' LEU . . . 153.7 -131.44 3.26 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.168 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 187' ' ' PRO . 36.2 m-85 -98.25 -28.61 13.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.124 0.487 . . . . 0.0 110.129 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 111.63 21.03 6.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.633 -0.794 . . . . 0.0 114.041 172.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 164' ' ' TYR . 55.7 p90 -130.47 151.94 50.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.666 0.733 . . . . 0.0 111.266 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 54.8 t30 -112.38 130.67 55.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.525 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.64 122.93 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.415 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 62.8 t-80 -102.65 143.17 32.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.5 m -133.63 140.36 47.04 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.519 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.68 174.12 6.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.037 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -50.86 -52.93 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.724 0.64 . . . . 0.0 110.483 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 t -143.33 72.29 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.404 0.621 . . . . 0.0 109.802 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -63.23 145.82 96.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.745 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.08 -15.5 18.41 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.202 2.601 . . . . 0.0 111.899 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -177.72 171.97 44.61 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.513 ' HG3' HG11 ' A' ' 215' ' ' VAL . 15.6 mm100 -89.77 138.38 31.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.322 0.561 . . . . 0.0 109.818 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.68 ' CE2' ' HB3' ' A' ' 169' ' ' HIS . 28.5 p90 -140.87 155.28 46.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.954 -172.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 199' ' ' ILE . 40.5 mm -85.28 116.07 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.439 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 23.8 tpt180 -76.24 -51.29 12.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.02 -175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -147.99 151.35 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.114 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.8 t -132.1 141.82 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 186' ' ' SER . 9.4 m-20 -84.49 130.7 52.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.519 ' HA ' ' OE2' ' A' ' 189' ' ' GLU . 67.1 Cg_exo -54.68 -22.54 29.23 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.693 2.929 . . . . 0.0 112.981 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -122.89 68.24 0.97 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.396 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.733 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 96.5 p -138.14 148.66 60.84 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.015 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.498 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 19.5 Cg_endo -61.15 -31.94 90.71 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.919 2.413 . . . . 0.0 112.09 174.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.54 -50.75 72.08 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.9 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 184' ' ' PRO . 27.1 tt0 -62.04 -45.56 93.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.454 0.645 . . . . 0.0 110.468 -177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.61 -22.39 65.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.602 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 95.5 p -85.08 -1.67 57.11 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.747 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.32 16.25 25.51 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.703 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 179' ' ' ILE . 3.1 tm? -92.59 120.44 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -117.44 175.9 5.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 0.0 110.588 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -81.87 154.31 25.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.871 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 73.53 -0.77 3.26 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.945 0.778 . . . . 0.0 112.096 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -74.03 143.2 45.62 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.4 ptp180 -102.73 147.62 26.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 179' ' ' ILE . 60.7 mt -104.85 127.79 59.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -174.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.31 -37.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.4 . . . . 0.0 110.554 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 229' ' ' LEU . 35.3 mt-10 -136.97 139.73 41.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.519 HG12 ' CE ' ' A' ' 207' ' ' MET . 14.9 p -133.65 120.09 36.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.558 170.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 226' ' ' THR . 3.3 t-20 62.63 34.17 15.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.714 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.09 -5.91 75.78 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.0 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.36 145.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 7.1 p -90.22 134.34 34.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.871 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.693 ' SD ' HG12 ' A' ' 215' ' ' VAL . 33.5 mmt -99.74 33.87 2.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.136 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.69 91.38 0.81 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.4 26.09 72.75 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.161 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.769 ' HA ' ' HE2' ' A' ' 210' ' ' LYS . 0.2 OUTLIER -78.06 152.88 32.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.166 0.508 . . . . 0.0 112.026 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.79 -172.74 2.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.827 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 215' ' ' VAL . 31.3 t60 -59.26 -49.85 76.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.03 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.93 90.49 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.894 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 210' ' ' LYS . 6.7 m-20 -61.64 -47.33 85.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.769 0.319 . . . . 0.0 111.41 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.693 HG12 ' SD ' ' A' ' 207' ' ' MET . 21.4 m -69.26 -37.27 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.97 -38.27 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.013 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 40.0 t -59.66 -47.73 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.35 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.32 91.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.271 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.451 HG21 HD13 ' B' ' 5' ' ' LEU . 84.3 mt -71.58 -47.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.583 -174.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -69.9 -33.95 72.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.07 62.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.778 0.323 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.25 -21.54 78.51 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.387 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.08 -101.82 0.85 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.385 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -133.92 10.09 3.9 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 5.9 tt0 -138.38 153.65 48.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.356 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.454 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 10.8 t -149.98 144.17 25.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 111.355 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 156' ' ' THR . 59.3 mttp -114.98 116.54 28.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.927 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.91 124.83 52.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.751 0.31 . . . . 0.0 111.145 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 201' ' ' GLU . 16.9 mt -98.42 119.87 37.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.711 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 24.6 m -122.91 147.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.87 147.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 163.15 21.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.34 82.66 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.34 0.518 . . . . 0.0 111.491 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.9 -37.89 82.28 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.986 0.422 . . . . 0.0 110.045 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.57 ' HA ' HD13 ' A' ' 150' ' ' LEU . 20.3 m -63.09 -47.94 80.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.856 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.46 -49.42 76.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.265 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 240' ' ' LYS . 32.3 mt-10 -64.42 -34.4 78.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.092 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.706 ' O ' ' HG2' ' A' ' 241' ' ' LYS . 52.4 t80 -62.1 -46.61 88.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.964 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 235' ' ' THR . 79.0 m-85 -70.72 -37.17 73.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.549 ' HG2' ' HA ' ' A' ' 237' ' ' GLU . 15.0 ptmt -67.95 -25.89 65.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 238' ' ' PHE . 20.4 pttp -61.99 -22.48 65.71 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.815 0.34 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 256' ' ' PRO . 64.8 m -111.86 -2.5 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.617 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.802 ' HE ' ' HA ' ' A' ' 243' ' ' ARG . 0.5 OUTLIER 55.72 29.45 13.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.228 -178.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.2 p -86.98 -12.31 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.629 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 48.1 mt 64.01 127.18 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.953 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 245' ' ' ILE . 3.6 Cg_exo -78.46 61.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.383 2.055 . . . . 0.0 112.358 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 249' ' ' GLU . 3.1 m -71.26 174.11 6.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.706 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 60.7 mt-30 -55.92 -27.03 50.39 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 0.0 111.576 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 247' ' ' SER . 10.8 pt-20 -62.76 -26.75 68.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.689 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 254' ' ' PRO . 36.8 m80 -89.66 -20.75 23.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.2 pp -74.96 -30.38 61.19 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.684 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.9 -7.96 20.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.138 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -117.52 -156.18 10.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.057 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.41 ' O ' ' HD2' ' A' ' 250' ' ' HIS . 86.5 Cg_endo -81.53 160.44 19.5 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.196 2.597 . . . . 0.0 113.353 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.671 HD11 ' HG2' ' A' ' 151' ' ' ARG . 11.1 mp -113.62 147.9 38.59 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.297 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.468 ' HB2' ' SG ' ' A' ' 242' ' ' CYS . 58.6 Cg_endo -70.48 122.13 8.63 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.707 2.272 . . . . 0.0 112.872 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 18.9 m -54.37 144.07 43.45 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.533 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 6.0 Cg_exo -79.43 106.13 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.964 2.443 . . . . 0.0 111.651 173.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -98.31 23.58 8.22 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.397 0.618 . . . . 0.0 110.226 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.9 m -86.33 72.52 10.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.712 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -75.53 -30.51 59.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.418 0.628 . . . . 0.0 110.304 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -100.29 66.95 0.54 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.481 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.71 137.92 53.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 52.3 mt -87.48 87.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.122 0.486 . . . . 0.0 109.843 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -95.44 151.5 19.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.128 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -107.09 98.73 8.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.101 0.477 . . . . 0.0 110.086 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 129.45 38.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.824 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 62.61 54.55 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.647 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 63.2 m -150.26 110.11 4.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.127 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.205 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 169' ' ' HIS . 85.6 m-20 62.11 -168.3 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -148.99 117.66 6.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.029 0.442 . . . . 0.0 110.652 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -97.15 114.29 25.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.742 177.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.483 ' OXT' ' HA3' ' A' ' 163' ' ' GLY . 80.5 mt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.36 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.0 146.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -112.75 98.81 46.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.754 0.312 . . . . 0.0 110.396 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.49 -15.15 37.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.377 2.051 . . . . 0.0 112.015 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.13 20.32 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 149' ' ' MET . 14.8 t -79.25 -18.38 52.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.452 0.644 . . . . 0.0 109.485 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.546 ' HG3' HG23 ' A' ' 148' ' ' THR . 51.8 mtt -116.56 119.12 34.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.351 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 235' ' ' THR . 3.6 mm? -83.85 69.78 10.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.486 0.66 . . . . 0.0 109.772 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.632 ' HG2' HD21 ' A' ' 255' ' ' LEU . 70.7 mtt-85 -99.35 138.97 20.6 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.656 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB2' HD21 ' A' ' 229' ' ' LEU . 6.1 Cg_exo -69.45 149.27 68.63 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.384 2.056 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -99.34 137.72 37.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.795 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 154' ' ' LEU . 14.3 mt -99.98 128.0 46.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 111.138 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 67.1 m -113.0 108.29 17.14 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.6 m -112.6 118.56 35.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.912 0.387 . . . . 0.0 111.171 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -130.97 151.59 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.051 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.686 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 22.9 mttp -109.67 156.2 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 13.2 ptmm? -78.94 122.79 26.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.377 0.608 . . . . 0.0 110.355 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.21 -95.84 1.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.967 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.33 -69.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.414 2.076 . . . . 0.0 111.892 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 t -149.11 38.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' LYS . . . 178.33 -179.97 48.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.717 -173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' B' ' 5' ' ' LEU . 42.4 m-85 -108.58 -19.15 13.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.964 0.411 . . . . 0.0 110.711 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 118.72 7.6 10.52 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.398 171.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.86 178.95 6.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.012 0.906 . . . . 0.0 111.072 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 33.0 t30 -141.1 129.78 22.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.749 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 98.9 mt -100.09 120.69 40.24 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 36.6 t-80 -111.73 143.06 43.26 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.2 m -122.42 159.6 27.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.612 0.244 . . . . 0.0 110.371 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 174' ' ' LYS . 12.9 t70 -140.98 165.61 27.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -51.74 -56.87 11.25 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.606 0.566 . . . . 0.0 111.536 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -101.09 34.02 2.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.463 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.519 ' CG ' ' HB3' ' A' ' 171' ' ' ASP . 70.3 mmtt -112.86 100.0 49.78 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.655 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.36 -0.87 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.415 . . . . 0.0 111.869 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.54 ' HA2' ' HE2' ' A' ' 210' ' ' LYS . . . -123.81 143.46 14.93 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.691 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG3' HG11 ' A' ' 215' ' ' VAL . 85.4 mm-40 -87.79 142.42 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 0.0 110.108 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -137.47 143.95 42.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.2 mm -71.46 120.81 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.945 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 27.2 tpt180 -82.58 -39.47 22.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.9 t -161.9 151.64 16.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.162 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.3 t -125.71 143.04 40.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.943 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 15.0 t70 -89.05 131.04 42.28 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.13 -26.49 7.99 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.998 3.132 . . . . 0.0 113.675 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -122.25 77.05 1.36 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.468 0.652 . . . . 0.0 109.884 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.665 ' HB2' ' HA3' ' A' ' 165' ' ' GLY . 94.8 p -147.74 155.13 44.82 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.698 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 33.5 Cg_endo -65.4 -23.8 58.0 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.165 1.91 . . . . 0.0 111.673 174.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.98 86.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.538 0.685 . . . . 0.0 109.705 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -66.19 -38.55 88.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.431 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.71 68.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.952 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.2 p -81.23 -18.97 44.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.84 35.67 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.815 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 12.9 tp -91.01 146.04 24.19 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HA ' ' HD3' ' A' ' 194' ' ' ARG . 14.6 mmt180 -129.39 171.96 11.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -87.89 154.98 20.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.89 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 75.05 2.24 3.93 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.688 0.795 . . . . 0.0 110.852 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 194' ' ' ARG . 2.7 m-20 -74.38 148.0 41.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.467 172.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -106.38 144.54 32.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.194 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -100.04 117.23 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.571 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.859 ' HB ' HD12 ' A' ' 229' ' ' LEU . 86.1 t -90.3 -41.2 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.586 . . . . 0.0 110.14 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 206' ' ' CYS . 52.6 mt-10 -147.41 140.65 25.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.977 176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.531 HG12 ' HE3' ' A' ' 207' ' ' MET . 7.4 p -131.14 124.19 55.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.794 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 219' ' ' ILE . 84.3 m-20 61.26 31.33 19.42 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.17 -3.65 86.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.236 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.78 134.84 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.656 ' HA ' ' HG2' ' A' ' 201' ' ' GLU . 61.9 m -84.63 131.12 34.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.806 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.734 ' SD ' HG12 ' A' ' 215' ' ' VAL . 27.0 mmt -98.76 68.6 1.78 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.22 0.534 . . . . 0.0 110.125 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.1 -76.77 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.757 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.24 42.63 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.54 ' HE2' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -59.18 140.6 55.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.972 0.891 . . . . 0.0 112.334 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 214' ' ' ASP . 25.0 mt-30 -119.76 173.44 7.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.495 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 216' ' ' VAL . 16.1 t60 -61.13 -46.76 89.24 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.174 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.39 -31.29 71.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.616 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 211' ' ' GLN . 13.5 t70 -68.12 -46.3 71.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.642 0.258 . . . . 0.0 110.745 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.734 HG12 ' SD ' ' A' ' 207' ' ' MET . 22.3 m -66.41 -36.69 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 212' ' ' HIS . 96.6 t -66.82 -42.89 89.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.028 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.8 m -60.1 -42.11 93.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.15 88.59 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.927 0.394 . . . . 0.0 111.056 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.561 ' HA ' ' ND2' ' A' ' 203' ' ' ASN . 70.8 mt -71.38 -46.31 65.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.906 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.85 -33.43 71.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.249 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.27 -18.97 65.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.419 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.38 -19.51 71.48 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.813 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 74.99 -87.19 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.911 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -100.72 -18.86 16.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 0.0 110.872 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.686 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 42.8 mt-10 -129.25 147.74 51.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.159 0.504 . . . . 0.0 111.193 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.5 ' HB ' HG23 ' A' ' 219' ' ' ILE . 9.3 t -138.99 131.96 29.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.012 173.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 43.6 mttp -107.39 114.82 29.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.368 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.06 126.77 52.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.078 0.466 . . . . 0.0 110.462 -175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.859 HD12 ' HB ' ' A' ' 200' ' ' VAL . 2.9 tm? -97.54 118.21 33.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.112 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.92 152.85 33.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.302 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 152' ' ' PRO . 18.1 m -130.34 133.55 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.462 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.05 157.75 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.149 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 ppt_? -52.2 -40.98 62.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 233' ' ' ARG . 16.8 pt-20 -72.48 -31.71 65.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.113 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.51 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.1 m -68.3 -45.54 72.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 110.093 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.42 -42.83 78.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.406 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 240' ' ' LYS . 41.5 mt-10 -61.67 -33.52 74.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.196 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -70.7 -46.36 63.25 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.17 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 246' ' ' PRO . 55.9 m-85 -66.21 -35.95 81.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.647 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 237' ' ' GLU . 18.0 ptmt -63.64 -26.67 68.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 237' ' ' GLU . 62.5 mttp -63.01 -32.11 73.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.442 ' HB2' HG12 ' A' ' 244' ' ' VAL . 59.3 m -102.18 3.0 37.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.636 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 57.61 35.62 25.91 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.08 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 242' ' ' CYS . 8.7 p -117.66 142.4 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.231 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.69 128.23 87.27 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 239' ' ' PHE . 37.0 Cg_endo -69.25 59.57 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.949 2.433 . . . . 0.0 112.746 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 p -70.12 159.55 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.573 0.701 . . . . 0.0 111.842 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 8.7 tt0 -59.36 -24.07 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.2 -1.364 . . . . 0.0 112.162 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.8 -27.49 69.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -77.46 -28.23 52.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.123 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 4.6 pp -74.13 -35.09 64.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.552 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 251' ' ' LEU . 6.9 t30 -90.87 -39.13 12.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.36 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.8 -129.73 6.62 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.703 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -91.24 156.12 3.77 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.183 2.589 . . . . 0.0 113.662 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.632 HD21 ' HG2' ' A' ' 151' ' ' ARG . 65.3 mt -105.67 169.2 7.27 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.521 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 255' ' ' LEU . 50.2 Cg_exo -54.46 123.5 13.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.046 1.831 . . . . 0.0 112.073 175.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.37 131.06 33.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.294 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.81 106.93 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.599 2.199 . . . . 0.0 111.747 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.28 41.17 0.87 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.408 0.623 . . . . 0.0 111.527 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.7 m -116.89 62.85 0.72 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.648 0.737 . . . . 0.0 109.51 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.45 -16.22 17.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.218 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -72.52 74.04 0.92 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.683 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.08 144.45 55.25 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.742 0.417 . . . . 0.0 110.938 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.9 mt -85.21 67.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.692 0.758 . . . . 0.0 109.956 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -118.65 111.15 18.17 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -68.33 126.45 29.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.698 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.71 159.13 42.85 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.502 ' H ' HD22 ' A' ' 268' ' ' ASN . 0.1 OUTLIER -140.02 170.25 16.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.618 0.247 . . . . 0.0 111.034 -175.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.5 t 63.32 79.86 0.25 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.071 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.249 176.919 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -111.0 -176.49 2.97 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 46.8 m -152.03 117.74 5.41 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.638 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 29.1 ptt-85 -101.12 124.81 47.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.438 0.637 . . . . 0.0 110.111 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' TYR . 73.6 mt . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.045 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 39.9 pt -116.25 172.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.271 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 148' ' ' THR . 1.6 m-20 -100.97 99.78 11.33 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.727 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 144' ' ' ILE . 18.0 Cg_exo -65.46 -22.55 59.02 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.425 2.084 . . . . 0.0 110.614 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -110.69 35.13 3.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.596 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 145' ' ' ASP . 11.9 t -69.74 -27.27 64.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 110.055 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 56.8 mtm -103.18 92.49 4.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 235' ' ' THR . 3.0 mm? -75.0 79.39 2.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.486 0.66 . . . . 0.0 110.348 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -114.7 118.63 40.81 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.841 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 231' ' ' VAL . 10.5 Cg_endo -54.62 142.68 71.52 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.221 2.614 . . . . 0.0 112.629 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.568 ' HA ' ' NE ' ' A' ' 153' ' ' ARG . 0.5 OUTLIER -86.49 131.54 34.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.235 -178.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 227' ' ' LYS . 65.7 tp -99.65 111.13 23.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 48.5 m -106.88 116.06 31.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.338 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.3 m -116.14 113.5 23.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 110.233 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.562 ' CG ' ' HB3' ' A' ' 164' ' ' TYR . 1.1 pmm? -122.3 148.62 44.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.53 ' HG2' ' HG2' ' A' ' 225' ' ' GLU . 33.4 mtmt -117.74 155.06 30.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.472 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.557 ' HD2' ' HA ' ' A' ' 224' ' ' ASP . 92.0 mttt -64.58 113.18 3.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.264 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 161' ' ' PRO . . . -103.74 -98.16 2.47 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.789 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 160' ' ' GLY . 24.7 Cg_exo -64.02 -68.55 0.04 OUTLIER 'Trans proline' 0 CA--C 1.527 0.161 0 C-N-CA 122.848 2.366 . . . . 0.0 112.526 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.2 t -130.3 6.97 4.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.937 0.398 . . . . 0.0 110.441 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' B' ' 5' ' ' LEU . . . 167.75 -147.5 11.72 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.541 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.562 ' HB3' ' CG ' ' A' ' 157' ' ' MET . 68.3 m-85 -96.73 -25.65 15.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.002 0.429 . . . . 0.0 110.902 -173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 186' ' ' SER . . . 107.25 17.44 11.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.353 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.38 159.33 37.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.87 0.835 . . . . 0.0 110.69 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 4' ' ' ARG . 0.2 OUTLIER -122.52 126.02 46.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 167' ' ' ASN . 92.8 mt -95.45 124.85 39.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 180' ' ' ARG . 51.0 t-80 -109.11 138.98 44.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 t -140.84 142.02 34.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -111.44 167.56 10.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.874 ' HA ' ' HE2' ' A' ' 172' ' ' LYS . 9.1 mmpt? -66.65 -29.29 69.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.193 0.521 . . . . 0.0 110.035 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.9 m -91.1 -8.19 49.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.215 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -122.32 87.05 48.26 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.942 -176.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -22.01 10.53 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.187 2.591 . . . . 0.0 112.163 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA3' HH21 ' A' ' 198' ' ' ARG . . . -76.55 117.1 4.86 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.61 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.626 ' HG3' HG21 ' A' ' 215' ' ' VAL . 59.1 mm-40 -67.81 140.54 56.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 111.453 -172.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.449 ' HB3' ' HG2' ' A' ' 198' ' ' ARG . 26.2 p90 -139.47 146.34 39.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.94 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.566 ' HB ' ' HA ' ' A' ' 195' ' ' ALA . 31.1 mm -72.76 117.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.1 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 169' ' ' HIS . 52.4 ttt180 -73.04 -52.1 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.502 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.8 m -155.74 151.48 27.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.114 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 189' ' ' GLU . 38.7 t -121.13 139.83 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 186' ' ' SER . 12.5 t70 -80.42 131.69 61.03 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -174.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 183' ' ' ASP . 5.2 Cg_endo -48.51 -31.03 17.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.993 3.128 . . . . 0.0 112.868 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -121.25 77.2 1.3 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 109.913 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.728 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 87.8 p -142.39 150.21 53.99 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 164' ' ' TYR . 18.6 Cg_endo -60.32 -29.22 88.4 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.743 2.296 . . . . 0.0 111.639 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 157' ' ' MET . . . -62.74 -48.65 78.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.173 174.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 182' ' ' VAL . 10.8 tp10 -62.34 -40.79 97.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.2 75.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.823 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.2 p -81.7 -4.23 55.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.315 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.24 29.83 21.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.801 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.2 tp -80.53 142.48 34.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -127.92 148.26 50.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.0 110.874 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 179' ' ' ILE . . . -77.16 156.15 31.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 74.61 -3.53 2.55 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.165 0.916 . . . . 0.0 111.895 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -87.51 152.96 21.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.573 HH21 ' HA3' ' A' ' 176' ' ' GLY . 80.2 mtp180 -113.91 144.42 43.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.449 0.642 . . . . 0.0 111.402 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 229' ' ' LEU . 55.0 mt -91.02 134.82 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.114 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.09 -36.36 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.274 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.564 ' HB2' HD12 ' A' ' 229' ' ' LEU . 48.6 mt-10 -138.86 141.12 38.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 219' ' ' ILE . 15.0 p -134.73 126.77 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.445 172.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 219' ' ' ILE . 44.5 m-20 58.2 31.91 21.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.834 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.52 22.07 76.4 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.463 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.49 146.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.08 123.81 22.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.683 ' SD ' HG12 ' A' ' 215' ' ' VAL . 8.8 tpp -127.43 5.7 6.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.866 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.15 81.37 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.291 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.89 24.67 8.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.269 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 214' ' ' ASP . 31.2 mmtp -86.68 154.11 21.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.491 . . . . 0.0 111.234 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.8 175.9 7.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.444 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.561 ' O ' HG22 ' A' ' 215' ' ' VAL . 24.8 t60 -58.69 -42.6 88.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.741 0.305 . . . . 0.0 111.694 -174.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.04 -38.81 96.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.392 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 210' ' ' LYS . 3.5 t70 -67.18 -43.48 82.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.616 0.246 . . . . 0.0 110.809 -177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.683 HG12 ' SD ' ' A' ' 207' ' ' MET . 7.3 m -65.16 -39.89 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.727 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.2 -40.03 84.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.913 0.387 . . . . 0.0 110.225 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 49.5 m -60.79 -42.04 96.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.486 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.28 96.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.172 0.511 . . . . 0.0 110.843 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.571 HG21 HD13 ' B' ' 5' ' ' LEU . 68.1 mt -70.57 -47.62 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.848 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -70.29 -33.15 71.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.11 69.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.607 0.241 . . . . 0.0 111.38 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.4 -35.2 78.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.222 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.94 -104.89 1.18 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.269 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.557 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 4.9 m-20 -111.21 10.42 21.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.212 0.53 . . . . 0.0 109.854 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 158' ' ' LYS . 94.8 mt-10 -141.1 162.98 34.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.968 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.516 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 10.4 t -155.0 136.59 14.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.453 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB3' HD11 ' A' ' 154' ' ' LEU . 56.9 mttp -104.64 114.78 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.677 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.427 HD13 ' SD ' ' A' ' 157' ' ' MET . 11.2 mp -109.32 127.05 54.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 110.804 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 201' ' ' GLU . 20.5 mt -104.69 119.37 38.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.715 174.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.17 147.57 20.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.241 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 152' ' ' PRO . 29.2 m -129.75 140.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.322 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.09 165.19 18.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 233' ' ' ARG . 10.1 mtm105 -52.53 -47.16 66.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.6 0.714 . . . . 0.0 109.416 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.35 -35.36 73.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.435 -177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.502 ' HA ' ' HB3' ' A' ' 150' ' ' LEU . 16.9 m -76.61 -47.97 20.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 240' ' ' LYS . 17.3 t70 -62.85 -47.45 83.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.062 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.72 -32.97 73.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.465 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 150' ' ' LEU . 65.1 t80 -63.63 -41.57 98.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.764 0.316 . . . . 0.0 111.156 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 244' ' ' VAL . 14.5 m-85 -65.23 -33.99 77.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.781 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 236' ' ' ASP . 52.0 mttm -58.77 -35.54 72.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.6 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 241' ' ' LYS . 41.5 mtpt -62.88 -27.97 69.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.714 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.2 m -96.8 -1.18 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 57.39 39.39 28.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.787 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 239' ' ' PHE . 11.7 p -144.76 151.93 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.138 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.11 133.6 29.99 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.742 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.09 133.24 37.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 111.599 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.9 p -151.65 170.7 19.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.277 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 251' ' ' LEU . 78.1 mt-30 -55.4 -36.86 66.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.21 0.528 . . . . 0.0 111.371 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -62.75 -28.96 70.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -80.27 -36.98 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.236 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 248' ' ' GLN . 3.4 pp -75.22 -32.1 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.631 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.6 -51.34 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.912 0.387 . . . . 0.0 110.198 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.99 -133.59 7.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.906 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -92.52 157.14 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.027 2.485 . . . . 0.0 113.613 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.59 150.74 43.08 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.59 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.22 158.48 39.59 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.72 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 258' ' ' PRO . 4.4 m -96.17 121.11 61.4 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.99 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 257' ' ' VAL . 14.5 Cg_exo -68.17 128.28 17.29 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.803 2.335 . . . . 0.0 111.579 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -92.12 50.67 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.208 0.528 . . . . 0.0 109.962 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 261' ' ' ASN . 10.7 m 57.42 -96.03 0.06 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.348 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 260' ' ' THR . 5.7 t-20 70.04 -43.49 0.54 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.063 0.545 . . . . 0.0 110.86 -174.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 260' ' ' THR . . . 157.17 -154.07 25.22 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.57 173.04 12.75 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.61 97.48 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.24 111.53 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.95 0.781 . . . . 0.0 111.039 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -121.61 50.11 1.45 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.92 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.51 80.28 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.699 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -103.2 21.69 15.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 48.2 t -91.27 108.82 20.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.298 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.958 176.575 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.46 164.02 28.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.342 0.591 . . . . 0.0 111.805 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -154.74 119.07 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.315 171.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 167' ' ' ASN . 32.5 ptt180 -99.9 131.69 45.72 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.06 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.663 ' O ' ' HA3' ' A' ' 163' ' ' GLY . 95.9 mt . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.989 -174.92 . . . . . . . . 1 1 . 1 stop_ save_